false
--01-31
Q3
2024
0001008586
141000
900000
0001008586
2023-02-01
2023-10-31
0001008586
2023-12-11
0001008586
2023-10-31
0001008586
2023-01-31
0001008586
2023-08-01
2023-10-31
0001008586
2022-08-01
2022-10-31
0001008586
2022-02-01
2022-10-31
0001008586
STRM:SoftwareAsAServiceMember
2023-08-01
2023-10-31
0001008586
STRM:SoftwareAsAServiceMember
2022-08-01
2022-10-31
0001008586
STRM:SoftwareAsAServiceMember
2023-02-01
2023-10-31
0001008586
STRM:SoftwareAsAServiceMember
2022-02-01
2022-10-31
0001008586
STRM:MaintenanceAndSupportMember
2023-08-01
2023-10-31
0001008586
STRM:MaintenanceAndSupportMember
2022-08-01
2022-10-31
0001008586
STRM:MaintenanceAndSupportMember
2023-02-01
2023-10-31
0001008586
STRM:MaintenanceAndSupportMember
2022-02-01
2022-10-31
0001008586
STRM:ProfessionalFeesAndLicensesMember
2023-08-01
2023-10-31
0001008586
STRM:ProfessionalFeesAndLicensesMember
2022-08-01
2022-10-31
0001008586
STRM:ProfessionalFeesAndLicensesMember
2023-02-01
2023-10-31
0001008586
STRM:ProfessionalFeesAndLicensesMember
2022-02-01
2022-10-31
0001008586
us-gaap:CommonStockMember
2023-01-31
0001008586
us-gaap:AdditionalPaidInCapitalMember
2023-01-31
0001008586
us-gaap:RetainedEarningsMember
2023-01-31
0001008586
us-gaap:CommonStockMember
2023-04-30
0001008586
us-gaap:AdditionalPaidInCapitalMember
2023-04-30
0001008586
us-gaap:RetainedEarningsMember
2023-04-30
0001008586
2023-04-30
0001008586
us-gaap:CommonStockMember
2023-07-31
0001008586
us-gaap:AdditionalPaidInCapitalMember
2023-07-31
0001008586
us-gaap:RetainedEarningsMember
2023-07-31
0001008586
2023-07-31
0001008586
us-gaap:CommonStockMember
2022-01-31
0001008586
us-gaap:AdditionalPaidInCapitalMember
2022-01-31
0001008586
us-gaap:RetainedEarningsMember
2022-01-31
0001008586
2022-01-31
0001008586
us-gaap:CommonStockMember
2022-04-30
0001008586
us-gaap:AdditionalPaidInCapitalMember
2022-04-30
0001008586
us-gaap:RetainedEarningsMember
2022-04-30
0001008586
2022-04-30
0001008586
us-gaap:CommonStockMember
2022-07-31
0001008586
us-gaap:AdditionalPaidInCapitalMember
2022-07-31
0001008586
us-gaap:RetainedEarningsMember
2022-07-31
0001008586
2022-07-31
0001008586
us-gaap:CommonStockMember
2023-02-01
2023-04-30
0001008586
us-gaap:AdditionalPaidInCapitalMember
2023-02-01
2023-04-30
0001008586
us-gaap:RetainedEarningsMember
2023-02-01
2023-04-30
0001008586
2023-02-01
2023-04-30
0001008586
us-gaap:CommonStockMember
2023-05-01
2023-07-31
0001008586
us-gaap:AdditionalPaidInCapitalMember
2023-05-01
2023-07-31
0001008586
us-gaap:RetainedEarningsMember
2023-05-01
2023-07-31
0001008586
2023-05-01
2023-07-31
0001008586
us-gaap:CommonStockMember
2023-08-01
2023-10-31
0001008586
us-gaap:AdditionalPaidInCapitalMember
2023-08-01
2023-10-31
0001008586
us-gaap:RetainedEarningsMember
2023-08-01
2023-10-31
0001008586
us-gaap:CommonStockMember
2022-02-01
2022-04-30
0001008586
us-gaap:AdditionalPaidInCapitalMember
2022-02-01
2022-04-30
0001008586
us-gaap:RetainedEarningsMember
2022-02-01
2022-04-30
0001008586
2022-02-01
2022-04-30
0001008586
us-gaap:CommonStockMember
2022-05-01
2022-07-31
0001008586
us-gaap:AdditionalPaidInCapitalMember
2022-05-01
2022-07-31
0001008586
us-gaap:RetainedEarningsMember
2022-05-01
2022-07-31
0001008586
2022-05-01
2022-07-31
0001008586
us-gaap:CommonStockMember
2022-08-01
2022-10-31
0001008586
us-gaap:AdditionalPaidInCapitalMember
2022-08-01
2022-10-31
0001008586
us-gaap:RetainedEarningsMember
2022-08-01
2022-10-31
0001008586
us-gaap:CommonStockMember
2023-10-31
0001008586
us-gaap:AdditionalPaidInCapitalMember
2023-10-31
0001008586
us-gaap:RetainedEarningsMember
2023-10-31
0001008586
us-gaap:CommonStockMember
2022-10-31
0001008586
us-gaap:AdditionalPaidInCapitalMember
2022-10-31
0001008586
us-gaap:RetainedEarningsMember
2022-10-31
0001008586
2022-10-31
0001008586
STRM:SecondAmendedAndRestatedLoanAndSecurityAgreementMember
2023-02-01
2023-10-31
0001008586
STRM:SecondAmendedAndRestatedLoanAndSecurityAgreementMember
2023-10-31
0001008586
STRM:SecondAmendedAndRestatedLoanAndSecurityAgreementMember
us-gaap:PrimeRateMember
2023-10-31
0001008586
STRM:SecondAmendedAndRestatedLoanAndSecurityAgreementMember
us-gaap:PrimeRateMember
2023-02-01
2023-10-31
0001008586
STRM:SecondAmendedAndRestatedLoanAndSecurityAgreementMember
2023-01-31
0001008586
us-gaap:LineOfCreditMember
2023-10-31
0001008586
us-gaap:LineOfCreditMember
2023-01-31
0001008586
us-gaap:OtherNoncurrentAssetsMember
2023-10-31
0001008586
us-gaap:OtherNoncurrentAssetsMember
2023-01-31
0001008586
us-gaap:SellingGeneralAndAdministrativeExpensesMember
2023-08-01
2023-10-31
0001008586
us-gaap:SellingGeneralAndAdministrativeExpensesMember
2022-08-01
2022-10-31
0001008586
us-gaap:SellingGeneralAndAdministrativeExpensesMember
2023-02-01
2023-10-31
0001008586
us-gaap:SellingGeneralAndAdministrativeExpensesMember
2022-02-01
2022-10-31
0001008586
STRM:EquityAwardMember
us-gaap:ShareBasedPaymentArrangementNonemployeeMember
2023-08-01
2023-10-31
0001008586
STRM:EquityAwardMember
us-gaap:ShareBasedPaymentArrangementNonemployeeMember
2023-02-01
2023-10-31
0001008586
STRM:EmployeesMember
2023-08-01
2023-10-31
0001008586
STRM:EmployeesMember
2023-02-01
2023-10-31
0001008586
STRM:EmployeesMember
2022-08-01
2022-10-31
0001008586
STRM:EmployeesMember
2022-02-01
2022-10-31
0001008586
STRM:BoardOfDirectorsMember
us-gaap:CommonStockMember
2023-08-01
2023-10-31
0001008586
STRM:BoardOfDirectorsMember
us-gaap:CommonStockMember
2023-02-01
2023-10-31
0001008586
STRM:BoardOfDirectorsMember
us-gaap:CommonStockMember
2022-08-01
2022-10-31
0001008586
STRM:BoardOfDirectorsMember
us-gaap:CommonStockMember
2022-02-01
2022-10-31
0001008586
STRM:ConsultantsMember
2023-08-01
2023-10-31
0001008586
STRM:ConsultantsMember
2023-02-01
2023-10-31
0001008586
STRM:ConsultantsMember
2022-08-01
2022-10-31
0001008586
STRM:ConsultantsMember
2022-02-01
2022-10-31
0001008586
2023-10-16
0001008586
2023-10-16
2023-10-16
0001008586
2023-02-01
0001008586
us-gaap:FairValueInputsLevel1Member
2023-01-31
0001008586
us-gaap:FairValueInputsLevel2Member
2023-01-31
0001008586
us-gaap:FairValueInputsLevel3Member
2023-01-31
0001008586
us-gaap:FairValueInputsLevel1Member
2023-10-31
0001008586
us-gaap:FairValueInputsLevel2Member
2023-10-31
0001008586
us-gaap:FairValueInputsLevel3Member
2023-10-31
0001008586
us-gaap:TransferredOverTimeMember
2023-08-01
2023-10-31
0001008586
us-gaap:TransferredOverTimeMember
2022-08-01
2022-10-31
0001008586
us-gaap:TransferredOverTimeMember
2023-02-01
2023-10-31
0001008586
us-gaap:TransferredOverTimeMember
2022-02-01
2022-10-31
0001008586
us-gaap:TransferredAtPointInTimeMember
2023-08-01
2023-10-31
0001008586
us-gaap:TransferredAtPointInTimeMember
2022-08-01
2022-10-31
0001008586
us-gaap:TransferredAtPointInTimeMember
2023-02-01
2023-10-31
0001008586
us-gaap:TransferredAtPointInTimeMember
2022-02-01
2022-10-31
0001008586
STRM:UnvestedRestrictedStockMember
2023-02-01
2023-10-31
0001008586
STRM:UnvestedRestrictedStockMember
2022-02-01
2022-10-31
0001008586
us-gaap:EmployeeStockOptionMember
2023-08-01
2023-10-31
0001008586
us-gaap:EmployeeStockOptionMember
2023-02-01
2023-10-31
0001008586
STRM:UnvestedRestrictedSharesMember
2023-08-01
2023-10-31
0001008586
STRM:UnvestedRestrictedSharesMember
2023-02-01
2023-10-31
0001008586
us-gaap:EmployeeStockOptionMember
2022-08-01
2022-10-31
0001008586
us-gaap:EmployeeStockOptionMember
2022-02-01
2022-10-31
0001008586
STRM:UnvestedRestrictedSharesMember
2022-08-01
2022-10-31
0001008586
STRM:UnvestedRestrictedSharesMember
2022-02-01
2022-10-31
0001008586
us-gaap:CostOfSalesMember
2023-01-31
0001008586
us-gaap:CostOfSalesMember
2023-02-01
2023-10-31
0001008586
us-gaap:CostOfSalesMember
2023-10-31
0001008586
us-gaap:SellingGeneralAndAdministrativeExpensesMember
2023-01-31
0001008586
us-gaap:SellingGeneralAndAdministrativeExpensesMember
2023-10-31
0001008586
us-gaap:ResearchAndDevelopmentExpenseMember
2023-01-31
0001008586
us-gaap:ResearchAndDevelopmentExpenseMember
2023-02-01
2023-10-31
0001008586
us-gaap:ResearchAndDevelopmentExpenseMember
2023-10-31
0001008586
STRM:SeveranceExpensesMember
2023-01-31
0001008586
STRM:SeveranceExpensesMember
2023-02-01
2023-10-31
0001008586
STRM:SeveranceExpensesMember
2023-10-31
0001008586
STRM:ProfessionalFeesMember
2023-01-31
0001008586
STRM:ProfessionalFeesMember
2023-02-01
2023-10-31
0001008586
STRM:ProfessionalFeesMember
2023-10-31
0001008586
STRM:AccruedExpensesMember
2023-01-31
0001008586
STRM:AccruedExpensesMember
2023-02-01
2023-10-31
0001008586
STRM:AccruedExpensesMember
2023-10-31
0001008586
STRM:AveleadMember
2022-11-20
2022-11-21
0001008586
STRM:AveleadMember
2022-11-21
0001008586
STRM:AveleadMember
srt:ScenarioForecastMember
2024-01-31
2024-01-31
0001008586
STRM:AveleadMember
srt:ScenarioForecastMember
2024-01-31
0001008586
STRM:SubleaseAgreementMember
2021-09-29
2021-10-02
0001008586
STRM:SubleaseAgreementMember
2023-08-01
2023-10-31
0001008586
STRM:SubleaseAgreementMember
2023-02-01
2023-10-31
0001008586
2021-10-31
0001008586
STRM:SuwaneeOfficeLeaseMember
2021-08-14
2021-08-16
0001008586
STRM:SuwaneeOfficeLeaseMember
2023-08-01
2023-10-31
0001008586
STRM:SuwaneeOfficeLeaseMember
2023-02-01
2023-10-31
0001008586
STRM:SecondModificationAgreementMember
2022-11-29
0001008586
us-gaap:BaseRateMember
STRM:SecondModificationAgreementMember
2022-11-28
2022-11-29
0001008586
us-gaap:BaseRateMember
STRM:SecondModificationAgreementMember
2022-11-29
0001008586
STRM:SecondAmendedAndRestatedLoanAgreementMember
2022-11-29
0001008586
us-gaap:BaseRateMember
STRM:SecondAmendedAndRestatedLoanAgreementMember
2022-11-28
2022-11-29
0001008586
us-gaap:BaseRateMember
STRM:SecondAmendedAndRestatedLoanAgreementMember
2022-11-29
0001008586
STRM:SecondAmendedAndRestatedLoanAgreementMember
2021-08-26
0001008586
STRM:SecondModificationAgreementMember
2022-11-28
2022-11-29
0001008586
STRM:SecondAmendedAndRestatedLoanAgreementMember
srt:MaximumMember
2023-10-31
0001008586
STRM:SecondAmendedAndRestatedLoanAgreementMember
srt:MinimumMember
2023-10-31
0001008586
STRM:SecondAmendedAndRestatedLoanAgreementMember
2021-08-25
2021-08-26
0001008586
STRM:OctoberThirtyOneTwoThousandAndTwentyTwoMember
srt:MinimumMember
2023-10-31
0001008586
STRM:OctoberThirtyOneTwoThousandAndTwentyTwoMember
srt:MaximumMember
2023-10-31
0001008586
STRM:JanuaryThirtyOneTwoThousandTwentyThreeMember
srt:MinimumMember
2023-10-31
0001008586
STRM:JanuaryThirtyOneTwoThousandTwentyThreeMember
srt:MaximumMember
2023-10-31
0001008586
STRM:AprilThirtyTwoThousandTwentyThreeMember
srt:MinimumMember
2023-10-31
0001008586
STRM:AprilThirtyTwoThousandTwentyThreeMember
srt:MaximumMember
2023-10-31
0001008586
STRM:JulyThirtyOneTwoThousandTwentyThreeMember
srt:MinimumMember
2023-10-31
0001008586
STRM:JulyThirtyOneTwoThousandTwentyThreeMember
srt:MaximumMember
2023-10-31
0001008586
STRM:OctoberThirtyOneTwoThousandTwentyThreeMember
srt:MinimumMember
2023-10-31
0001008586
STRM:OctoberThirtyOneTwoThousandTwentyThreeMember
srt:MaximumMember
2023-10-31
0001008586
STRM:JanuaryThirtyOneTwoThousandTwentyFourMember
srt:MinimumMember
2023-10-31
0001008586
STRM:JanuaryThirtyOneTwoThousandTwentyFourMember
srt:MaximumMember
2023-10-31
0001008586
STRM:AprilThirtyTwoThousandTwentyFourMember
srt:MaximumMember
2023-10-31
0001008586
STRM:AprilThirtyTwoThousandTwentyFourMember
srt:MinimumMember
2023-10-31
0001008586
STRM:JulyThirtyOneTwoThousandTwentyFourAndThereafterMember
srt:MaximumMember
2023-10-31
0001008586
STRM:JulyThirtyOneTwoThousandTwentyFourAndThereafterMember
srt:MinimumMember
2023-10-31
0001008586
STRM:PurchaseAgreementMember
STRM:TwoThousandTwentyTwoOfferingMember
2022-10-23
2022-10-24
0001008586
STRM:PurchaseAgreementMember
STRM:TwoThousandTwentyTwoOfferingMember
2022-10-24
0001008586
STRM:OneHundredEightyConsultingLLCMember
2022-06-22
0001008586
STRM:OneHundredEightyConsultingLLCMember
2023-06-28
0001008586
STRM:ThirdAmendedAndRestatedTwoThousandThirteenStockIncentivePlanMember
2023-02-01
2023-10-31
0001008586
STRM:ThirdAmendedAndRestatedTwoThousandThirteenStockIncentivePlanMember
2022-06-07
0001008586
STRM:ThirdAmendedAndRestatedTwoThousandThirteenStockIncentivePlanMember
srt:MaximumMember
2023-10-31
0001008586
2022-06-07
0001008586
2023-06-15
2023-06-15
0001008586
STRM:ThirdAmendedAndRestatedTwoThousandThirteenStockIncentivePlanMember
2023-06-15
0001008586
STRM:ThirdAmendedAndRestatedTwoThousandThirteenStockIncentivePlanMember
srt:MaximumMember
2023-06-15
0001008586
STRM:MasterServicesAgreementMember
STRM:OneHundredEightyConsultingLLCMember
2023-08-01
2023-10-31
0001008586
STRM:MasterServicesAgreementMember
STRM:OneHundredEightyConsultingLLCMember
2023-02-01
2023-10-31
0001008586
STRM:MasterServicesAgreementMember
STRM:OneHundredEightyConsultingLLCMember
2023-10-01
2023-10-31
0001008586
STRM:MasterServicesAgreementMember
STRM:OneHundredEightyConsultingLLCMember
2022-08-01
2022-10-31
0001008586
STRM:MasterServicesAgreementMember
STRM:OneHundredEightyConsultingLLCMember
2022-02-01
2022-10-31
0001008586
STRM:MasterServicesAgreementMember
STRM:OneHundredEightyConsultingLLCMember
us-gaap:ShareBasedPaymentArrangementNonemployeeMember
2023-08-01
2023-10-31
0001008586
STRM:MasterServicesAgreementMember
STRM:OneHundredEightyConsultingLLCMember
us-gaap:ShareBasedPaymentArrangementNonemployeeMember
2023-02-01
2023-10-31
0001008586
STRM:SOWMember
STRM:OneHundredEightyConsultingLLCMember
2023-08-01
2023-10-31
0001008586
STRM:SOWMember
STRM:OneHundredEightyConsultingLLCMember
2023-02-01
2023-10-31
0001008586
us-gaap:CustomerRelationshipsMember
2023-02-01
2023-10-31
0001008586
STRM:ClientRelationshipsMember
srt:MinimumMember
2023-10-31
0001008586
STRM:ClientRelationshipsMember
srt:MaximumMember
2023-10-31
0001008586
STRM:ClientRelationshipsMember
2023-10-31
0001008586
STRM:ClientRelationshipsMember
2023-02-01
2023-10-31
0001008586
STRM:InternallyDevelopedSoftwareMember
2023-10-31
0001008586
STRM:InternallyDevelopedSoftwareMember
2023-02-01
2023-10-31
0001008586
us-gaap:TrademarksAndTradeNamesMember
2023-10-31
0001008586
us-gaap:TrademarksAndTradeNamesMember
2023-02-01
2023-10-31
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
xbrli:pure
STRM:Integer
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
FORM
10-Q
(Mark
One)
☒ |
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For
the quarterly period ended October 31, 2023
OR
☐ |
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For
the transition period from __________ to ____________
Commission
File Number: 000-28132
STREAMLINE
HEALTH SOLUTIONS, INC.
(Exact
name of registrant as specified in its charter)
Delaware |
|
31-1455414 |
(State
or other jurisdiction of
incorporation
or organization) |
|
(I.R.S.
Employer
Identification
No.) |
2400
Old Milton Pkwy., Box 1353
Alpharetta,
GA 30009
(Address
of principal executive offices) (Zip Code)
(888)
997-8732
(Registrant’s
telephone number, including area code)
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
Common
Stock, $0.01 par value per share |
|
STRM |
|
Nasdaq
Capital Market |
Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit such files). Yes ☒ No ☐
Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”,
“smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large
accelerated filer ☐ |
Accelerated
filer ☐ |
Non-accelerated
filer ☒ |
Smaller
reporting company ☒ |
|
|
|
|
Emerging
growth company ☐ |
|
|
|
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
The
number of shares outstanding of the Registrant’s Common Stock, $0.01 par value per share, as of December 11 , 2023 was 58,829,461.
TABLE
OF CONTENTS
PART
I. FINANCIAL INFORMATION
Item
1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
STREAMLINE
HEALTH SOLUTIONS, INC.
CONDENSED
CONSOLIDATED BALANCE SHEETS
(rounded
to the nearest thousand dollars, except share and per share information)
| |
October 31, 2023 | | |
January 31, 2023 | |
| |
(Unaudited) | | |
| |
ASSETS | |
| | | |
| | |
Current assets: | |
| | | |
| | |
Cash and cash equivalents | |
$ | 2,557,000 | | |
$ | 6,598,000 | |
Accounts receivable, net of allowance for credit losses of $94,000 and $132,000, respectively | |
| 3,653,000 | | |
| 7,719,000 | |
Contract receivables | |
| 763,000 | | |
| 960,000 | |
Prepaid and other current assets | |
| 742,000 | | |
| 710,000 | |
Total current assets | |
| 7,715,000 | | |
| 15,987,000 | |
Non-current assets: | |
| | | |
| | |
Property and equipment, net of accumulated amortization of $278,000 and $246,000 respectively | |
| 94,000 | | |
| 79,000 | |
Right-of use asset for operating lease | |
| — | | |
| 32,000 | |
Capitalized software development costs, net of accumulated amortization of $7,560,000 and $6,224,000, respectively | |
| 6,248,000 | | |
| 5,846,000 | |
Intangible assets, net of accumulated amortization of $3,978,000 and $2,627,000, respectively | |
| 12,479,000 | | |
| 14,793,000 | |
Goodwill | |
| 13,276,000 | | |
| 23,089,000 | |
Other | |
| 1,293,000 | | |
| 1,695,000 | |
Total non-current assets | |
| 33,390,000 | | |
| 45,534,000 | |
Total assets | |
$ | 41,105,000 | | |
$ | 61,521,000 | |
See
accompanying notes to condensed consolidated financial statements.
STREAMLINE
HEALTH SOLUTIONS, INC.
CONDENSED
CONSOLIDATED BALANCE SHEETS (CONTINUED)
(rounded
to the nearest thousand dollars, except share and per share information)
| |
October 31, 2023 | | |
January 31, 2023 | |
| |
| (Unaudited) | | |
| | |
LIABILITIES AND STOCKHOLDERS’ EQUITY | |
| | | |
| | |
Current liabilities: | |
| | | |
| | |
Accounts payable | |
$ | 736,000 | | |
$ | 626,000 | |
Accrued expenses | |
| 2,883,000 | | |
| 3,265,000 | |
Current portion of term loan | |
| 1,250,000 | | |
| 750,000 | |
Deferred revenues | |
| 5,983,000 | | |
| 8,361,000 | |
Current portion of operating lease obligation | |
| — | | |
| 35,000 | |
Acquisition earnout liability | |
| 1,833,000 | | |
| 3,738,000 | |
Total current liabilities | |
| 12,685,000 | | |
| 16,775,000 | |
Non-current liabilities: | |
| | | |
| | |
Term loan, net of current portion and deferred financing costs | |
| 8,042,000 | | |
| 8,964,000 | |
Line of credit | |
| 500,000 | | |
| — | |
Deferred revenues, less current portion | |
| 127,000 | | |
| 167,000 | |
Other non-current liabilities | |
| — | | |
| 104,000 | |
Total non-current liabilities | |
| 8,669,000 | | |
| 9,235,000 | |
Total liabilities | |
| 21,354,000 | | |
| 26,010,000 | |
Commitments and contingencies – Note 8 | |
| - | | |
| - | |
Stockholders’ equity: | |
| | | |
| | |
Common stock, $0.01 par value per share, 85,000,000 shares authorized; 58,793,990 and 57,567,210 shares issued and outstanding, respectively | |
| 588,000 | | |
| 576,000 | |
Additional paid in capital | |
| 133,492,000 | | |
| 131,973,000 | |
Accumulated deficit | |
| (114,329,000 | ) | |
| (97,038,000 | ) |
Total stockholders’ equity | |
| 19,751,000 | | |
| 35,511,000 | |
Total liabilities and stockholders’ equity | |
$ | 41,105,000 | | |
$ | 61,521,000 | |
See
accompanying notes to condensed consolidated financial statements.
STREAMLINE
HEALTH SOLUTIONS, INC.
UNAUDITED
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(rounded
to the nearest thousand dollars, except share and per share information)
| |
2023 | | |
2022 | | |
2023 | | |
2022 | |
| |
Three Months Ended October 31, | | |
Nine Months Ended October 31, | |
| |
2023 | | |
2022 | | |
2023 | | |
2022 | |
Revenues: | |
| | | |
| | | |
| | | |
| | |
Software as a service | |
$ | 3,924,000 | | |
$ | 3,209,000 | | |
$ | 10,630,000 | | |
$ | 9,157,000 | |
Maintenance and support | |
| 1,070,000 | | |
| 1,120,000 | | |
| 3,327,000 | | |
| 3,348,000 | |
Professional fees and licenses | |
| 1,139,000 | | |
| 1,888,000 | | |
| 3,278,000 | | |
| 5,639,000 | |
Total revenues | |
| 6,133,000 | | |
| 6,217,000 | | |
| 17,235,000 | | |
| 18,144,000 | |
Operating expenses: | |
| | | |
| | | |
| | | |
| | |
Cost of software as a service | |
| 1,677,000 | | |
| 1,742,000 | | |
| 5,159,000 | | |
| 4,771,000 | |
Cost of maintenance and support | |
| 129,000 | | |
| 84,000 | | |
| 250,000 | | |
| 220,000 | |
Cost of professional fees and licenses | |
| 1,072,000 | | |
| 1,744,000 | | |
| 3,202,000 | | |
| 4,992,000 | |
Cost of goods and services | |
| 1,072,000 | | |
| 1,744,000 | | |
| 3,202,000 | | |
| 4,992,000 | |
Selling, general and administrative expense | |
| 4,122,000 | | |
| 4,055,000 | | |
| 12,079,000 | | |
| 12,629,000 | |
Research and development | |
| 1,304,000 | | |
| 1,754,000 | | |
| 4,310,000 | | |
| 4,527,000 | |
Impairment of goodwill | |
| 9,813,000 | | |
| — | | |
| 9,813,000 | | |
| — | |
Impairment of long-lived assets | |
| 963,000 | | |
| — | | |
| 963,000 | | |
| — | |
Total operating expenses | |
| 19,080,000 | | |
| 9,379,000 | | |
| 35,776,000 | | |
| 27,139,000 | |
Operating loss | |
| (12,947,000 | ) | |
| (3,162,000 | ) | |
| (18,541,000 | ) | |
| (8,995,000 | ) |
Other (expense) income: | |
| | | |
| | | |
| | | |
| | |
Interest expense | |
| (266,000 | ) | |
| (198,000 | ) | |
| (781,000 | ) | |
| (519,000 | ) |
Acquisition earnout valuation adjustments | |
| 1,182,000 | | |
| 163,000 | | |
| 1,905,000 | | |
| 188,000 | |
Other | |
| — | | |
| 68,000 | | |
| 31,000 | | |
| 151,000 | |
Income tax benefit (expense) | |
| 120,000 | | |
| (9,000 | ) | |
| 59,000 | | |
| (22,000 | ) |
Net loss | |
$ | (11,911,000 | ) | |
$ | (3,138,000 | ) | |
$ | (17,327,000 | ) | |
$ | (9,197,000 | ) |
Basic and Diluted Earnings Per Share: | |
| | | |
| | | |
| | | |
| | |
Net loss per common share – basic and diluted | |
$ | (0.21 | ) | |
$ | (0.07 | ) | |
$ | (0.31 | ) | |
$ | (0.19 | ) |
Weighted average number of common shares – basic and diluted | |
| 56,710,335 | | |
| 47,730,009 | | |
| 56,346,300 | | |
| 47,329,923 | |
See
accompanying notes to condensed consolidated financial statements.
STREAMLINE
HEALTH SOLUTIONS, INC.
UNAUDITED
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(rounded
to the nearest thousand dollars, except share information)
| |
| | |
| | |
| | |
| | |
| |
| |
Common stock (Shares) | | |
Common stock (Amount) | | |
Additional
paid in
capital | | |
Accumulated
deficit | | |
Total stockholders’
equity | |
| |
| | |
| | |
| | |
| | |
| |
Balance at January 31, 2023 | |
| 57,567,210 | | |
$ | 576,000 | | |
$ | 131,973,000 | | |
$ | (97,038,000 | ) | |
$ | 35,511,000 | |
Restricted stock issued | |
| 1,185,927 | | |
| 12,000 | | |
| (12,000 | ) | |
| — | | |
| — | |
Restricted stock forfeited | |
| (28,400 | ) | |
| (1,000 | ) | |
| 1,000 | | |
| — | | |
| — | |
Surrender of shares | |
| (88,326 | ) | |
| (1,000 | ) | |
| (178,000 | ) | |
| — | | |
| (179,000 | ) |
Share-based compensation | |
| — | | |
| — | | |
| 595,000 | | |
| — | | |
| 595,000 | |
Adoption of ASU 2016-13 | |
| — | | |
| — | | |
| — | | |
| 36,000 | | |
| 36,000 | |
Net loss | |
| — | | |
| — | | |
| — | | |
| (2,901,000 | ) | |
| (2,901,000 | ) |
Balance at April 30, 2023 | |
| 58,636,411 | | |
| 586,000 | | |
| 132,379,000 | | |
| (99,903,000 | ) | |
| 33,062,000 | |
| |
| | | |
| | | |
| | | |
| | | |
| | |
Restricted stock issued | |
| 385,720 | | |
| 4,000 | | |
| (4,000 | ) | |
| — | | |
| — | |
Restricted stock forfeited | |
| (77,000 | ) | |
| (1,000 | ) | |
| 1,000 | | |
| — | | |
| — | |
Surrender of shares | |
| (50,060 | ) | |
| — | | |
| (73,000 | ) | |
| — | | |
| (73,000 | ) |
Share-based compensation | |
| — | | |
| — | | |
| 630,000 | | |
| — | | |
| 630,000 | |
Net loss | |
| — | | |
| — | | |
| — | | |
| (2,515,000 | ) | |
| (2,515,000 | ) |
Balance at July 31, 2023 | |
| 58,895,071 | | |
$ | 589,000 | | |
$ | 132,933,000 | | |
$ | (102,418,000 | ) | |
$ | 31,104,000 | |
| |
| | | |
| | | |
| | | |
| | | |
| | |
Restricted stock issued | |
| 176,054 | | |
| 2,000 | | |
| (2,000 | ) | |
| — | | |
| — | |
Restricted stock forfeited | |
| (239,100 | ) | |
| (2,000 | ) | |
| 2,000 | | |
| — | | |
| — | |
Surrender of shares | |
| (38,035 | ) | |
| (1,000 | ) | |
| (18,000 | ) | |
| — | | |
| (19,000 | ) |
Share-based compensation | |
| — | | |
| — | | |
| 577,000 | | |
| — | | |
| 577,000 | |
Net loss | |
| — | | |
| — | | |
| — | | |
| (11,911,000 | ) | |
| (11,911,000 | ) |
Balance at October 31, 2023 | |
| 58,793,990 | | |
$ | 588,000 | | |
$ | 133,492,000 | | |
$ | (114,329,000 | ) | |
$ | 19,751,000 | |
| |
Common
stock (Shares) | | |
Common
stock (Amount) | | |
Additional paid in capital | | |
Accumulated deficit | | |
Total stockholders’ equity | |
| |
| | |
| | |
| | |
| | |
| |
Balance at January 31, 2022 | |
| 47,840,950 | | |
$ | 478,000 | | |
$ | 119,225,000 | | |
$ | (85,659,000 | ) | |
$ | 34,044,000 | |
Restricted stock issued | |
| 408,031 | | |
| 4,000 | | |
| (4,000 | ) | |
| — | | |
| — | |
Restricted stock forfeited | |
| (63,900 | ) | |
| — | | |
| — | | |
| — | | |
| — | |
Surrender of shares | |
| (95,701 | ) | |
| (1,000 | ) | |
| (140,000 | ) | |
| — | | |
| (141,000 | ) |
Share-based compensation | |
| — | | |
| — | | |
| 326,000 | | |
| — | | |
| 326,000 | |
Net loss | |
| — | | |
| — | | |
| — | | |
| (2,787,000 | ) | |
| (2,787,000 | ) |
Balance at April 30, 2022 | |
| 48,089,380 | | |
| 481,000 | | |
| 119,407,000 | | |
| (88,446,000 | ) | |
| 31,442,000 | |
| |
| | | |
| | | |
| | | |
| | | |
| | |
Exercise of stock options | |
| 5,000 | | |
| — | | |
| 6,000 | | |
| — | | |
| 6,000 | |
Restricted stock issued | |
| 726,801 | | |
| 7,000 | | |
| (7,000 | ) | |
| — | | |
| — | |
Restricted stock forfeited | |
| (20,000 | ) | |
| — | | |
| — | | |
| — | | |
| — | |
Share-based compensation | |
| — | | |
| — | | |
| 331,000 | | |
| — | | |
| 331,000 | |
Net loss | |
| — | | |
| — | | |
| — | | |
| (3,272,000 | ) | |
| (3,272,000 | ) |
Balance at July 31, 2022 | |
| 48,801,181 | | |
$ | 488,000 | | |
$ | 119,737,000 | | |
$ | (91,718,000 | ) | |
$ | 28,507,000 | |
Balance | |
| 48,801,181 | | |
$ | 488,000 | | |
$ | 119,737,000 | | |
$ | (91,718,000 | ) | |
$ | 28,507,000 | |
| |
| | | |
| | | |
| | | |
| | | |
| | |
Restricted stock issued | |
| 118,836 | | |
| 1,000 | | |
| (1,000 | ) | |
| — | | |
| — | |
Restricted stock forfeited | |
| (75,200 | ) | |
| (1,000 | ) | |
| 1,000 | | |
| — | | |
| — | |
Surrender of shares | |
| (14,472 | ) | |
| — | | |
| (24,000 | ) | |
| — | | |
| (24,000 | ) |
Share-based compensation | |
| — | | |
| — | | |
| 555,000 | | |
| — | | |
| 555,000 | |
Issuance of common stock | |
| 6,299,989 | | |
| 63,000 | | |
| 8,253,000 | | |
| — | | |
| 8,316,000 | |
Offering expenses | |
| — | | |
| — | | |
| (52,000 | ) | |
| — | | |
| (52,000 | ) |
Net loss | |
| — | | |
| — | | |
| — | | |
| (3,138,000 | ) | |
| (3,138,000 | ) |
Balance at October 31, 2022 | |
| 55,130,334 | | |
$ | 551,000 | | |
$ | 128,469,000 | | |
$ | (94,856,000 | ) | |
$ | 34,164,000 | |
Balance | |
| 55,130,334 | | |
$ | 551,000 | | |
$ | 128,469,000 | | |
$ | (94,856,000 | ) | |
$ | 34,164,000 | |
See
accompanying notes to condensed consolidated financial statements.
STREAMLINE
HEALTH SOLUTIONS, INC.
UNAUDITED
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(rounded
to the nearest thousand dollars)
| |
2023 | | |
2022 | |
| |
Nine months Ended October 31, | |
| |
2023 | | |
2022 | |
Net loss | |
$ | (17,327,000 | ) | |
$ | (9,197,000 | ) |
| |
| | | |
| | |
Adjustments to reconcile net loss to net cash used in operating activities: | |
| | | |
| | |
Depreciation and amortization | |
| 3,264,000 | | |
| 3,272,000 | |
Acquisition earnout valuation adjustments | |
| (1,905,000 | ) | |
| (188,000 | ) |
Benefit for deferred income taxes | |
| (104,000 | ) | |
| — | |
Share-based compensation expense | |
| 1,626,000 | | |
| 1,212,000 | |
Impairment of goodwill | |
| 9,813,000 | | |
| — | |
Impairment of long-lived assets | |
| 963,000 | | |
| — | |
Provision for credit losses | |
| — | | |
| 21,000 | |
Changes in assets and liabilities: | |
| | | |
| | |
Accounts and contract receivables | |
| 4,299,000 | | |
| 492,000 | |
Other assets | |
| (65,000 | ) | |
| (868,000 | ) |
Accounts payable | |
| 109,000 | | |
| (373,000 | ) |
Accrued expenses and other liabilities | |
| (417,000 | ) | |
| 1,159,000 | |
Deferred revenue | |
| (2,417,000 | ) | |
| (251,000 | ) |
Net cash used in operating activities | |
| (2,161,000 | ) | |
| (4,721,000 | ) |
Cash flows from investing activities: | |
| | | |
| | |
Purchases of property and equipment | |
| (47,000 | ) | |
| (10,000 | ) |
Capitalization of software development costs | |
| (1,562,000 | ) | |
| (1,435,000 | ) |
Net cash used in investing activities | |
| (1,609,000 | ) | |
| (1,445,000 | ) |
Cash flows from financing activities: | |
| | | |
| | |
Repayment of bank term loan | |
| (500,000 | ) | |
| (125,000 | ) |
Proceeds from line of credit | |
| 500,000 | | |
| — | |
Proceeds from issuance of common stock | |
| — | | |
| 8,316,000 | |
Payments for costs directly attributable to the issuance of common stock | |
| — | | |
| (52,000 | ) |
Payments related to settlement of employee share-based awards | |
| (271,000 | ) | |
| (165,000 | ) |
Other | |
| — | | |
| 6,000 | |
Net cash (used in) provided by financing activities | |
| (271,000 | ) | |
| 7,980,000 | |
Net (decrease) increase in cash and cash equivalents | |
| (4,041,000 | ) | |
| 1,814,000 | |
Cash and cash equivalents at beginning of period | |
| 6,598,000 | | |
| 9,885,000 | |
Cash and cash equivalents at end of period | |
$ | 2,557,000 | | |
$ | 11,699,000 | |
See
accompanying notes to condensed consolidated financial statements.
STREAMLINE
HEALTH SOLUTIONS, INC.
NOTES
TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
October
31, 2023
NOTE
1 — BASIS OF PRESENTATION
Streamline
Health Solutions, Inc. and each of its wholly-owned subsidiaries, Streamline Health, LLC, Avelead Consulting, LLC, Streamline Consulting
Solutions, LLC and Streamline Pay & Benefits, LLC, (collectively, unless the context requires otherwise, “we,” “us,”
“our,” “Streamline,” or the “Company”), operate in one segment as a provider of healthcare information
technology solutions and associated services. The Company provides these capabilities through the licensing of its Coding & Clinical
Documentation Improvement (CDI) solutions, eValuator coding analysis platform, RevID, and other workflow software applications and the
use of such applications by software as a service (“SaaS”). The Company also provides audit services to help clients optimize
their internal clinical documentation and coding functions, as well as implementation and consulting services to complement its software
solutions. The Company’s software and services enable hospitals and integrated healthcare delivery systems in the United States
and Canada to capture, store, manage, route, retrieve and process patient clinical, financial and other healthcare provider information
related to the patient revenue cycle.
The
accompanying unaudited condensed consolidated financial statements have been prepared by us pursuant to the rules and regulations applicable
to quarterly reports on Form 10-Q of the U.S. Securities and Exchange Commission (the “SEC”). Certain information and note
disclosures normally included in annual financial statements prepared in accordance with U.S. generally accepted accounting principles
(“GAAP”) have been condensed or omitted pursuant to those rules and regulations, although we believe that the disclosures
made are adequate to make the information not misleading. The condensed consolidated financial statements include the accounts of Streamline
Health Solutions, Inc. and each of its wholly-owned subsidiaries. In the opinion of the Company’s management, all adjustments (consisting
of normal recurring accruals) considered necessary for a fair presentation of the condensed consolidated financial statements have been
included. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements
and notes thereto included in the Company’s most recent annual report on Form 10-K. Operating results for the three and nine months
ended October 31, 2023 are not necessarily indicative of the results that may be expected
for the fiscal year ending January 31, 2024.
The
Company has one operating segment and one reporting unit due to the singular nature of our products, product development and distribution
process, and client base as a provider of computer software-based solutions and services for acute-care healthcare providers.
All
amounts in the condensed consolidated financial statements, notes and tables have been rounded to the nearest thousand dollars, except
share and per share amounts, unless otherwise indicated. All references to a fiscal year refer to the fiscal year commencing February
1 in that calendar year and ending on January 31 of the following calendar year.
Going
Concern
The
Company’s financial statements are prepared on a going concern basis, which contemplates the realization of assets and the satisfaction
of obligations in the normal course of business. To date, the Company has not generated sufficient revenues to allow it to generate cash
flow from operations. The Company has historically accumulated losses and used cash from its financing activities to supplement its operations.
Further, the Company’s current forecast projects the Company will not be able to maintain compliance with certain of its
financial covenants under its current credit agreement in the next twelve months. These
conditions raise substantial doubt about the ability of the Company to continue as a going concern within one year after the date that
the financial statements are issued.
In
view of these matters, continuation as a going concern is dependent upon the Company’s ability to achieve cash from operations
and raise additional debt or equity capital to fund its ongoing operations. The Company expects to generate positive operating cash
flow in the next two fiscal quarters based upon executed contracts which it expects to be fully implemented.
As of October 31, 2023, the Company had approximately $9.75 million of total
outstanding debt associated with its term loan and revolver, $1.25 million of which is classified as a current liability. The Company
is engaged in ongoing discussions with its current banking partner, Western Alliance Bank, with whom it maintains a good working relationship;
however, the Company does not have written or executed agreements as of the issuance of this Form 10-Q. The Company’s ability to
refinance its existing debt is based upon credit markets and economic forces that are outside of its control. There can be no assurance
that the Company will be successful in raising additional capital or that such capital, if available, will be on terms that are acceptable
to the Company.
The
financial statements do not include any adjustments to the amount and classification of assets and liabilities that may be necessary
should the Company not continue as a going concern.
NOTE
2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Our
significant accounting policies are presented in “Note 2 – Significant Accounting Policies” in the fiscal year 2022
Annual Report on Form 10-K. Users of financial information for interim periods are encouraged to refer to the notes to the consolidated
financial statements contained in the Annual Report on Form 10-K when reviewing interim financial results.
Use
of Estimates
The
preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts
reported in the financial statements and accompanying notes. On an ongoing basis, management evaluates its estimates and judgments, including
those related to the recognition of revenue, share-based compensation, capitalization of software development costs, intangible assets,
the allowance for credit losses, contingent consideration, and income taxes. Actual results could differ from those estimates.
Reclassification
Certain amounts for the three and nine months ended October 31, 2022 were reclassified to conform to the current
period classification. For the three and nine months ended October 31, 2023, the Company incurred certain acquisition-related costs related
to the acquisition of Avelead totaling $0 and $44,000, respectively, consisting primarily of professional service fees. For the three and nine months ended October 31,
2022, the Company incurred acquisition-related costs totaling $2,000 and $141,000, respectively, consisting primarily of professional service fees. The
aforementioned acquisition-related costs for the three and nine months ended October 31, 2022 were previously presented in a separate,
single caption and are now included in selling, general, and administrative expense in the accompanying condensed consolidated statements
of operations, which is consistent with the presentation for the current period.
Fair
Value of Financial Instruments
The
Financial Accounting Standards Board’s (“FASB”) authoritative guidance on fair value measurements establishes a framework
for measuring fair value. This guidance enables the reader of the financial statements to assess the inputs used to develop those measurements
by establishing a hierarchy for ranking the quality and reliability of the information used to determine fair values. Under this guidance,
assets and liabilities carried at fair value must be classified and disclosed in one of the following three categories:
Level
1: Quoted market prices in active markets for identical assets or liabilities.
Level
2: Observable market-based inputs or unobservable inputs that are corroborated by market data.
Level
3: Unobservable inputs that are not corroborated by market data.
The
carrying amounts of cash and cash equivalents, accounts receivable, accounts payable and accrued expenses approximate fair value based
on the short-term maturity of these instruments. Cash and cash equivalents are classified as Level 1. There were no transfers of assets
or liabilities between Levels 1, 2, or 3 during the nine months ended October 31, 2023 and
2022.
The
table below provides information on the fair value of our liabilities:
SCHEDULE
OF FAIR VALUE OF LIABILITIES
| |
Total Fair | | |
Quoted Prices in Active Markets | | |
Significant Other Observable Inputs | | |
Significant Unobservable
Inputs | |
| |
Value | | |
(Level 1) | | |
(Level 2) | | |
(Level 3) | |
At January 31, 2023 | |
| | | |
| | | |
| | | |
| | |
Acquisition earnout liability (1) | |
$ | 3,738,000 | | |
$ | — | | |
$ | — | | |
$ | 3,738,000 | |
At October 31, 2023 | |
| | | |
| | | |
| | | |
| | |
Acquisition earnout liability (1) | |
$ | 1,833,000 | | |
$ | — | | |
$ | — | | |
$ | 1,833,333 | |
The
fair value of the Company’s term loan and outstanding balance of the revolving line of credit under its Second Amended and
Restated Loan and Security Agreement (as amended and modified, the “Second Amended and Restated Loan Agreement”) was
determined through an analysis of the interest rate spread from the date of closing the loan (August 2021) to the date of the most
recent balance sheets, October 31, 2023 and January 31, 2023. The
term loan bears interest at a per annum rate equal to the Prime Rate (as published in The Wall Street Journal) plus 1.5%,
with a Prime “floor” rate of 3.25%.
The prime rate is variable and, thus accommodates changes in the market interest rate. However, the interest rate spread (the 1.5%
added to the Prime Rate) is fixed. We estimated the impact of the changes in the interest rate spread by analogizing the effect of
the change in the published “Corporate Bond Rates,” reduced for any changes in the market interest rate. This
provided us with an estimated change to the interest rate spread of approximately 0.5%
from (i) the date we entered the Second Amended and Restated Loan Agreement for the term loan or (ii) the date of each draw on the
revolving line of credit to the end of the fiscal third quarter, October 31, 2023, and end of the fiscal year, January 31, 2023. The
fair value of the debt as of October 31, 2023 and January 31, 2023 was estimated to be $9,054,000 and
$9,550,000,
respectively, or a discount to book value of $196,000 and
$200,000,
respectively. The fair value of the line of credit as of October 31, 2023 and January 31, 2023 was estimated to be $488,000
and $0,
respectively, or a discount to book value of $12,000
and $0,
respectively. Long-term debt is classified as Level 2.
Revenue
Recognition
We
derive revenue from the sale of internally-developed software, either by licensing for local installation or by a SaaS delivery model,
through the Company’s direct sales force or through third-party resellers. Licensed, locally-installed customers on a perpetual
model utilize the Company’s support and maintenance services for a separate fee, whereas term-based locally installed license fees
and SaaS fees include support and maintenance. We also derive revenue from professional services that support the implementation, configuration,
training and optimization of the applications, as well as audit services and consulting services.
We
recognize revenue in accordance with Accounting Standards Codification (ASC) 606, Revenue from Contracts with Customers, under
the core principle of recognizing revenue to depict the transfer of promised goods or services to customers in an amount that reflects
the consideration to which the entity expects to be entitled in exchange for those goods or services.
Disaggregation
of Revenue
The
following table provides information about disaggregated revenue by type and nature of revenue stream:
SCHEDULE OF DISAGGREGATION OF REVENUE
| |
October 31, 2023 | | |
October 31, 2022 | | |
October 31, 2023 | | |
October 31, 2022 | |
| |
Three Months Ended | | |
Nine Months Ended | |
| |
October 31, 2023 | | |
October 31, 2022 | | |
October 31, 2023 | | |
October 31, 2022 | |
Over time revenue | |
$ | 6,133,000 | | |
$ | 6,217,000 | | |
$ | 17,161,000 | | |
$ | 18,021,000 | |
Point in time revenue | |
| — | | |
| — | | |
| 74,000 | | |
| 123,000 | |
Total revenue | |
$ | 6,133,000 | | |
$ | 6,217,000 | | |
$ | 17,235,000 | | |
$ | 18,144,000 | |
The
Company includes revenue categories of (i) over time and (ii) point in time revenue. The Company includes revenue categories of (i) SaaS,
(ii) maintenance and support, (iii) professional services, and (iv) audit services as over time revenue. For point in time revenue, the
performance obligation is recognized as the point in time when the obligation is fully satisfied. The Company includes (i) software licenses
as point in time revenue.
Contract
Receivables and Deferred Revenues
The
Company receives payments from customers based upon contractual billing schedules. Contract receivables include amounts related to the
Company’s contractual right to consideration for completed performance obligations not yet invoiced. Deferred revenue includes
payments received in advance of performance under the contract. The Company’s contract receivables and deferred revenue are reported
on an individual contract basis at the end of each reporting period. Contract receivables are classified as current or noncurrent based
on the timing of when we expect to bill the customer. Deferred revenue is classified as current or noncurrent based on the timing of
when we expect to recognize revenue. During the nine months ended October 31, 2023, the
Company recognized approximately $6,772,000 in revenue from deferred revenues outstanding as of January 31, 2023. Revenue allocated to
remaining performance obligations was $23,045,000 as of October 31, 2023, of which the Company
expects to recognize approximately 56% over the next 12 months and the remainder thereafter.
Deferred
costs (costs to fulfill a contract and contract acquisition costs)
The
Company defers the direct costs, which include salaries and benefits, for professional services related to SaaS contracts as a cost to
fulfill a contract. These deferred costs will be amortized on a straight-line basis over the period of expected benefit which is the
contractual term. As of October 31, 2023 and January 31, 2023, the Company had deferred
costs of $98,000 and $94,000, respectively, net of accumulated amortization of $235,000 and $176,000, respectively. Amortization expense
of these costs was $24,000 and $22,000 for the three months ended October 31, 2023 and 2022,
respectively, and $59,000 and $62,000 for the nine months ended October 31, 2023 and 2022,
respectively, and is included in cost of SaaS in the condensed consolidated statements of operations.
Contract
acquisition costs, which consist of sales commissions paid or payable, are considered incremental and recoverable costs of obtaining
a contract with a customer. Sales commissions for initial and renewal contracts are deferred and then amortized on a straight-line basis
over the contract term. As a practical expedient, the Company expenses sales commissions as incurred when the amortization period of
related deferred commission costs is expected to be one year or less.
As
of October 31, 2023 and January 31, 2023, deferred commission costs paid and payable,
which are included on the consolidated balance sheets within other non-current assets totaled $1,195,000
and $1,534,000,
respectively, net of accumulated amortization and impairment totaling $1,238,000
and $820,000,
respectively. Amortization expense associated with deferred sales commissions, which is included in selling,
general and administrative expense in the condensed consolidated statements of operations, was $129,000
and $110,000
for the three months ended October 31, 2023 and 2022, respectively. Amortization
expense for the nine months ended October 31, 2023 and 2022 was $383,000
and $298,000,
respectively. For the three and nine months ended October 31, 2023, the Company recorded an impairment of $35,000
for deferred commission costs related to the client termination notification received in October 2023. There were no impairment
charges recorded for the three and nine months ended October 31, 2022.
Equity
Awards
The
Company accounts for share-based payments based on the grant-date fair value of the awards with compensation cost recognized as expense
over the requisite service period, and forfeitures are recognized as incurred. For awards to non-employees, the Company recognizes compensation
expense in the same manner as if the entity had paid cash for the goods or services. The Company incurred total compensation expense
related to share-based awards for the three and nine months ended October 31, 2023 of $517,000
and $1,626,000, respectively, which includes $60,000 and $176,000, respectively, of capitalized non-employee stock compensation, compared
to share-based compensation expense of $555,000 and $1,212,000, respectively, for the three and nine months ended October
31, 2022. During third quarter of fiscal year 2023, the Company accelerated the vesting of approximately 260,000 previously outstanding and unvested
shares of restricted common stock of the Company.
The
fair value of stock options granted are estimated at the date of grant using a Black-Scholes option pricing model. Option pricing model
input assumptions such as expected term, expected volatility and risk-free interest rate impact the fair value estimate. These assumptions
are subjective and are generally derived from external (such as, risk-free rate of interest) and historical data (such as, volatility
factor and expected term). Future grants of equity awards accounted for as share-based compensation could have a material impact on reported
expenses depending upon the number, value and vesting period of future awards.
The
Company issues restricted stock awards in the form of Company common stock. The fair value of these awards is based on the market closing
price per share on the grant date. For the three and nine months ended October 31, 2023,
the Company issued 45,000
and 1,130,000
shares of restricted common stock to employees,
respectively, compared to 65,000
and 865,000
shares of restricted common stock for the three
and nine months ended October 31, 2022, respectively. The Company expenses the compensation
cost of these awards as the restriction period lapses, which is typically a three-year period. For the three and nine months ended October
31, 2023, the Company issued 0
and 258,621
shares of restricted common stock to the Board
of Directors, respectively, compared to 0
and 200,731
shares of restricted common stock for the three
and nine months ended October 31, 2022, respectively. For the three and nine months ended
October 31, 2023, the Company issued 131,054
and 359,080
shares of restricted common stock to consultants,
respectively, compared to 53,836
and 187,937
shares of restricted common stock for the three
and nine months ended October 31, 2022, respectively.
Income
Taxes
Income
taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences
attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective
tax bases and for tax credit and loss carry-forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected
to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. In assessing net
deferred tax assets, the Company considers whether it is more likely than not that some or all of the deferred tax assets will not be
realized. The Company establishes a valuation allowance when it is more likely than not that all or a portion of deferred tax assets
will not be realized. Refer to Note 6 – Income Taxes for further details.
The
Company provides for uncertain tax positions and the related interest and penalties based upon management’s assessment of whether
certain tax positions are more likely than not to be sustained upon examination by tax authorities. The Company believes it has appropriately
accounted for any uncertain tax positions as of October 31, 2023.
Net
Loss Per Common Share
The
Company presents basic and diluted earnings per share (“EPS”) data for the Company’s common stock.
The
Company’s unvested restricted stock awards are considered non-participating securities because holders are not entitled to non-forfeitable
rights to dividends or dividend equivalents during the vesting term. Diluted EPS for the Company’s common stock is computed using
the treasury stock method.
The
following is the calculation of the basic and diluted net loss per share of common stock for the three and nine months ended October
31, 2023 and 2022:
SCHEDULE OF BASIC AND DILUTED NET LOSS PER SHARE OF COMMON STOCK
| |
October 31, 2023 | | |
October 31, 2022 | | |
October 31, 2023 | | |
October 31, 2022 | |
| |
Three Months Ended | | |
Nine Months Ended | |
| |
October 31, 2023 | | |
October 31, 2022 | | |
October 31, 2023 | | |
October 31, 2022 | |
Basic and diluted loss per share: | |
| | | |
| | | |
| | | |
| | |
Net loss | |
$ | (11,911,000 | ) | |
$ | (3,138,000 | ) | |
$ | (17,327,000 | ) | |
$ | (9,197,000 | ) |
Basic and diluted net loss per share of common stock from operations | |
$ | (0.21 | ) | |
$ | (0.07 | ) | |
$ | (0.31 | ) | |
$ | (0.19 | ) |
Weighted average shares outstanding – basic and diluted (1)(2) | |
| 56,710,335 | | |
| 47,730,009 | | |
| 56,346,300 | | |
| 47,329,923 | |
Weighted average shares outstanding - basic | |
| 56,710,335 | | |
| 47,730,009 | | |
| 56,346,300 | | |
| 47,329,923 | |
Restructuring
On
October 16, 2023, the Company announced it was executing a strategic restructuring designed to reduce expenses while maintaining the
Company’s ability to expand its SaaS business. The strategic restructuring initiatives included a reduction in force,
resulting in the termination of 26 employees,
approximately 24%
of the Company’s workforce. To execute the strategic restructuring, the Company estimates the one-time restructuring costs
associated with the workforce reduction to be approximately $900,000, and
the Company expects the expenses associated with the strategic restructuring to be substantially recognized by the end of fiscal
year 2023. The estimated costs pertain to severance and other employee termination-related costs and various professional fees the
Company may require to assist with execution of the strategic restructuring. The following is a reconciliation of the strategic
restructuring liability that is reflected on the Company’s condensed consolidated balance sheet under “Accrued
expenses”.
SCHEDULE OF RECONCILIATION OF THE
RESTRUCTURING LIABILITY
| |
(in
thousands) | |
| |
| | |
| | |
| | |
| | |
As
of October 31, 2023 | |
| |
Accrued
Balance as of January 31, 2023 | | |
2023
Expenses to Date | | |
2023
Cash Payments | | |
Accrued
Balance as of October 31, 2023 | | |
Total
Costs Incurred to Date | | |
Total
Expected Costs | |
Severance
expense | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Cost
of sales | |
$ | — | | |
$ | 154 | | |
$ | — | | |
$ | 154 | | |
$ | 154 | | |
$ | 154 | |
Selling,
general, and administrative | |
| — | | |
| 350 | | |
| — | | |
| 350 | | |
| 350 | | |
| 350 | |
Research
and development | |
| — | | |
| 227 | | |
| — | | |
| 227 | | |
| 227 | | |
| 227 | |
Total
severance expense | |
$ | — | | |
$ | 731 | | |
$ | — | | |
$ | 731 | | |
$ | 731 | | |
$ | 731 | |
Professional
fees | |
| — | | |
| 18 | | |
| — | | |
| 18 | | |
| 18 | | |
$ | 169 | |
Total | |
$ | — | | |
$ | 749 | | |
$ | — | | |
$ | 749 | | |
$ | 749 | | |
| 900 | |
Non-Cash
Items
For
the three and nine months ended October 31, 2023, the Company recorded capitalized software purchased with stock, totaling $60,000
and $176,000,
respectively, as non-cash items as it relates to non-cash investing activities in the condensed consolidated statements of cash
flow.
Accounting
Pronouncements Recently Adopted
On
February 1, 2023, the Company adopted ASU No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit
Losses on Financial Instruments (“ASU 2016-13”), as amended. ASU 2016-13 requires an allowance for expected credit losses
to be applied to financial assets at inception and reflect the risk of credit loss over the life of the asset. The Company estimated
current expected credit losses based on historical credit loss rates and applied an increase to account for future economic conditions.
The Company’s allowance for doubtful accounts as of January 31, 2023, prior to the adoption of ASU 216-13, was $132,000. The Company
estimated the current expected credit loss related to accounts receivable as of the adoption date of February 1, 2023 to be $96,000.
The Company recorded the adjustment in accounting policy change of $36,000 to the opening accumulated deficit balance for the year of
adoption.
SCHEDULE OF ACCOUNTING PRONOUNCEMENTS RECENTLY ADOPTED
| |
January 31, 2023 | | |
CECL Adoption | | |
Provision adjustments | | |
Write-offs & Recoveries | | |
October 31, 2023 | |
Allowance for credit losses | |
$ | (132,000 | ) | |
$ | 36,000 | | |
| — | | |
| — | | |
$ | (96,000 | ) |
For
the period ended October 31, 2023, the Company estimated the current expected credit loss
related to accounts receivable using historical credit loss rates and applied an adjustment to account for future economic conditions
in accordance with ASU 2016-13. The Company had no further impact on the allowance for credit losses during the nine-month period ended
October 31, 2023.
Recent
Accounting Pronouncements Not Yet Adopted
The
Company does not believe there are any other new accounting pronouncements that have been issued that might have a material impact on
its financial position or results of operations.
NOTE
3 — BUSINESS COMBINATION
Avelead
Acquisition
The
Company acquired all the equity interests of Avelead Consulting, LLC (“Avelead”) as part of the Company’s strategic
expansion into the acute-care health care revenue cycle management industry (the “Transaction”). The Transaction was completed
on August 16, 2021.
On
November 21, 2022, the Company made cash payments of $2,012,000
and issued 1,871,037
unregistered securities in the form of restricted common stock, par value $0.01
per share, with respect to the first year earnout consideration. The estimated aggregate value of the first year earnout payment was
$5,000,000.
The second (and final) year earnout payment is expected to be paid during the quarter ending January 31, 2024 and consists of
$1,214,000 of cash payments and 1,589,342 unregistered securities in the form of restricted common stock, par value $0.01 per share.
These liabilities are reflected at the estimated fair value of the future commitment on the Company’s condensed consolidated
balance sheet as “Acquisition Earnout Liability” and totaled $1,833,000
as of October 31, 2023.
NOTE
4 — OPERATING LEASES
We
determine whether an arrangement is a lease at inception. Right-of-use assets represent our right to use an underlying asset for the
lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease right-of-use
assets and liabilities are recognized at commencement date based on the present value of lease payments over the expected lease term.
Since our lease arrangements do not provide an implicit rate, we use our incremental borrowing rate for the expected remaining lease
term at commencement date for new and existing leases in determining the present value of future lease payments. Operating lease expense
is recognized on a straight-line basis over the lease term.
Alpharetta
Office Lease
On
October 1, 2021, the Company entered into an agreement with a third-party to sublease its office space in Alpharetta, Georgia. The
sublease term was for 18
months, which coincided with the Company’s underlying lease (see below). The Company received $292,000
from the sublessee over the term of the sublease. The sublease did not relieve the Company of its original obligation under the
lease, and therefore the Company did not adjust the operating lease right-of-use asset and related liability. The sublease
terminated on March 31, 2023. For the three and nine months ended October 31, 2023, the Company recorded $0 and $32,000, respectively,
as other income related to the sublease. For the three and nine months ended October 31, 2022, the Company recorded
$49,000 and $145,000, respectively, as other income related to the sublease.
The
Company entered into a lease for office space in Alpharetta, Georgia, on March 1, 2020. The lease terminated on March 31, 2023. At inception,
the Company recorded a right-of use asset of $540,000,
and related current and long-term operating lease obligation in the accompanying consolidated balance sheet. The Company used a discount
rate of 6.5%
to determine the lease liability. For the three and nine months ended October 31, 2023, the Company had lease operating costs of approximately
$0 and $32,000, respectively. For the three and nine months ended October 31, 2022, the Company had lease
operating costs of approximately $48,000 and $145,000, respectively.
Suwanee
Office Lease
Upon
acquiring Avelead on August 16, 2021 (refer to Note 3 – Business Combination), the Company assumed an operating lease
agreement for the corporate office space of Avelead. The lessor is an entity controlled by one of the sellers of Avelead and that
seller is a former employee of the Company. The initial 36-month term lease commenced March 1, 2019 and expired on February
28, 2022. The Company previously renewed the lease for an additional 12-month term which expired February 28, 2023 and was
not renewed. For the three and nine months ended October 31, 2023, the Company recorded rent expense of $0 and $6,000,
respectively. For the three and nine months ended October 31, 2022, the Company recorded
rent expense of $18,000 and $55,000, respectively.
NOTE
5 — DEBT
Outstanding
principal balances consisted of the following at:
SCHEDULE
OF OUTSTANDING PRINCIPAL BALANCES
| |
October 31, 2023 | | |
January 31, 2023 | |
Term loan | |
$ | 9,250,000 | | |
$ | 9,750,000 | |
Financing cost payable | |
| 120,000 | | |
| 69,000 | |
Deferred financing cost | |
| (78,000 | ) | |
| (105,000 | ) |
Total | |
| 9,292,000 | | |
| 9,714,000 | |
Less: Current portion of term loan | |
| (1,250,000 | ) | |
| (750,000 | ) |
Non-current portion of term loan | |
| 8,042,000 | | |
| 8,964,000 | |
Non-current portion of line of credit | |
| 500,000 | | |
| — | |
Total non-current portion of debt | |
$ | 8,542,000 | | |
$ | 8,964,000 | |
Term
Loan and Revolving Line of Credit
On
November 29, 2022, the Company executed a Second Modification to Second Amended and Restated Loan Agreement (the “Second Modification”).
The Second Modification includes an expansion of the Company’s total borrowing to include a $2,000,000 non-formula revolving line
of credit. The revolving line of credit will be co-terminus with the term loan and matures on August 26, 2026. There are no requirements
to draw on the line of credit. Amounts outstanding under the line of credit portion of the Second Amended and Restated Loan Agreement
bear interest at a per annum rate equal to the Prime Rate (as published in The Wall Street Journal) plus 1.5%, with a Prime “floor”
rate of 3.25%. The Second Modification amended certain financial covenants in the Second Amended and Restated Loan Agreement. At January
31, 2023 and October 31, 2023, there was $0 and $500,000 outstanding on the revolving
line of credit, respectively.
Under
the Second Amended and Restated Loan Agreement, the Company has a term loan facility with an initial maximum principal amount of $10,000,000.
Amounts outstanding under the Second Amended and Restated Loan Agreement bear interest at a per annum rate equal to the Prime Rate (as
published in The Wall Street Journal) plus 1.5%, with a Prime “floor” rate of 3.25%. The Second Amended and Restated Loan
Agreement has a five-year term, and the maximum principal amount was advanced in a single-cash advance on or about the original closing
date (August 2021). Interest is due monthly, and the Company shall make monthly interest-only payments through the one-year anniversary
of the original closing date. Under the Second Amended and Restated Loan Agreement, principal repayments are required of $500,000 in
the second year, $1,000,000 in the third year, $2,000,000 in the fourth year, and $3,000,000 in the fifth year with the remaining outstanding
principal balance and all accrued but unpaid interest due in full on the maturity date. The Second Amended and Restated Loan Agreement
may also require early repayments if certain conditions are met.
The
Second Amended and Restated Loan Agreement includes customary financial covenants as follows:
|
● |
Minimum
Cash. Borrowers shall, at all times, maintain unrestricted cash of Borrowers at Bank in an amount not less than Two Million
Dollars ($2,000,000). |
|
|
|
|
● |
Maximum
Debt to ARR Ratio. Borrowers’ Maximum Debt to ARR Ratio, measured on a quarterly basis as of the last day of each fiscal
quarter, shall not be greater than the amount set forth under the heading “Maximum Debt to ARR Ratio” as of, and for
each of the dates appearing adjacent to such “Maximum Debt to ARR Ratio”. |
SCHEDULE OF MAXIMUM DEBT TO ARR RATIO
Quarter Ending | |
Maximum Debt to ARR Ratio |
October 31, 2022 | |
0.80 to 1.00 |
January 31, 2023 | |
0.70 to 1.00 |
April 30, 2023 | |
0.65 to 1.00 |
July 31, 2023 | |
0.60 to 1.00 |
October 31, 2023 | |
0.55 to 1.00 |
January 31, 2024 | |
0.50 to 1.00 |
|
● |
Maximum
Debt to Adjusted EBITDA Ratio. Commencing with the quarter ending April 30, 2024, Borrowers’ Maximum Debt to Adjusted
EBITDA Ratio, measured on a quarterly basis as of the last day of each fiscal quarter for the trailing four (4) quarter period then
ended, shall not be greater than the amount set forth under the heading “Maximum Debt to Adjusted EBITDA Ratio” as of,
and for each of the dates appearing adjacent to such “Maximum Debt to Adjusted EBITDA Ratio”. |
SCHEDULE OF MAXIMUM DEBT TO ADJUSTED EBITDA RATIO
Quarter Ending | |
Maximum
Debt to Adjusted
EBITDA Ratio |
April 30, 2024 | |
3.50 to 1.00 |
July 31, 2024 and on the last day of each quarter thereafter | |
2.00 to 1.00 |
|
● |
Fixed
Charge Coverage Ratio. Commencing with the quarter ending April 30, 2024, Borrowers shall maintain a Fixed Charge Coverage
Ratio of not less than 1.20 to 1.00, measured on a quarterly basis as of the last day of each fiscal quarter for the trailing four
(4) quarter period then ended. |
The
Second Amended and Restated Loan Agreement also includes customary negative covenants, subject to exceptions, which limit transfers,
capital expenditures, indebtedness, certain liens, investments, acquisitions, dispositions of assets, restricted payments, and the business
activities of the Company, as well as customary representations and warranties, affirmative covenants and events of default, including
cross defaults and a change of control default. The line of credit also is subject to customary prepayment requirements. Substantially
all the assets of the Company are collateralized by the Second Amended and Restated Loan Agreement. For the periods ended January 31,
2023 and October 31, 2023, the Company was in compliance with the Second Amended and Restated Loan Agreement covenants. However, the Company’s current forecast projects the Company may not be able to maintain compliance with certain
of its financial covenants under the Second Amended and Restated Loan Agreement in the future. The Company is
forecasted to miss certain future covenants. See Note 1 – Basis of Presentation for detail regarding the Company’s assessment
as a going concern.
The
Company records costs related to the maintenance of the Second Amended and Restated Loan Agreement as deferred financing costs, net of
the term loan. These deferred financing costs are being amortized over the remaining term of the loan. The Company has incurred $250,000
in financing costs which becomes payable at the earlier of the term date of the loan, or pre-payment. These costs are being accreted,
through interest expense, to the full value of the $250,000 over the remaining term of the loan.
NOTE
6 — INCOME TAXES
Income
tax benefit increased to $59,000 for
the nine months ended October 31, 2023 compared to expense of $22,000 in the prior year
comparable period. The effective income tax rate on continuing operations of approximately -0-% differs from our combined federal
and state statutory rate of 25% primarily due to the full valuation allowance the Company currently maintains on its net deferred tax
asset.
The
Company has recorded $340,000 and $333,000 in reserves for uncertain tax positions as of October
31, 2023 and January 31, 2023, respectively.
The
Company and its subsidiaries are subject to U.S. federal income tax as well as income taxes in multiple state and local jurisdictions.
The Company has concluded all U.S. federal tax matters for years through January 31, 2019. All material state and local income tax matters
have been concluded for years through January 31, 2018. The Company is no longer subject to IRS examination for periods prior to the
tax year ended January 31, 2019; however, carryforward losses that were generated prior to the tax year ended January 31, 2019 may still
be adjusted by the IRS if they are used in a future period.
NOTE
7 — EQUITY
Capital
Raise
On
October 24, 2022, the Company entered into purchase agreements with certain investors pursuant to which the Company agreed to issue and
sell in a registered direct offering (the “2022 Offering”) an aggregate of 6,299,989 shares of common stock, par value $0.01
per share, at a purchase price of $1.32 per share. The gross proceeds to the Company from the 2022 Offering were approximately $8,316,000.
The Company used the proceeds of the 2022 Offering for general corporate purposes. The 2022 Offering closed on October 26, 2022.
Registration
of Shares Issued to 180 Consulting
On
June 22, 2022, the Company filed a Registration Statement on Form S-3 (Registration No. 333-265773) for the purpose of registering for
resale 272,653 shares of common stock issued to 180 Consulting, LLC (“180 Consulting”). The Registration Statement was declared
effective by the SEC on July 1, 2022.
On
June 28, 2023, the Company filed a Registration Statement on Form S-3 (Registration No. 333-272993) for purpose of registering for resale
394,127 shares of common stock issued to 180 Consulting, LLC (“180 Consulting”). The Registration Statement was declared
effective by the SEC on July 10, 2023.
Authorized
Shares Increase
At
the Annual Meeting of Stockholders held on June 7, 2022, the Company’s stockholders approved an amendment to the Streamline Health
Solutions, Inc. Third Amended and Restated 2013 Stock Incentive Plan to increase the number of shares of the Company’s common stock
authorized for issuance thereunder by 2,000,000 shares, from 8,223,246 shares to 10,223,246 shares. The Company’s stockholders
also approved an amendment to the Company’s Certificate of Incorporation, as amended, to increase the total number of authorized
shares of the Company’s common stock from 65,000,000 shares to 85,000,000 shares.
At
the Annual Meeting of Stockholders held on June 15, 2023, the Company’s stockholders approved an amendment to the Streamline Health
Solutions, Inc. Third Amended and Restated 2013 Stock Incentive Plan to increase the available number of shares of the Company’s
common stock authorized for issuance thereunder by 1,000,000 shares, from 10,223,246 shares to 11,223,246 shares.
NOTE
8 — COMMITMENTS AND CONTINGENCIES
Consulting
Agreement with 180 Consulting, LLC
On
March 19, 2020, the Company entered into a Master Services Agreement (the “MSA”) with 180 Consulting, pursuant to which 180
Consulting has provided and will continue to provide a variety of consulting services in support of eValuator products including product
management, operational consulting, staff augmentation, internal systems platform integration and software engineering services, among
others, through separate executed statements of work (“SOWs”). On September 20, 2021, the Company entered into a separate
MSA in support of Avelead products. Certain of the SOWs include the ability of 180 Consulting to earn common stock of the company at
a conversion rate to be calculated 20 days after the execution of the related SOW. The MSA includes a termination clause upon a 90-day
written notice. While no related party has a direct or indirect material interest in this MSA or the related SOWs, individuals providing
services to the Company under the MSA and the SOWs may share workspace and administrative costs with 121G Consulting, LLC (“121G”).
Mr. Green is a “member” of 121G, and, accordingly, has a financial interest in that entity. 180 Consulting earned 100,037
and 358,190 shares for the three and nine months ended October 31, 2023, respectively, and has earned an aggregate of 1,273,394 shares
of the Company’s common stock through October 31, 2023. 180 Consulting earned 183,284 and 293,190 shares for the three and nine
months ended October 31, 2022, respectively. For services rendered by 180 Consulting during the three and nine months ended October 31,
2023, the Company incurred fees of $639,000 and $2,558,000, respectively, and capitalized non-employee stock compensation of $60,000
and $176,000, respectively. The Company paid fees of $751,000 and $1,781,000 for services rendered by 180 Consulting during the three
and nine months ended October 31, 2022.
Inclusive
of the MSA executed with 180 Consulting are SOWs that provide for the Company to sublicense software through 180 Consulting that is owned
by 121G. This is a services agreement for access to software that assists the Company in implementing and integrating with our clients’
technology. The license agreement is designed such that there is no material financial benefit that accrues to 121G. 180 Consulting licenses
the software from 121G at cost. The Company paid approximately $87,000 and $468,000 for the SOWs that include the sublicense agreement
for the three and nine months ended October 31, 2023, respectively, which are included in the aforementioned totals above.
NOTE
9 — GOODWILL AND INTANGIBLE ASSETS
Goodwill
represents the excess cost over fair value of the net assets of acquired businesses and is not amortized. The Company performs an impairment
assessment of goodwill annually during the fourth quarter of its fiscal year with a valuation date of November 1, or more
frequently if a triggering event occurs.
The
Company’s intangible assets consist of client relationships, acquired and developed technology, and trade names. These
assets are recorded at cost, less accumulated amortization and impairment, if any. All the Company’s intangible assets are
definite lived and amortized on a straight-line basis over their estimated useful lives. Subsequent testing of intangible assets is
conducted when a triggering event occurs that would indicate impairment may exist.
In
October 2023, the Company was notified by a legacy client of its intent to not renew its contract as of its end date on December 31,
2023. At that time, the Company elected to accelerate the execution of a planned strategic restructuring that was designed to reduce
costs while maintaining the Company’s ability to expand its SaaS business. Both the client termination and the execution of the
strategic restructuring were announced on October 16, 2023. Following these announcements, the Company’s share price declined significantly.
Based on these events (collectively, the “Triggering Events”), the Company identified indicators of possible impairment and
initiated testing using a valuation date of October 31, 2023. The impairment tests were conducted under guidance of ASC Topic 360, Impairment
and Disposal of Long-Lived Assets (“ASC 360”) for certain long-lived assets, including capitalized contract costs, developed
technology, client relationships and trade names, and in accordance with ASC Topic 350, Intangibles – Goodwill and Other (“ASC
350”) with respect to the reporting unit’s goodwill.
Goodwill
The
changes in the carrying amount of goodwill were as follows:
SCHEDULE
OF CARRYING AMOUNT OF GOODWILL
| |
Nine Months Ended | |
| |
October 31, 2023 | |
Balance as of January 31, 2023 | |
$ | 23,089,000 | |
Impairment | |
| (9,813,000 | ) |
Balance as of October 31, 2023 | |
$ | 13,276,000 | |
The
Company determined that effective January 31, 2023, it had one reporting unit for purposes of evaluation of goodwill. Based on the Triggering
Events and in conjunction with its preparation of its financial statements for the three and nine months ended October 31, 2023, the
Company tested the reporting unit’s goodwill for possible impairment as of October 31, 2023. The testing for impairment was performed
under the guidance of ASC 360. The testing utilized a discounted debt-free net cash flow (“DCF”) method under the income
approach and the market capitalization method (“MCM”) under the market approach. The sum of the weighted values of each method
was used to derive the fair value of the Company’s equity.
The MCM calculates the aggregate market value of
the Company based on the total number of shares outstanding and the current market price of the shares as of the valuation date. Data
on similar mergers and acquisitions within healthcare technology are observed to determine control premium that represents a stock premium
percentage offered by an acquirer to a public company. The control premium applied to the aggregate market value represents MCM calculated
fair value.
The DCF incorporates the use of projected financial information and a discount
rate using a weighted average cost of capital with cost of equity estimated based on the capital asset pricing model. The cash-flow projections
are based on financial forecasts developed by management that include forecasts of future operating results based on internal budgets
and strategic plans to invest in working capital to support anticipated revenue growth. External factors and business conditions are considered
by management when setting the long-term growth rates. The selected discount rate considers the risk and nature of the reporting unit’s
cash flows and the rates of return market participants would require to invest their capital in the Company.
The
Company concluded that its goodwill was impaired based on the weighted combination of the DCF and MCM value estimates which resulted in a
calculated fair value lower than the equity carrying value. The Company recorded an impairment of goodwill in the amount of $9,813,000
reported as “Goodwill Impairment” on its Condensed Consolidated Statement of Operations for the period ended October 31, 2023.
Intangible
Assets
The
changes in the carrying amounts of the Company’s finite-lived assets were as follows:
SCHEDULE
OF FINITE-LIVED INTANGIBLE ASSETS
| |
| |
October 31, 2023 | |
| |
Estimated Useful Life | |
Gross Assets | | |
Accumulated Amortization | | |
Impairment | | |
Net Assets | |
Finite-lived assets: | |
| |
| | | |
| | | |
| | | |
| | |
Client relationships | |
8-10 years | |
$ | 9,700,000 | | |
$ | 2,216,000 | | |
$ | 963,000 | | |
$ | 6,521,000 | |
Internally developed software | |
9 years | |
| 6,380,000 | | |
| 1,565,000 | | |
| — | | |
$ | 4,815,000 | |
Trademarks and tradenames | |
15 years | |
| 1,340,000 | | |
| 197,000 | | |
| — | | |
$ | 1,143,000 | |
Total | |
| |
$ | 17,420,000 | | |
$ | 3,978,000 | | |
| 963,000 | | |
$ | 12,479,000 | |
ASC
360 defines a multi-step process to test long-lived assets, including intangible assets, for recoverability that if failed would indicate
impairment. First, the Company must consider whether indicators of impairment of long-lived assets are present, which the Company determined
the Triggering Events in conjunction with preparation of its financial statements for the three
and nine months ended October 31, 2023 provided such indication.
Next, the Company must review the long-lived assets to define asset group(s)
that would reflect the lowest level of assets to which discrete cash flows are identifiable. In performing this review, the Company identified
that the long-lived asset “client relationships” related to Avelead should be classified as abandoned (the “Abandoned
Asset”) with the Company determining that it no longer has plans to provide the corresponding consulting service. The Abandoned
Asset’s carrying value would need to be set to its salvage value which would be zero given no future cash flows.
The Company determined the lowest level of discrete cash flows is at the
reporting unit level, and all remaining long-lived assets (excluding the Abandoned Asset) and goodwill would represent its only asset
group. Recoverability is assessed by comparing that the sum of the discrete undiscounted cash flows exceeds the carrying value of the
asset group. The undiscounted cash flow projections are based on 8-year (representing the useful life of the primary asset in the asset
group) financial forecasts developed by management that include forecasts of future operating results based on internal budgets and strategic
plans to investment in working capital to support anticipated revenue growth.
The
undiscounted cash flows for the long-lived assets were above the carrying amounts indicating that the long-lived asset group is
recoverable and no further impairment to long-lived assets exists as of October 31, 2023. For the three-month period ended October
31, 2023, the Company recorded $963,000
as “Impairment of long-lived assets” on its Condensed Consolidated Statement of Operations to adjust the Abandoned Asset
to its salvage value of zero.
NOTE
10 - RELATED PARTY TRANSACTIONS
Refer
to Note 3 – Business Combination. The Company acquired Avelead on August 16, 2021. Accordingly, the Company assumed a lease for
corporate office space from a selling equity-holder of Avelead that is a former employee of the Company. This lease term ended February
2023. For the three and nine months ended October 31, 2023, the Company recorded rent expense of $0 and $6,000, respectively. For the
three and nine months ended October 31, 2022, the Company recorded rent expense of $18,000 and $55,000, respectively (refer to Note 4
– Operating Leases).
Item
2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
FORWARD-LOOKING
STATEMENTS
We
make forward-looking statements in this Quarterly Report on Form 10-Q (this “Report”) and in other materials we file with
the SEC or otherwise make public. This Report, therefore, contains statements about future events and expectations which are forward-looking
statements within the meaning of Sections 27A of the Securities Act of 1933, as amended (the “Securities Act”), and 21E of
the Securities Exchange Act of 1934, as amended (the “Exchange Act”). In addition, our senior management makes forward-looking
statements to analysts, investors, the media and others. Statements with respect to expected revenue, income, receivables, backlog, client
attrition, acquisitions and other growth opportunities, sources of funding operations and acquisitions, the integration of our solutions,
the performance of our channel partner relationships, the sufficiency of available liquidity, research and development, and other statements
of our plans, beliefs or expectations are forward-looking statements. These and other statements using words such as “anticipate,”
“believe,” “estimate,” “expect,” “intend,” “plan,” “project,”
“target,” “can,” “could,” “may,” “should,” “will,” “would”
and similar expressions also are forward-looking statements. Each forward-looking statement speaks only as of the date of the particular
statement. The forward-looking statements we make are not guarantees of future performance, and we have based these statements on our
assumptions and analyses in light of our experience and perception of historical trends, current conditions, expected future developments
and other factors we believe are appropriate under the circumstances. Forward-looking statements by their nature involve substantial
risks and uncertainties that could significantly affect expected results, and actual future results could differ materially from those
described in such statements. Management cautions against putting undue reliance on forward-looking statements or projecting any future
results based on such statements or present or historical earnings levels.
Among
the factors that could cause actual future results to differ materially from our expectations are the risks and uncertainties described
under “Risk Factors” and elsewhere in our Annual Report on Form 10-K for the fiscal year ended January 31, 2023 and in our
subsequent filings with the SEC, and include among others, the following:
|
● |
competitive
products and pricing; |
|
|
|
|
● |
product
demand and market acceptance; |
|
|
|
|
● |
entry
into new markets; |
|
|
|
|
● |
the
possibility that any of the anticipated benefits of the acquisition of Avelead Consulting, LLC (“Avelead”) will not be
realized or will not be realized within the expected time period, the businesses of the Company and the Avelead segment may not be
integrated successfully, or such integration may be more difficult, time-consuming or costly than expected, or revenues following
the Avelead acquisition may be lower than expected; |
|
|
|
|
● |
new
product and services development and commercialization; |
|
|
|
|
● |
key
strategic alliances with vendors and channel partners that resell our products; |
|
|
|
|
● |
uncertainty
in continued relationships with customers due to termination rights; |
|
|
|
|
● |
our
ability to control costs; |
|
|
|
|
● |
availability,
quality and security of products produced, and services provided by third-party vendors; |
|
|
|
|
● |
the
healthcare regulatory environment; |
|
|
|
|
● |
potential
changes in legislation, regulation and government funding affecting the healthcare industry; |
|
|
|
|
● |
healthcare
information systems budgets; |
|
● |
availability
of healthcare information systems trained personnel for implementation of new systems, as well as maintenance of legacy systems; |
|
|
|
|
● |
the
success of our relationships with channel partners; |
|
|
|
|
● |
fluctuations
in operating results; |
|
|
|
|
● |
our
future cash needs; |
|
|
|
|
● |
the
consummation of resources in researching acquisitions, business opportunities or financings and capital market transactions; |
|
|
|
|
● |
the
failure to adequately integrate past and future acquisitions into our business; |
|
|
|
|
● |
critical
accounting policies and judgments; |
|
|
|
|
● |
changes
in accounting policies or procedures as may be required by the Financial Accounting Standards Board or other standard-setting organizations; |
|
|
|
|
● |
changes
in economic, business and market conditions impacting the healthcare industry and the markets in which we operate; |
|
|
|
|
● |
impairment of our goodwill and other intangible assets; |
|
|
|
|
● |
the
extent to which health epidemics and other outbreaks of communicable diseases could disrupt our operations and/or materially and
adversely affect our business and financial conditions; |
|
|
|
|
● |
our
ability to maintain compliance with the terms of our credit facilities; and |
|
|
|
|
● |
our
ability to maintain compliance with the continued listing standards of the Nasdaq Capital Market (“Nasdaq”). |
Most
of these risk factors are beyond our ability to predict or control. Any of these factors, or a combination of these factors, could materially
affect our future financial condition or results of operations and the ultimate accuracy of our forward-looking statements. There also
are other factors that we may not describe (generally because we currently do not perceive them to be material) that could cause actual
results to differ materially from our expectations. We expressly disclaim any obligation to update or revise any forward-looking statements,
whether as a result of new information, future events or otherwise, except as required by law.
On
August 16, 2021, the Company entered into a Unit Purchase Agreement (“UPA”) to acquire Avelead, a recognized leader in providing
solutions and services to improve revenue integrity for healthcare providers nationwide. The Company believes Avelead’s solutions
will complement and extend the value the Company can deliver to its customers. Operations for Avelead are included in the Company’s
consolidated financial information from the acquisition date. Refer to Note 3 – Business Combination in our unaudited condensed
consolidated financial statements included in Part I, Item I, “Financial Statements” for further information on the Avelead
acquisition.
During
the fiscal third quarter ended October 31, 2022, the Company strengthened its balance sheet through a capital raise. On October 24,
2022, the Company entered into purchase agreements with certain investors pursuant to which the Company agreed to issue and sell in
a registered direct offering (the “2022 Offering”), an aggregate of 6,299,989 shares of common stock, par value $0.01 per share, at a purchase
price of $1.32 per share. The gross proceeds to the Company from the 2022 Offering were approximately $8.3 million. The 2022
Offering closed on October 26, 2022.
The
Company expanded its existing relationship with its debt partner, Western Alliance Bank, in the fourth quarter of 2022. On November 29,
2022, the Company executed a Second Modification to the Second Amended and Restated Loan Agreement (“Second Modification”).
The Second Modification includes an expansion of the Company’s total borrowing to include a $2,000,000 non-formula revolving line
of credit. The revolving line of credit is co-terminus with the term loan, which matures on August 26, 2026. The Second Modification
includes modified covenants through the term of the Second Amended and Restated Loan Agreement. See Item 1, Note 5 - Debt, for discussion
of the Second Modification.
On October 16, 2023, the Company announced it was executing a strategic
restructuring designed to reduce expenses while maintaining the Company’s ability to expand its SaaS business. The strategic restructuring
initiatives included a reduction in force, resulting in the termination of 26 employees, or approximately 24% of the Company’s workforce.
To execute the strategic restructuring, the Company estimates the one-time restructuring costs associated with the workforce reduction
to be approximately $900,000, and the Company expects the expenses associated with the strategic restructuring to be substantially recognized
by the end of fiscal year 2023. The Company recorded $749,000 of the estimated expenses in the three months ending October 31, 2023, which
consisted of approximately $730,000 in severance and other employee termination-related expenses and approximately $19,000 in incurred
legal fees. The remaining estimated cost pertains to various professional fees the Company may require to assist with execution of the
strategic restructuring. The Company expects to realize approximately $5,800,000 in annualized cost savings as a result of the strategic
restructuring. Approximately 60% of the expected savings are related to the reduction in force and will be realized beginning in the fourth
quarter of fiscal year 2023. The remaining expected savings are vendor related expenses which are expected to result in cost savings beginning
in the first quarter of fiscal year 2024.
Results
of Operations
Revenues
| |
Three Months Ended | | |
| | |
| |
($ in thousands): | |
October 31, 2023 | | |
October 31, 2022 | | |
Change | | |
% Change | |
| |
| | |
| | |
| | |
| |
Software as a service | |
$ | 3,924 | | |
$ | 3,209 | | |
$ | 715 | | |
| 22 | % |
Maintenance and support | |
| 1,070 | | |
| 1,120 | | |
| (50 | ) | |
| (4 | )% |
Professional fees and licenses | |
| 1,139 | | |
| 1,888 | | |
| (749 | ) | |
| (40 | )% |
Total Revenues | |
$ | 6,133 | | |
$ | 6,217 | | |
$ | (84 | ) | |
| (1 | )% |
| |
Nine Months Ended | | |
| | |
| |
($ in thousands): | |
October 31, 2023 | | |
October 31, 2022 | | |
Change | | |
% Change | |
| |
| | |
| | |
| | |
| |
Software as a service | |
$ | 10,630 | | |
$ | 9,157 | | |
$ | 1,473 | | |
| 16 | % |
Maintenance and support | |
| 3,327 | | |
| 3,348 | | |
| (21 | ) | |
| (1 | )% |
Professional fees and licenses | |
| 3,278 | | |
| 5,639 | | |
| (2,361 | ) | |
| (42 | )% |
Total Revenues | |
$ | 17,235 | | |
$ | 18,144 | | |
$ | (909 | ) | |
| (5 | )% |
Software
as a Service (SaaS) — Revenue from SaaS for the three- and nine-month periods ended October 31, 2023 increased by $715,000
and $1,473,000, respectively, compared to the prior year periods. The increase in SaaS revenue for the three and nine-month period ended
October 31, 2023 is primarily due to new clients on the Company’s eValuator, RevID and Compare products offset by non-renewals
of certain clients. Beginning in the first quarter of fiscal 2024, we anticipate lower SaaS revenue for the short term due primarily
to a large client non-renewal of RevID and Compare.
We
have approximately $2.7 million of annualized contract value of SaaS contracts to be implemented as of October 31, 2023.
The industry has been impacted by hospital personnel shortages and a backlog of hospital IT projects. This has resulted in slower contract-to-implementation
timelines, which is delaying revenue recognition for such contracts. It is uncertain how long these headwinds will impact our implementation
timelines.
Maintenance
and support — For both the three- and nine-month periods ended October 31, 2023, revenue from maintenance and support remained
relatively consistent compared to the prior year periods. The Company does not anticipate maintenance and support growth due to the Company’s
shift to its growth products that are classified as software as a service.
Professional
fees and licenses — Proprietary software revenue for the three- and nine-month periods ended October 31, 2023 remained
consistent compared to the prior year periods. The Company has primarily shifted the business from perpetual software licenses to a SaaS model. Software license sales come solely from our channel partners; therefore, the periodic amounts are less predictable
and consistent than recurring revenues.
For
the three- and nine-month periods ended October 31, 2023, revenue from professional services decreased by $749,000 and $2,110,000, respectively,
compared to the prior year periods. The decrease in professional fees is primarily driven by the termination of client consulting agreements
at the close of fiscal year 2022 that did not align with the Company’s long-term strategy. These terminations resulted in a decrease
in professional services revenue for the three and nine months ended October 31, 2023 of $884,000 and $2,572,000, respectively,
compared to the prior year periods. The Company is primarily focused on growth of its SaaS products, and, accordingly, is not expecting
growth in professional services for the remainder of the fiscal year.
For the three-month period ended October 31, 2023, revenue from audit services
remained consistent compared to the prior year period. For the nine-month period ended October 31,2023, audit services revenue overall
decreased by $201,000 compared to the prior year period. This decrease included $938,000 of revenue in the prior year nine-month period
for agreements not renewed by clients that was offset by $611,000 from new audit service agreements plus $126,000 of additional revenue
from amended agreements with increased scope. The company is primarily focused on utilizing audit services to support its eValuator product.
Accordingly, the Company does not expect revenue growth in the future in audit services.
Cost
of Sales
| |
Three Months Ended | | |
| | |
| |
(in thousands): | |
October 31, 2023 | | |
October 31, 2022 | | |
Change | | |
% Change | |
Cost of software as a service | |
$ | 1,677 | | |
$ | 1,742 | | |
$ | (65 | ) | |
| (4 | )% |
Cost of maintenance and support | |
| 129 | | |
| 84 | | |
| 45 | | |
| 54 | % |
Cost of professional fees and licenses | |
| 1,072 | | |
| 1,744 | | |
| (672 | ) | |
| (39 | )% |
Total cost of sales | |
$ | 2,878 | | |
$ | 3,570 | | |
$ | (692 | ) | |
| (19 | )% |
| |
Nine Months Ended | | |
| | |
| |
(in thousands): | |
October 31, 2023 | | |
October 31, 2022 | | |
Change | | |
% Change | |
Cost of software as a service | |
$ | 5,159 | | |
$ | 4,771 | | |
$ | 388 | | |
| 8 | % |
Cost of maintenance and support | |
| 250 | | |
| 220 | | |
| 30 | | |
| 14 | % |
Cost of professional fees and licenses | |
| 3,202 | | |
| 4,992 | | |
| (1,790 | ) | |
| (36 | )% |
Total cost of sales | |
$ | 8,611 | | |
$ | 9,983 | | |
$ | (1,372 | ) | |
| (14 | )% |
Cost
of software as a service (SaaS) - The cost of SaaS solutions is comprised of salaries, amortization of capitalized software
development and third-party content provider costs. Certain costs in SaaS solutions are tied to volumes, such as number of users.
These costs include coding tools supporting eValuator and a third-party system that enable the Company’s products to ingest
data from the hospital system. For the three months ended October 31, 2023, the cost of SaaS solutions decreased $65,000 compared to
the prior year period. The decrease is driven by lower personnel costs of $216,000 offset by an increase in amortization of
capitalized assets for RevID and Compare of $69,000 compared to the prior year three-month period. For the nine months ended October
31,2023 the cost of software as a service increased $388,000 compared to the prior year period. The increase was driven by an
increase in vendor costs of $1,008,000 offset by lower personnel costs of $690,000 compared to the prior year nine-month period. The
Company expects the cost of SaaS solutions will continue to increase as revenue increases.
For
the three and nine months ended October 31, 2023, the cost of SaaS solutions includes non-cash charges of $572,000 and $1,692,000,
respectively, related to the amortization of capitalized software, which impacts SaaS margin by 15% and 16%,
respectively. The Company expects margins related to SaaS solutions to increase in the future for clients currently in the process
of implementation. Certain costs, such as labor and third-party content providers, impact the gross margin before a customer is
fully implemented and revenue is recognized.
Cost
of maintenance and support - The cost of maintenance and support includes compensation and benefits for client support personnel
and the cost of third-party content provider contracts. The costs for the three and nine months ended October 31, 2023 remained consistent
with the comparable prior year periods.
Cost
of professional fees and licenses – The cost of professional fees and licenses include each of professional services, audit
and coding services and software licenses. The overall change for cost of professional fees and licenses for the three and nine months
ended October 31, 2023 decreased $672,000 and $1,790,000, respectively, compared to the prior year periods.
The
cost of professional fees includes compensation and benefits for personnel and related expenses. For the three and nine months ended
October 31, 2023, professional services costs decreased by $659,000 and $1,847,000, respectively, compared to the prior year
periods. These decreases were driven by a large customer contract cancellation at the end of fiscal year 2022 resulting in lower
personnel and third-party contractor costs. This lower cost of professional fees is expected to continue, when compared with the
prior year, throughout fiscal year 2023.
The
cost of audit services includes compensation and benefits for audit services personnel, and related expenses. The costs for the
three months ended October 31, 2023 remained consistent compared to the prior year period with a slight increase of $13,000. The costs for the nine months ended
October 31, 2023 increased, compared to the corresponding prior year period, by $159,000 due to an increase in employee related
expenses.
The
cost of software licenses for the three and nine months ended October 31, 2023 decreased by $27,000 and $102,000, respectively, compared
to the prior year periods due to lower amortization of development costs related to the Company’s coding/CDI product. The Company
expects software license costs to continue to decrease due to the maturity of the non-SaaS software products.
Selling,
General and Administrative Expense
| |
Three Months Ended | | |
| | |
| |
($ in thousands): | |
October 31, 2023 | | |
October 31, 2022 | | |
Change | | |
% Change | |
General and administrative expenses | |
$ | 2,798 | | |
$ | 2,692 | | |
$ | 106 | | |
| 4 | % |
Sales and marketing expenses | |
| 1,324 | | |
| 1,363 | | |
| (39 | ) | |
| (3 | )% |
Total selling, general, and administrative expense | |
$ | 4,122 | | |
$ | 4,055 | | |
$ | 67 | | |
| 2 | % |
| |
Nine Months Ended | | |
| | |
| |
($ in thousands): | |
October 31, 2023 | | |
October 31, 2022 | | |
Change | | |
% Change | |
General and administrative expenses | |
$ | 8,220 | | |
$ | 8,253 | | |
$ | (33 | ) | |
| (0 | )% |
Sales and marketing expenses | |
| 3,859 | | |
| 4,376 | | |
| (517 | ) | |
| (12 | )% |
Total selling, general, and administrative expense | |
$ | 12,079 | | |
$ | 12,629 | | |
$ | (550 | ) | |
| (4 | )% |
General
and administrative expenses consist primarily of compensation and related benefits, reimbursable travel and entertainment expenses
related to our executive and administrative staff, general corporate expenses, amortization of intangible assets, and occupancy
costs. For the three months ended October 31, 2023, the increase in general and administrative expenses of $106,000 was driven
primarily by an increase in stock compensation expense of $207,000 due to accelerated vesting of grants, as well as an increase of
severance expense of $278,000, offset by decreased employee salaries, bonuses, and benefits of $208,000. The Company also saw a
decrease in rent expense of $57,000 and a decrease of $77,000 related to computer equipment and software. For the nine months ended
October 31, 2023, the general and administrative expenses remained generally consistent compared to the prior year
period.
Sales
and marketing expenses consist primarily of compensation and related benefits and travel and entertainment expenses related to our sales
and marketing staff, as well as advertising and marketing expenses, including trade shows. For the three months ended October 31, 2023,
sales and marketing expenses remained consistent compared to the prior year period. For the nine months ended October 31, 2023, the decrease
of $517,000 was primarily driven by a decrease in professional services and marketing expenses of $446,000, severance expense of $105,000,
and travel-related expenses of $60,000, offset by an increase in salaries, bonuses, commissions, and benefits of
$77,000, compared to the prior year period.
Research
and Development
| |
Three Months Ended | | |
| | |
| |
($ in thousands): | |
October 31, 2023 | | |
October 31, 2022 | | |
Change | | |
% Change | |
Research and development expense | |
$ | 1,304 | | |
$ | 1,754 | | |
$ | (450 | ) | |
| (26 | )% |
Capitalized research and development cost | |
| 535 | | |
| 563 | | |
| (28 | ) | |
| (5 | )% |
| |
Nine Months Ended | | |
| | |
| |
($ in thousands): | |
October 31, 2023 | | |
October 31, 2022 | | |
Change | | |
% Change | |
Research and development expense | |
$ | 4,310 | | |
$ | 4,527 | | |
$ | (217 | ) | |
| (5 | )% |
Capitalized research and development cost | |
| 1,556 | | |
| 1,450 | | |
| 106 | | |
| 7 | % |
Research
and development expense consists primarily of compensation and related benefits and the use of independent contractors for specific near-term
development projects. Research and development expenses for the three and nine months ended October 31, 2023 decreased by $450,000 and
$217,000, respectively, compared to the prior year periods. The prior year comparable periods included additional one-time non-capitalizable projects completed by our third-party
partner plus higher headcount from operating separate product innovation teams. The consolidation of the teams and completion of the one-time
projects reduced the overall research and development expense for fiscal year 2023.
Capitalized
research and development costs for the three months ended October 31, 2023 remained consistent with the prior year period.
Capitalized research and development costs for the nine months ended October 31, 2023 increased by approximately $106,000 compared
to the prior year period due to additional projects being capitalized for the products. With the recent strategic restructuring, the Company expects capitalization rates will decrease.
Impairment
of Goodwill
| |
Three Months Ended | | |
| | |
| |
($ in thousands): | |
October 31, 2023 | | |
October 31, 2022 | | |
Change | | |
% Change | |
Impairment of Goodwill | |
$ | 9,813 | | |
$ | — | | |
$ | 9,813 | | |
| 100 | % |
| |
Nine Months Ended | | |
| | |
| |
($ in thousands): | |
October 31, 2023 | | |
October 31, 2022 | | |
Change | | |
% Change | |
Impairment of Goodwill | |
$ | 9,813 | | |
$ | — | | |
$ | 9,813 | | |
| 100 | % |
Based on the Triggering Events and in conjunction with its preparation
of its financial statements for the three and nine months ended October 31, 2023, the Company tested the reporting unit’s goodwill
for possible impairment as of October 31, 2023. Refer to the Goodwill section of Note 9 — Goodwill and Intangible Assets of the
unaudited condensed consolidated financial statements included in Part I, Item I, “Financial Statements” for more information
on the goodwill impairment testing.
The
Company concluded that goodwill was impaired based on the weighted combination of the DCF and MCM value estimates which resulted in a calculated
fair value lower than its carrying value. The Company recorded an impairment of goodwill in the amount of $9,813,000 for the three- and
nine-month periods ended October 31, 2023, with no goodwill impairments reported in the prior year comparable periods.
Impairment
of long-lived assets
| |
Three Months Ended | | |
| | |
| |
($ in thousands): | |
October 31, 2023 | | |
October 31, 2022 | | |
Change | | |
% Change | |
Impairment of long-lived assets | |
$ | 963 | | |
$ | — | | |
$ | 963 | | |
| 100 | % |
| |
| | | |
| | | |
| | | |
| | |
| |
Nine Months Ended | | |
| | |
| |
($ in thousands): | |
October 31, 2023 | | |
October 31, 2022 | | |
Change | | |
% Change | |
Impairment of long-lived assets | |
$ | 963 | | |
$ | — | | |
$ | 963 | | |
| 100 | % |
| |
| | | |
| | | |
| | | |
| | |
Based
on the Triggering Events and in conjunction with its preparation of its financial statements for the three and nine months ended October
31, 2023, the Company tested long-lived assets, including intangible assets, for recoverability that, if failed, would indicate impairment.
The Company, in reviewing long-lived assets to define asset group(s), identified an abandoned asset. A separate long-lived asset for
“client relationships” related to Avelead was no longer going to be used following the Company’s determination that
these services were not part of its core offerings going forward. The Company adjusted the abandoned asset’s carrying value to
its salvage value which would be zero given no future cash flows.
Refer to the Intangible
Assets section of Note 9 — Goodwill and Intangible Assets of the unaudited condensed consolidated financial statements included
in Part I, Item I, “Financial Statements” for more information on the long-lived asset impairment testing.
For
the three- and nine-month periods ended October 31, 2023, the Company recorded $963,000 representing the impairment of the Abandoned
Asset with no other long-lived impairments reported in the prior year comparable periods.
Other
Income (Expense)
| |
Three Months Ended | | |
| | |
| |
($ in thousands): | |
October 31, 2023 | | |
October 31, 2022 | | |
Change | | |
% Change | |
Interest expense | |
$ | (266 | ) | |
$ | (198 | ) | |
$ | (68 | ) | |
| 34 | % |
Acquisition earnout valuation adjustments | |
| 1,182 | | |
| 163 | | |
| 1,019 | | |
| 625 | % |
Miscellaneous income | |
| — | | |
| 68 | | |
| (68 | ) | |
| (100 | )% |
Total other income | |
$ | 916 | | |
$ | 33 | | |
$ | 883 | | |
| 2,676 | % |
| |
Nine Months Ended | | |
| | |
| |
($ in thousands): | |
October 31, 2023 | | |
October 31, 2022 | | |
Change | | |
% Change | |
Interest expense | |
$ | (781 | ) | |
$ | (519 | ) | |
$ | (262 | ) | |
| 50 | % |
Acquisition earnout valuation adjustments | |
| 1,905 | | |
| 188 | | |
| 1,717 | | |
| 913 | % |
Miscellaneous income | |
| 31 | | |
| 151 | | |
| (120 | ) | |
| (79 | )% |
Total other (expense) income | |
$ | 1,155 | | |
$ | (180 | ) | |
$ | 1,335 | | |
| (742 | )% |
Interest
expense consists of interest associated with the term loan, deferred financing costs, and line of credit, less interest related to capitalization
of software. Interest expense increased for the three and nine months ended October 31, 2023 from the comparable prior year periods primarily
due to the $10,000,000 term loan and $500,000 outstanding line or credit with Western Alliance Bank (See Note 5 – Debt) and the
associated increased interest rate on that debt. Interest rate increases are expected to continue to increase interest expense (year-over-year)
through the remainder of fiscal year 2023.
The
acquisition earnout valuation is related to the liabilities associated with the Avelead acquisition (Refer to Note 3 –
Business Combination of the unaudited condensed consolidated financial statements included in Part I, Item I, “Financial
Statements”). For the three and nine months ended October 31, 2023, the Company recorded a valuation income adjustment of
$1,182,000 and $1,905,000, respectively, compared to $163,000 and $188,000, respectively, for the comparable prior year periods. The
valuation adjustment is caused by the decrease in the value of the stock to be transferred under the arrangement.
Miscellaneous
income is primarily from the sublease of the Alpharetta location (Refer to Note 4 – Operating Leases of the unaudited condensed
consolidated financial statements included in Part I, Item I, “Financial Statements”).
Provision
for Income Taxes
We
recorded an income tax benefit of $120,000 and income tax expense of $9,000 for the three months ended October 31, 2023 and 2022, respectively,
and income tax benefit of $59,000 and income tax expense of $22,000 for the nine months ended October 31, 2023 and 2022, respectively,
which is comprised of estimated federal, state and local income tax provisions. The
Company has a substantial amount of net operating losses for federal and state income tax purposes. The effective income tax rate on continuing operations of approximately
0% differs from our combined federal and state statutory rate of 25% primarily due to the full valuation allowance the Company currently
maintains on its net deferred tax asset.
Use
of Non-GAAP Financial Measures
In
order to provide investors with greater insight and allow for a more comprehensive understanding of the information used by management
and the Board of Directors in its financial and operational decision-making, the Company has supplemented the condensed consolidated
financial statements presented on a GAAP basis in this Report with the following non-GAAP financial measures: EBITDA, Adjusted EBITDA
and Adjusted EBITDA Margin.
These
non-GAAP financial measures have limitations as analytical tools and should not be considered in isolation or as a substitute for analysis
of Company results as reported under GAAP. The Company compensates for such limitations by relying primarily on our GAAP results and
using non-GAAP financial measures only as supplemental data. We also provide a reconciliation of non-GAAP to GAAP measures used. Investors
are encouraged to carefully review this reconciliation. In addition, because these non-GAAP measures are not measures of financial performance
under GAAP and are susceptible to varying calculations, these measures, as defined by us, may differ from and may not be comparable to
similarly titled measures used by other companies.
EBITDA,
Adjusted EBITDA, and Adjusted EBITDA Margin
We
define: (i) EBITDA as net earnings (loss) before net interest expense, income tax expense (benefit), depreciation and amortization;
(ii) Adjusted EBITDA as net earnings (loss) before net interest expense, income tax expense (benefit), depreciation, amortization,
share-based compensation expense, transaction related expenses and other expenses that do not relate to our core operations such as
severances and impairment charges; and (iii) Adjusted EBITDA Margin as Adjusted EBITDA as a percentage of GAAP net revenue. EBITDA,
Adjusted EBITDA and Adjusted EBITDA Margin are used to facilitate a comparison of our operating performance on a consistent basis
from period to period and provide for a supplemental understanding of factors and trends affecting our business than GAAP measures
alone. These measures assist management and the Board of Directors, and may be useful to investors in comparing our operating performance
consistently over time as they remove the impact of our capital structure (primarily interest charges), asset base (primarily
depreciation and amortization), items outside the control of the management team (taxes) and expenses that do not relate to our core
operations including: transaction-related expenses (such as professional and advisory services), corporate restructuring expenses
(such as severances) and other operating costs that are expected to be non-recurring. Adjusted EBITDA removes the impact of
share-based compensation expense, which is another non-cash item.
The
Board of Directors and management also use these measures (i) as one of the primary methods for planning and forecasting overall expectations
and for evaluating, on at least a quarterly and annual basis, actual results against such expectations; and (ii) as a performance evaluation
metric in determining achievement of certain executive and associate incentive compensation programs.
Our
lender uses a measurement that is similar to the Adjusted EBITDA measurement described herein to assess our operating performance. The
lender under our Second Amended and Restated Loan Agreement requires delivery of compliance reports certifying compliance with financial
covenants, certain of which are based on a measurement that is similar to the Adjusted EBITDA measurement reviewed by our management
and Board of Directors.
EBITDA,
Adjusted EBITDA, and Adjusted EBITDA Margin are not measures of liquidity under GAAP or otherwise and are not alternatives to cash flow
from continuing operating activities, despite the supplemental information provided by these measures regarding the use and analysis
of these measures as mentioned above. EBITDA, Adjusted EBITDA, and Adjusted EBITDA Margin, as disclosed in this Report have limitations
as analytical tools, and you should not consider these measures in isolation or as a substitute for analysis of our results as reported
under GAAP; nor are these measures intended to be measures of liquidity or free cash flow for our discretionary use. Some of the limitations
of EBITDA and its variations are:
|
● |
EBITDA
does not reflect our cash expenditures or future requirements for capital expenditures or contractual commitments; |
|
|
|
|
● |
EBITDA
does not reflect changes in, or cash requirements for, our working capital needs; |
|
|
|
|
● |
EBITDA
does not reflect the interest expense, or the cash requirements to service interest or principal payments under our Second Amended
and Restated Loan Agreement; |
|
|
|
|
● |
EBITDA
does not reflect income tax payments that we may be required to make; and |
|
|
|
|
● |
Although
depreciation and amortization are non-cash charges, the assets being depreciated and amortized often will have to be replaced in
the future, and EBITDA does not reflect any cash requirements for such replacements. |
Adjusted
EBITDA has all the inherent limitations of EBITDA. To properly and prudently evaluate our business, the Company encourages readers to
review the GAAP financial statements included elsewhere in this Report, and not rely on any single financial measure to evaluate our
business. We also strongly urge readers to review the reconciliation of these non-GAAP financial measures to the most comparable GAAP
measure in this section, along with the condensed consolidated financial statements included above.
The
following table reconciles EBITDA and Adjusted EBITDA to net loss from continuing operations for the three and nine months ended October
31, 2023 (amounts in thousands). All of the items included in the reconciliation from EBITDA and Adjusted EBITDA to net loss are either
recurring non-cash items, or items that management does not consider in assessing our on-going operating performance. In the case of
the non-cash items, management believes that investors may find it useful to assess the Company’s comparative operating performance
because the measures without such items are less susceptible to variances in actual performance resulting from depreciation, amortization
and other expenses that do not relate to our core operations and are more reflective of other factors that affect operating performance.
In the case of items that do not relate to our core operations, management believes that investors may find it useful to assess our operating
performance if the measures are presented without these items because their financial impact does not reflect ongoing operating performance.
| |
Three Months Ended | | |
Nine Months Ended | |
In thousands, except per share data | |
October 31, 2023 | | |
October 31, 2022 | | |
October 31, 2023 | | |
October 31, 2022 | |
Adjusted EBITDA Reconciliation | |
| | | |
| | | |
| | | |
| | |
Net Loss | |
$ | (11,911 | ) | |
$ | (3,138 | ) | |
$ | (17,327 | ) | |
$ | (9,197 | ) |
Interest expense | |
| 266 | | |
| 198 | | |
| 781 | | |
| 519 | |
Income tax (benefit) expense | |
| (120 | ) | |
| 9 | | |
| (59 | ) | |
| 22 | |
Depreciation and amortization | |
| 1,105 | | |
| 1,053 | | |
| 3,186 | | |
| 3,212 | |
EBITDA | |
$ | (10,660 | ) | |
$ | (1,878 | ) | |
$ | (13,419 | ) | |
$ | (5,444 | ) |
Share-based compensation expense | |
| 517 | | |
| 555 | | |
| 1,626 | | |
| 1,212 | |
Impairment of goodwill | |
| 9,813 | | |
| — | | |
| 9,813 | | |
| — | |
Impairment of long-lived assets | |
| 963 | | |
| — | | |
| 963 | | |
| — | |
Non-cash valuation adjustments | |
| (1,182 | ) | |
| (163 | ) | |
| (1,905 | ) | |
| (188 | ) |
Acquisition-related costs, severance, and transaction-related bonuses | |
| 213 | | |
| 387 | | |
| 389 | | |
| 1,010 | |
Restructuring charges | |
| 749 | | |
| — | | |
| 749 | | |
| — | |
Other non-recurring charges | |
| — | | |
| (73 | ) | |
| (33 | ) | |
| (140 | ) |
Adjusted EBITDA | |
$ | 413 | | |
$ | (1,172 | ) | |
$ | (1,817 | ) | |
$ | (3,550 | ) |
Adjusted EBITDA margin (1) | |
| 7 | % | |
| (19 | )% | |
| (11 | )% | |
| (20 | )% |
(1) |
Adjusted
EBITDA as a percentage of GAAP net revenue. |
Application
of Critical Accounting Policies
The
preparation of financial statements in conformity with GAAP requires management to make estimates and judgments that affect the
reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements
and the reported amount of revenue and expenses during the reporting period. Management considers an accounting policy to be
critical if the accounting policy requires management to make particularly difficult, subjective, or complex judgments about matters
that are inherently uncertain. A summary of our critical accounting policies is included in Note 2 to our consolidated financial
statements in our Annual Report on Form 10-K for the fiscal year ended January 31, 2023. Except as discussed below, there have been
no material changes to the critical accounting policies disclosed in our Annual Report on Form 10-K for the fiscal year ended
January 31, 2023.
Goodwill
and Intangible Assets
The Company completed its annual goodwill assessment during the fourth quarter
of fiscal year 2022. We determined, as of January 31, 2023, the Company has one reporting unit for purposes of evaluation of goodwill
as a result of the Company’s consolidation of operations of Streamline and Avelead at the end of fiscal year 2022. We used a weighted
sum of income and market approaches to determine the fair value of the Company’s goodwill. Under the income approach, the fair value
was based on the present value of the estimated debt-free, discounted cash flows that the reporting unit is expected to generate. Cash
flow projections were based on management’s estimates of revenue growth rates and operating margins, taking into consideration industry
and market conditions. The discount rate was based on the weighted average cost of capital appropriate for the Company.
In the third quarter of 2023, the Company received a notice from a significant
SaaS client of its intent not to renew its contract following the expiration of the current term on December 31, 2023. The Company also
announced it was accelerating a planned strategic restructuring to allow it to reduce costs while continuing to focus on expanding its
SaaS operations. These announcements triggered a significant decrease in the Company’s share price. Based on these factors, we determined
there were indicators that the goodwill may be impaired, and accordingly, performed an interim goodwill impairment test as of October
31, 2023. The results of the impairment test showed that the fair value of the reporting unit was lower than the carrying value, resulting
in a $9.8 million goodwill impairment charge. As of October 31, 2023, the remaining goodwill balance of the Company after recording the
goodwill impairment charge was $13 million.
Also, during the third quarter of 2023, due to the factors discussed above,
we assessed whether the carrying amounts of the Company’s long-lived assets may not be recoverable and, therefore, impaired. Our
assessment resulted in an impairment charge of $1 million, primarily related to client relationships related to a subset of consulting
related services the Company expects to not be a core part of its business going forward. The charge was calculated using the asset’s
salvage value as it was considered no longer held for use.
The
fair value of our reporting unit and intangible assets is subjective in nature and involves the use of significant estimates and assumptions,
particularly related to future operating results and cash flows. These estimates and assumptions include, but are not limited to, revenue
growth rates and operating margins used to calculate projected future cash flows, risk-adjusted discount rates, and future economic and
market conditions. If we do not achieve our forecasts or the Company’s share price declines further, it is possible the goodwill
of the Company could be deemed to be impaired again in a future period.
The
risks and potential impacts on the fair value of our goodwill and long-lived assets are included in our risk factor disclosures referenced
under “Item 1A. Risk Factors” in the Company’s Quarterly Report on Form 10-Q for the quarter ended October 31, 2023.
Liquidity,
Capital Resources, and Going Concern
The
Company’s liquidity is dependent upon numerous factors including: (i) the timing and amount of revenue and collection of contractual
amounts from customers, (ii) amounts invested in research and development and capital expenditures, and (iii) the level of operating
expenses, all of which can vary significantly from quarter to quarter. The Company’s primary cash requirements include regular
payment of payroll and other business expenses, principal and interest payments on debt and capital expenditures, which generally include
computer hardware. Operations are funded with cash generated by operations and borrowings under credit facilities.
Information concerning the Company’s assessment as a going concern is included in Note 1 – Basis of Presentation in our unaudited
condensed consolidated financial statements included in Part I, Item I, “Financial Statements”. Cash and cash equivalent
balances at October 31, 2023 and January 31, 2023 were approximately $2,557,000 and $6,598,000, respectively.
On
October 24, 2022, the Company entered into purchase agreements with certain investors pursuant to which the Company agreed to issue
and sell in a registered direct offering (the “2022 Offering”) an aggregate of 6,299,989 shares of common stock, par
value $0.01 per share, at a purchase price of $1.32 per share. The gross proceeds to the Company
from the 2022 Offering were approximately $8.3 million. The Company intends to use the proceeds of the 2022 Offering for general
corporate purposes. The 2022 Offering closed on October 26, 2022.
The
Company has liquidity through the Second Amended and Restated Loan Agreement described in more detail in Note 5 – Debt in our unaudited
condensed consolidated financial statements included in Part I, Item I, “Financial Statements”. The Company has a term loan
facility with an initial, maximum, principal amount of $10,000,000. Amounts outstanding under the Second Amended and Restated Loan Agreement
bear interest at a per annum rate equal to the Prime Rate (as published in The Wall Street Journal) plus 1.5%, with a Prime “floor”
rate of 3.25%. The Second Modification amended the covenants of the Second Amended and Restated Loan Agreement. Refer to Note 5 –
Debt for information regarding the Second Modification. At October 31, 2023, there was $500,000 outstanding on the revolving
line of credit.
The
Second Amended and Restated Loan Agreement includes customary financial covenants, including the requirements that the Company achieve
certain EBITDA levels and fixed coverage ratios and maintain certain cash balances and certain recurring revenue levels. The Second Amended
and Restated Loan Agreement also includes customary negative covenants, subject to exceptions, which limit transfers, capital expenditures,
indebtedness, certain liens, investments, acquisitions, dispositions of assets, restricted payments, and the business activities of the
Company, as well as customary representations and warranties, affirmative covenants and events of default, including cross defaults and
a change of control default. As of October 31, 2023, the Company was in compliance with all debt covenants under the Second Amended and
Restated Loan Agreement. The Company is forecasted to miss certain future covenants. See Note 1 – Basis of Presentation for detail
regarding the Company’s assessment as a Going Concern.
Significant
cash obligations
(in thousands) | |
October 31, 2023 | | |
January 31, 2023 | |
Term loan (1) | |
$ | 9,292 | | |
$ | 9,714 | |
Acquisition earnout liability (2) | |
| 1,833 | | |
| 3,738 | |
Restructuring severance (3) | |
| 731 | | |
| — | |
Line of credit (4) | |
| 500 | | |
| — | |
(1) |
Term
loan balance is reported net of deferred financing costs of $78,000 and $105,000 as of October 31, 2023 and January 31, 2023, respectively,
and financing cost payable of $120,000 and $69,000 as of October 31, 2023 and January 31, 2022, respectively. Refer to Note 5 –
Debt for additional information. The term loan payable as of October 31, 2023 and January 31, 2023 was bank term debt under the Second
Amended and Restated Loan Agreement. |
|
|
(2) |
The
fair value of the acquisition earnout liability is based upon a probability-weighted discounted cash flow as of October 31, 2023
and January 31, 2023, respectively. The second year earnout is expected to be paid during the quarterly period ending January 31, 2024, subject
to a dispute and resolution process. Refer to Note 3 — Business Combination. |
|
|
(3) |
Refer to the “Restructuring” section of Note 2 – Summary
of Significant Accounting Policies. The outstanding severance payable balance was related to the recent restructuring. |
|
|
(4) |
Refer
to Note 5 – Debt for additional information. The outstanding balance of the line of credit as of October 31, 2023 was related
to the Second Amended and Restated Loan Agreement. |
Operating
cash flow activities
| |
Nine months Ended | |
(in thousands) | |
October 31, 2023 | | |
October 31, 2022 | |
Net loss from continuing operations | |
$ | (17,327 | ) | |
$ | (9,197 | ) |
Non-cash adjustments to net loss | |
| 13,657 | | |
| 4,317 | |
Cash impact of changes in assets and liabilities | |
| 1,509 | | |
| 159 | |
Net cash used in operating activities | |
$ | (2,161 | ) | |
$ | (4,721 | ) |
The net cash used in operating activities improved during the nine months
ended October 31, 2023 compared with the prior year comparable period. This improvement was a higher cash impact of changes in operating
assets and liabilities, driven by a decrease in accounts and contract receivables as a result of the timing of cash payments received,
and a decrease in both deferred revenue and accrued expense for the period ended October 31, 2023. Both the net loss from continuing
operations and the non-cash adjustments to net loss for the nine months ended October 31, 2023 include impairment of long-lived assets of $963,000
and impairment of goodwill of $9,813,000.
Investing
cash flow activities
| |
Nine months Ended | |
(in thousands) | |
October 31, 2023 | | |
October 31, 2022 | |
Purchases of property and equipment | |
$ | (47 | ) | |
$ | (10 | ) |
Capitalized software development costs | |
| (1,562 | ) | |
| (1,435 | ) |
Net cash used in investing activities | |
$ | (1,609 | ) | |
$ | (1,445 | ) |
The cash used in investing activities for the nine months ended October
31, 2023 and October 31, 2022, includes capitalized software development costs. Capitalization of costs is expected to begin to decrease
for the remainder of fiscal year 2023 as a result of the recently announced strategic restructuring. See discussion and analysis in “Research
and development costs” above.
Financing
cash flow activities
| |
Nine months Ended | |
(in thousands) | |
October 31, 2023 | | |
October 31, 2022 | |
Repayment of term loan payable | |
$ | (500 | ) | |
$ | (125 | ) |
Proceeds from line of credit | |
| 500 | | |
| — | |
Proceeds from issuance of common stock | |
| — | | |
| 8,316 | |
Payments for costs directly attributable to the issuance of common stock | |
| — | | |
| (52 | ) |
Payments related to settlement of employee share-based awards | |
$ | (271 | ) | |
$ | (165 | ) |
Other | |
$ | — | | |
$ | 6 | |
Net cash (used in) provided by financing activities | |
$ | (271 | ) | |
$ | 7,980 | |
The
cash used in financing activities in the nine months ended October 31, 2023, and October 31, 2022, includes principal payments on
the term loan related to the Second Amended and Restated Loan Agreement and payments related to settlement of employee share-based
awards. The Company received proceeds from the line of credit related to the Second Amended and Restated Loan Agreement for the nine
months ended October 31, 2023. The cash provided by financing activities in the nine months ended October 31, 2022 was a result of the 2022 Offering of the Company’s common stock, which closed on October 26, 2022.
Item
3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
As
a “smaller reporting company,” as defined by Item 10 of Regulation S-K, we are not required to provide this information.
Item
4. CONTROLS AND PROCEDURES
Evaluation
of Disclosure Controls and Procedures
Our
President and Chief Executive Officer (who serves as our principal executive officer) and our Interim Chief Financial Officer (who
serves as our principal financial officer) have evaluated the effectiveness of our disclosure controls and procedures (as defined in
Exchange Act Rule 13a-15(e) as of October 31, 2023. Based on that evaluation, our President and Chief Executive Officer and our
Interim Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of October 31,
2023.
Changes
in Internal Control over Financial Reporting
There
were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act)
that occurred during the quarter ended October 31, 2023 that have materially affected, or are reasonably likely to materially affect,
our internal control over financial reporting.
PART
II. OTHER INFORMATION
Item
1. LEGAL PROCEEDINGS
We
are, from time to time, a party to various legal proceedings and claims, which arise in the ordinary course of business. We are not aware
of any legal matters that could have a material adverse effect on our consolidated results of operations, financial position, or cash
flows.
Item
1A. RISK FACTORS
An
investment in our common stock or other securities involves a number of risks. You should carefully consider each of the risks described
in our Annual Report on Form 10-K for the fiscal year ended January 31, 2023 which Annual Report includes a detailed discussion of the
Company’s risk factors. If any of the risks develop into actual events, our business, financial condition, or results of operations
could be negatively affected, the market price of our common stock or other securities could decline, and you may lose all or part of
your investment.
Except
as described below, there have been no material changes to the risk factors disclosed in Item 1A of our Annual Report on Form 10-K for
the fiscal year ended January 31, 2023.
We
may not be able to generate sufficient cash flows or raise additional debt and equity capital to fund our ongoing operations. We will
need to raise additional funding, which may not be available on acceptable terms, if at all. If we are unable to raise additional capital
in amounts and on terms sufficient to fund our ongoing operations, our lack of additional capital and results of operations could limit
our ability to continue operations.
Our
ability to continue as a going concern is dependent upon generating sufficient cash flow from operations and obtaining additional debt
and equity financing. If our ability to generate cash flow from operations is curtailed or delayed, our financial condition and results
of operations could be materially impacted. We have been dependent on sales of our equity securities and debt financing to meet our ongoing
cash requirements. There can be no assurances that we would be able to obtain debt or equity financing when needed, on terms acceptable
to the Company, or at all, and our failure to raise additional capital in amounts and on terms sufficient to fund our operations could
limit our ability to continue operations.
If
we do not meet the continued listing standards of The Nasdaq Capital Market, our common stock could be delisted from trading, which could
limit investors’ ability to make transactions in our common stock and subject us to additional trading restrictions.
Our
common stock is currently listed on The Nasdaq Capital Market which imposes continued listing requirements with respect to listed shares.
On October 24, 2023, we received a letter from the Listing Qualifications Department of Nasdaq, indicating that our common stock was
subject to potential delisting from The Nasdaq Capital Market because, for a period of thirty (30) consecutive business days, the bid
price of our common stock had closed below the minimum $1.00 per share requirement for continued listing on The Nasdaq Capital Market
pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Requirement”). Nasdaq stated in its letter that in accordance
with the Nasdaq Listing Rules, we have been provided an initial period of one hundred eighty (180) calendar days, or until April 22,
2024, to regain compliance with the Bid Price Requirement. The letter states that Nasdaq will provide written notification that we have
achieved compliance with the Bid Price Requirement if at any time before April 22, 2024, the bid price of our common stock closes at
$1.00 per share or more for a minimum of ten (10) consecutive business days.
If
we fail to regain compliance by April 22, 2024, we may be eligible for an additional one hundred eighty (180) calendar day compliance
period to demonstrate compliance with the Bid Price Requirement. To qualify for the additional one hundred eighty (180) day period, we
will be required to meet the continued listing requirement for market value of publicly held shares set forth in Nasdaq Listing Rule
5550(a) and all other listing standards for The Nasdaq Capital Market set forth in Nasdaq Listing Rule 5505, with the exception of the
Bid Price Requirement, and will need to provide written notice to Nasdaq to cure the deficiency during the second compliance period by
effecting a reverse stock split, if necessary. If we do not qualify for the second compliance period or we fail to regain compliance
during the second one hundred eighty (180)-day period, then Nasdaq will notify us of its determination to delist our common stock, at
which we would have an opportunity to appeal the delisting determination to a Hearings Panel.
In
the event that our common stock is delisted from The Nasdaq Capital Market and is not eligible for quotation or listing on another market
or exchange, trading of our common stock could be conducted only in the over-the-counter market or on an electronic bulletin board established
for unlisted securities such as the Pink Sheets or the OTC Bulletin Board. In such event, it could become more difficult to dispose of,
or obtain accurate price quotations for, our common stock, and there would likely also be a reduction in our coverage by securities analysts
and the news media, which could cause the price of our common stock to decline further. Also, it may be difficult for us to raise additional
capital if we are not listed on a major exchange.
Such
a delisting would also likely have a negative effect on the price of our common stock and would impair your ability to sell or purchase
our common stock when you wish to do so. In the event of a delisting, we may take actions to restore our compliance with The Nasdaq Capital
Market listing requirements, but we can provide no assurance that any such action taken by us would allow our common stock to become
listed again, stabilize the market price or improve the liquidity of our common stock, prevent our common stock from dropping below the
Bid Price Requirement or prevent future non-compliance with The Nasdaq Capital Market listing requirements.
If
our goodwill or other intangible assets become impaired, our results of operations and capitalization could be negatively impacted.
We
have significant intangible assets, including goodwill and other long-lived assets, which are susceptible to valuation adjustments as
a result of changes in various factors or conditions. Whenever events or changes in circumstances indicate that the carrying value may
not be recoverable, we will be required to assess the potential impairment of goodwill and other intangible assets. Factors that could
trigger an impairment of such assets include, but are not limited to, (i) changes in our organization or management reporting structure
that could result in additional reporting units, which may require alternative methods of estimating fair values or greater disaggregation
or aggregation in our analysis by reporting unit; (ii) under performance relative to historical or projected future operating results;
(iii) changes in the strategy for our overall business; (iv) negative industry or economic trends; (v) decline in our stock price for
a sustained period; and (vi) our market capitalization declining to below net book value.
For
the fiscal quarter ended October 31, 2023, the Company recorded (i) a goodwill impairment charge of $9,813,000 as a result of the impairment
analysis in connection with the significant decline in the Company’s share price that was in response to the Company announcing
acceleration of a strategic restructure plus a significant SaaS client notice to terminate as of December 31, 2023 and (ii) an impairment
on finite-lived assets of $963,000 due to the Company’s conclusion that its Customer Relationships (Consulting) asset was considered
abandoned and therefore fully impaired under ASC 360 as of October 31, 2023. Future adverse changes in these or other unforeseeable factors
could result in additional impairment charges that would negatively impact our results of operations and financial position in the reporting
period identified.
Item
2. Unregistered Sales of Equity Securities, Use of Proceeds, AND ISSUER PURCHASES OF EQUITY SECURITIES
During
the three months ended October 31, 2023, the Company issued to 180 Consulting an aggregate of 131,054 shares of common stock as compensation
for services previously rendered during the three months ended July 31, 2023. Such shares were issued pursuant to the Master Services
Agreement, effective March 19, 2020, by and between the Company and 180 Consulting and related statements of work. The shares were issued
in a private placement in reliance on the exemption from registration available under Section 4(a)(2) of the Securities Act, including
Regulation D promulgated thereunder and the certificate representing such shares has a legend imprinted on it stating that the shares
have not been registered under the Securities Act and cannot be transferred until properly registered under the Securities Act or pursuant
to an exemption from such registration.
The
following table sets forth information with respect to our repurchases of common stock during the three months ended October 31, 2023:
| |
| | |
| | |
Total | | |
Maximum | |
| |
| | |
| | |
Number
of | | |
Number | |
| |
| | |
| | |
Shares | | |
of
Shares | |
| |
| | |
| | |
Purchased | | |
that
May | |
| |
Total | | |
| | |
as
Part of | | |
Yet
Be | |
| |
Number
of | | |
| | |
Publicly | | |
Purchased | |
| |
Shares | | |
Average | | |
Announced | | |
under
the | |
| |
Purchased | | |
Price
Paid | | |
Plans
or | | |
Plans
or | |
| |
| (1) | | |
| per
Share | | |
| Programs | | |
| Programs | |
Aug
1 - Aug 31 | |
| — | | |
$ | — | | |
| — | | |
| — | |
Sep
1 - Sep 30 | |
| 4,923 | | |
| 0.95 | | |
| — | | |
| — | |
Oct
1 - Oct 31 | |
| 33,112 | | |
| 0.43 | | |
| — | | |
| — | |
Total | |
| 38,035 | | |
$ | 0.50 | | |
| — | | |
| — | |
(1) |
Amount
represents shares surrendered by employees to satisfy tax withholding obligations resulting from restricted stock that vested during
the three months ended October 31, 2023. |
Item
5. OTHER INFORMATION
During
the three months ended October 31, 2023, none of our directors or officers (as defined in Rule 16a-1(f) of the Securities Exchange Act
of 1934, as amended) adopted or terminated a Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement (as such terms are
defined in Item 408 of Regulation S-K of the Securities Act of 1933).
Item
6. EXHIBITS
See
Index to Exhibits.
INDEX
TO EXHIBITS
Exhibit
No. |
|
Description
of Exhibit |
3.1 |
|
Certificate of Incorporation of Streamline Health Solutions, Inc. f/k/a LanVision Systems, Inc., as amended through August 19, 2014 (Incorporated by reference from Exhibit 3.1 of the Quarterly Report on Form 10-Q, filed September 15, 2014). |
3.2 |
|
Certificate of Amendment of Certificate of Incorporation of Streamline Health Solutions, Inc. (Incorporated by reference from Exhibit 3.1 of the Current Report on Form 8-K, filed May 24, 2021). |
3.3 |
|
Certificate of Amendment of Certificate of Incorporation of Streamline Health Solutions, Inc. (Incorporated by reference from Exhibit 3.1 of the Current Report on Form 8-K, filed June 8, 2022). |
3.4 |
|
Bylaws of Streamline Health Solutions, Inc., as amended and restated through March 28, 2014 (Incorporated by reference from Exhibit 3.1 of the Current Report on Form 8-K, filed April 3, 2014). |
10.1 |
|
Amendment No. 3 to Streamline Health Solutions, Inc. Third Amended and Restated 2013 Stock Incentive Plan, dated June 15, 2023 (Incorporated by reference from Appendix B to the Company’s Definitive Proxy Statement, dated May 11, 2023, for the Company’s 2023 Annual Meeting of Stockholders). |
10.2 |
|
Employment Agreement, dated December 4, 2023, by and between Company and Bryant James Reeves |
31.1* |
|
Certification
by President and Chief Executive Officer pursuant to Rule 13a-14(a) of the Exchange Act. |
31.2* |
|
Certification by Chief Financial Officer pursuant to Rule 13a-14(a) of the Exchange Act. |
32.1* |
|
Certification
by President and Chief Executive Officer pursuant to 18 U.S.C. Section 1350. |
32.2* |
|
Certification by Chief Financial Officer pursuant to 18 U.S.C. Section 1350. |
101.INS* |
|
INLINE
XBRL INSTANCE DOCUMENT |
101.SCH* |
|
INLINE
XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT |
101.CAL* |
|
INLINE
XBRL TAXONOMY EXTENSION CALCULATION LINKBASE |
101.DEF* |
|
INLINE
XBRL TAXONOMY EXTENSION DEFINITION LINKBASE |
101.LAB* |
|
INLINE
XBRL TAXONOMY EXTENSION LABELS LINKBASE |
101.PRE* |
|
INLINE
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE |
104* |
|
COVER
PAGE INTERACTIVE DATA FILE (FORMATTED AS INLINE XBRL AND CONTAINED IN EXHIBIT 101) |
Our
SEC file number reference for documents filed with the SEC pursuant to the Securities Exchange Act of 1934, as amended, is 000-28132.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
|
STREAMLINE
HEALTH SOLUTIONS, INC. |
|
|
|
DATE:
December 14, 2023 |
By:
|
/s/
Benjamin L. Stilwill |
|
|
Benjamin
L. Stilwill
President
and Chief Executive Officer |
|
|
|
DATE:
December 14, 2023 |
By:
|
/s/
Bryant J. Reeves III |
|
|
Bryant
J. Reeves III |
|
|
Interim
Chief Financial Officer |
Exhibit
10.2
EMPLOYMENT
AGREEMENT
This
EMPLOYMENT AGREEMENT (together with Exhibit A attached hereto, the “Agreement”) is entered as of December
4th, 2023, by and between Streamline Health, LLC, a Delaware limited liability company with its headquarters in Alpharetta,
Georgia (the “Company”), and Bryant James Reeves, a resident of the state of Georgia (“Executive”).
RECITALS:
WHEREAS,
the Company is a wholly owned subsidiary of Streamline Health Solutions, Inc. (“STRM”);
WHEREAS,
the Company and Executive hereby agree that Executive will serve as an officer of the Company pursuant to the terms and conditions set
forth in this Agreement.
NOW,
THEREFORE, in consideration of the premises and the agreements contained herein, and for other good and valuable consideration, the
receipt and adequacy of which the parties hereby acknowledge, the parties agree as follows:
1.
EMPLOYMENT
The
Company hereby agrees to employ Executive, and Executive, in consideration of such employment and other consideration set forth herein,
hereby accepts employment, upon the terms and conditions set forth herein.
2.
POSITION AND DUTIES
During
the Term (as defined in Section 10 of this Agreement), Executive will be employed as Interim CFO may also serve as an officer or director
of affiliates of the Company for no additional compensation, as part of Executive’s services to the Company hereunder. While employed
hereunder, Executive will do all things necessary, legal and incident to the above positions, and otherwise will perform such executive-level
functions, as the President of Streamline Health, LLC (the “President”) or other person as may be designated by the
Company as are commensurate with Executive’s position, to whom Executive will report, or other person(s) the Board of Directors
of STRM (the “Board”) may establish from time to time.
3.
COMPENSATION AND BENEFITS
Subject
to such modifications as may be contemplated by Exhibit A attached hereto and approved from time to time by the Board or the Compensation
Committee of the Board of Directors of STRM (the “Committee”), and unless otherwise consented to by Executive, during
the Term, Executive will receive the compensation and benefits listed on the attached Exhibit A, which is incorporated herein
and expressly made a part of this Agreement. Such compensation and benefits will be paid and provided by the Company in accordance with
the Company’s regular payroll, compensation and benefits plans, programs and policies, as in effect from time to time.
4.
EXPENSES
The
Company will pay or reimburse Executive for all travel and out-of-pocket expenses reasonably incurred or paid by Executive in connection
with the performance of Executive’s duties as an employee of the Company upon compliance with the Company’s procedures for
expense reimbursement, including the presentation of expense statements or receipts or such other supporting documentation as the Company
may reasonably require. All expenses eligible for reimbursement in connection with the Executive’s employment with the Company
must be incurred by Executive during the term of employment and must be in accordance with the Company’s expense reimbursement
policies. The amount of reimbursable expenses incurred in one taxable year will not affect the expenses eligible for reimbursement in
any other taxable year. Each category of reimbursement will be paid as soon as administratively practicable, but in no event will any
such reimbursement be paid after the last day of the taxable year following the taxable year in which the expense was incurred. No right
to reimbursement is subject to liquidation or exchange for other benefits.
5.
BINDING AGREEMENT
The
Company warrants and represents to Executive that the Company, acting by the officer executing this Agreement on its behalf of the Company,
has the full right and authority to enter into this Agreement and to perform all of its obligations hereunder.
6.
OUTSIDE EMPLOYMENT
Executive
will devote Executive’s full time and attention to the performance of the duties incident to Executive’s position with the
Company, and will not have any other employment with any other enterprise or substantial responsibility for any enterprise which would
be inconsistent with Executive’s duty to devote Executive’s full time and attention to Company matters; provided, however,
that the foregoing will not prevent Executive from participation in any charitable or civic organization or, subject to President
consent, which consent will not be unreasonably withheld, from service in a non-executive capacity on the boards of directors of up to
two (2) other companies that does not interfere with Executive’s performance of the duties and responsibilities to be performed
by Executive under this Agreement.
7.
CONFIDENTIAL INFORMATION AND TRADE SECRETS
The
Company is in the business of providing solutions, including comprehensive suites of health information management solutions relating
to enterprise content management, computer assisted coding, business analytics, clinical analytics, patient scheduling and integrated
workflow systems, that help hospitals, physician groups and other healthcare organizations improve efficiencies and business processes
across the enterprise to enhance and protect revenues, offering a flexible, customizable way to optimize the clinical and financial performance
of any healthcare organization (the “Business”).
For
the purpose of this Agreement, “Confidential Information” will mean proprietary or confidential data, information,
documents, or materials (in oral, written, unwritten or electronic form) which belongs to or pertains to the Company’s Business
and which was disclosed to Executive or which Executive became aware of as a consequence of Executive’s relationship with the Company.
Confidential Information includes, without limitation, the Company’s services, processes, patents, systems, equipment, creations,
designs, formats, programming, discoveries, inventions, improvements, computer programs, data kept on computers, engineering, research,
development, applications, financial information, information regarding services and products in development, market information, including
test marketing or localized marketing, other information regarding processes or plans in development, trade secrets, training manuals,
know-how of the Company, and the customers, clients, suppliers and others with whom the Company does or has in the past done, business
(including any information about the identity of the Company’s customers or suppliers and written customer lists and customer prospect
lists), or information about customer requirements, transactions, work orders, pricing policies, plans or any other Confidential Information,
which the Company deems confidential and proprietary and which is generally not known to others outside the Company and which gives or
tends to give the Company a competitive advantage over persons who do not possess such information or the secrecy of which is otherwise
of value to the Company in the conduct of its business — regardless of when and by whom such information was developed or acquired,
and regardless of whether any of these are described in writing, reduced to practice, copyrightable or considered copyrightable, patentable
or considered patentable; provided, however, that “Confidential Information” will not include general industry
information or information which is publicly available or is otherwise in the public domain without breach of this Agreement, information
which Executive has lawfully acquired from a source other than through their employment with the Company, or information which is required
to be disclosed pursuant to any law, regulation or rule of any governmental body or authority or court order (in which event Executive
will immediately notify the Company of such requirement or order so as to give the Company an opportunity to seek a protective order
or other manner of protection prior to production or disclosure of the information). Executive acknowledges that Confidential Information
is novel and proprietary to and of considerable value to the Company.
Confidential
Information will also include confidential information of third parties, clients or prospective clients that has been provided to the
Company or to Executive in conjunction with Executive’s employment, which information the Company is obligated to treat as confidential.
Confidential Information does not include information voluntarily disclosed to the public by the Company, except where such public disclosure
has been made by the Executive without authorization from the Company, or which has been independently developed and disclosed by others,
or which has otherwise entered the public domain through lawful means.
Executive
acknowledges that all Confidential Information is the valuable, unique and special asset of the Company and that the Company owns the
sole and exclusive right, title and interest in and to this Confidential Information.
(a)
To the extent that the Confidential Information rises to the level of a trade secret under applicable law, then Executive will, during
Executive’s employment and for as long thereafter as the Confidential Information remains a trade secret (or for the maximum period
of time otherwise allowed under applicable law) protect and maintain the confidentiality of these trade secrets and refrain from disclosing,
copying or using the trade secrets without the Company’s prior written consent, except as necessary in Executive’s performance
of Executive’s duties while employed with the Company.
(b)
To the extent that the Confidential Information defined above does not rise to the level of a trade secret under applicable law, Executive
will not, during Executive’s employment and thereafter for a period of two (2) years, disclose, or cause to be disclosed in any
way, Confidential Information, or any part thereof, to any person, firm, corporation, association or any other operation or entity, or
use the Confidential Information on Executive’s own behalf, for any reason or purpose except as necessary in the performance of
her duties while employed with the Company. Executive further agrees that, during Executive’s employment and thereafter for a period
of two (2) years, Executive will not distribute, or cause to be distributed, Confidential Information to any third person or permit the
reproduction of Confidential Information, except on behalf of the Company in Executive’s capacity as an employee of the Company.
Executive will take all reasonable care to avoid unauthorized disclosure or use of the Confidential Information. Executive agrees that
all restrictions contained in this Section 7 are reasonable and valid under the circumstances and hereby waives all defenses to the strict
enforcement thereof by the Company.
Notwithstanding
the foregoing, nothing in this Agreement is intended to or will be used in any way to prevent Executive from testifying truthfully under
oath in a judicial proceeding or to limit Executive’s right to communicate with a government agency, as provided for, protected
under or warranted by applicable law. Further, Executive shall not be held criminally or civilly liable under any federal or state trade
secret law for the disclosure of a trade secret that (i) is made in confidence to a federal, state, or local government official, either
directly or indirectly, or to an attorney and solely for the purpose of reporting or investigating a suspected violation of law or (ii)
is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal. In addition, if Executive
files a lawsuit for retaliation for reporting a suspected violation of law, Executive may disclose the trade secret to their attorney
and use the trade secret information in the court proceeding, as long as Executive files any document containing the trade secret under
seal and does not disclose the trade secret, except pursuant to court order.
Executive
agrees that, upon the request of the Company, or in any event immediately upon termination of their employment for whatever reason, Executive
will immediately deliver up to the Company or its designee all Confidential Information in Executive’s possession or control, and
all notes, records, memoranda, correspondence, files and other papers, and all copies thereof, relating to or containing Confidential
Information. Executive does not have, nor can Executive acquire, any property or other rights in Confidential Information.
8.
PROPERTY OF THE COMPANY
All
ideas, inventions, discoveries, proprietary information, know-how, processes and other developments and, more specifically, improvements
to existing inventions, conceived by Executive, alone or with others, during the term of Executive’s employment with the Company,
whether or not during working hours and whether or not while working on a specific project, that are within the scope of the Company’s
Business operations or that relate to any work or projects of the Company, shall be deemed to be a “work made for hire” (as
defined in the United States Copyright Act, 17 U.S.C.A. §101 et seq., as amended) to the greatest extend possible and are and will
remain the exclusive property of the Company. Inventions, improvements and discoveries relating to the Business of the Company conceived
or made by Executive, either alone or with others, while employed with the Company are conclusively and irrefutably presumed to have
been made during the period of employment and are the sole property of the Company. The Executive will promptly disclose in writing any
such matters to the Company but to no other person without the consent of the Company. Executive hereby assigns and agrees to assign
all right, title and interest in and to such matters to the Company. Executive will, upon request of the Company, execute such assignments
or other instruments and assist the Company in the obtaining, at the Company’s sole expense, of any patents, trademarks or similar
protection, if available, in the name of the Company.
9.
PROTECTIVE COVENANTS
(a)
Non-Solicitation of Customers, Clients, or Vendors. During Executive’s employment and for a period of two (2) years following
the date of any voluntary or involuntary termination of Executive’s employment for any reason, Executive agrees not to solicit,
directly or indirectly (including by assisting others), any business from any of the Company’s customers, clients, or vendors (including
actively sought prospective customers, clients, or vendors) with whom Executive has had material contact during the most recent two (2)
years prior to the solicitation for the purpose of providing products or services that are competitive with those provided by the Company.
(b)
Non-Piracy of Employees. During Executive’s employment and for a period of two (2) years following the date of any voluntary
or involuntary termination of Executive’s employment for any reason, Executive covenants and agrees that Executive will not, directly
or indirectly, on Executive’s own behalf or on behalf of any other person or entity (i) solicit, recruit or hire (or attempt to
solicit, recruit or hire) or otherwise assist anyone in soliciting, recruiting or hiring, any employee or independent contractor of the
Company who performed work for the Company and with whom Executive had material business contact within the last year of Executive’s
employment with the Company to work for or provide services to any business that competes with the Business, or (ii) otherwise encourage,
solicit or support any such employee or independent contractor to leave their or their employment or engagement with the Company or to
violate the terms of any agreement or understanding between that individual and the Company.
(c)
Non-Compete. During Executive’s employment with the Company and for a period of two (2) years following the date of any
voluntary, or one (1) year following the date of any involuntary, termination of Executive’s employment for any reason, Executive
agrees not to, directly or indirectly, either on Executive’s own behalf or on behalf of any other person or entity, in the Territory,
compete with the Company by performing services for any person or entity competitor engaging in competition with the Business, that are
the same as or similar to the duties performed by Executive during the most recent two (2)-year period, provided that the foregoing will
not prohibit Executive from owning not more than five percent (5%) of the outstanding stock of a corporation subject to the reporting
requirements of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The “Territory”
will be defined to be that geographic area comprised of the following states in the United States of America, the District of Columbia,
and the Canadian provinces of Quebec and Alberta:
Alabama |
Indiana |
Nebraska |
South
Carolina |
Alaska |
Iowa |
Nevada |
South
Dakota |
Arizona |
Kansas |
New
Hampshire |
Tennessee |
Arkansas |
Kentucky |
New
Jersey |
Texas |
California |
Louisiana |
New
Mexico |
Utah |
Colorado |
Maine |
New
York |
Vermont |
Connecticut
Delaware |
Maryland |
North
Carolina |
Virginia |
Florida |
Massachusetts |
North
Dakota |
Washington |
Georgia |
Michigan |
Ohio |
West
Virginia |
Hawaii |
Minnesota |
Oklahoma |
Wisconsin |
Idaho |
Mississippi |
Oregon |
Wyoming |
Illinois |
Missouri |
Pennsylvania |
|
|
Montana |
Rhode
Island |
|
;
provided, however, that the Territory described herein is a good faith estimate of the geographic area that is now applicable as
the area in which the Company does business during the term of Executive’s employment, and the Company and Executive agree that
this non-compete covenant will ultimately be construed to cover only so much of such Territory as relates to the geographic areas in
which the Executive does business for and on behalf of the Company within the most recent two (2)-year period.
10.
TERM
Unless
earlier terminated pursuant to Section 11 herein, the term of this Agreement will be for a period beginning on the effective date specified
in Exhibit A and ending on 12/05/2024 (the “Initial Term”). Upon expiration of the Initial Term, this Agreement
will automatically renew in successive twelve (12)-month periods (each a “Renewal Period”), unless Executive or the
Company notifies the other party at least sixty (60) days prior to the end of the Initial Term or the applicable Renewal Period that
this Agreement will not be renewed. The Initial Term, and, if this Agreement is renewed in accordance with this Section 10, each Renewal
Period, will be included in the definition of “Term” for purposes of this Agreement. Unless waived in writing by the
Company, the requirements of Section 7 (Confidential Information and Trade Secrets), Section 8 (Property of the Company) and Section
9 (Protective Covenants) will survive the expiration or termination of this Agreement or Executive’s employment for any reason.
11.
TERMINATION
(a)
Death. This Agreement and Executive’s employment hereunder will be terminated on the death of Executive, effective as of
the date of Executive’s death. In such event, the Company will pay to the estate of Executive the sum of (i) accrued but unpaid
Base Salary (as defined in Exhibit A) earned prior to Executive’s death (to be paid in accordance with normal practices of the
Company or as otherwise required by law) and (ii) expenses incurred by Executive prior to their death for which Executive is entitled
to reimbursement under (and paid in accordance with) Section 4 herein, and Executive will be entitled to no severance or other post-termination
benefits.
(b)
Continued Disability. This Agreement and Executive’s employment hereunder may be terminated, at the option of the Company,
upon a Continued Disability (as defined herein) of Executive. For the purposes of this Agreement, and unless otherwise required under
Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”), “Continued Disability”
will be defined as the inability or incapacity (either mental or physical) of Executive to continue to perform Executive’s duties
hereunder for a continuous period of one hundred twenty (120) working days, or if, during any calendar year of the Term hereof because
of disability, Executive was unable to perform Executive’s duties hereunder for a total period of one hundred eighty (180) working
days regardless of whether or not such days are consecutive. The determination as to whether Executive is unable to perform the duties
of Executive’s job will be made by the Board or the Committee in its reasonable discretion; provided, however, that if Executive
is not satisfied with the decision of the Board or the Committee, Executive will submit to examination by three (3) competent physicians
who practice in the metropolitan area in which the Company maintains its principal executive office, one of whom will be selected by
the Company, another of whom will be selected by Executive, with the third to be selected by the physicians so selected. The determination
of a majority of the physicians so selected will supersede the determination of the Board or the Committee and will be final and conclusive.
In the event of the termination of Executive’s employment due to Continued Disability, the Company will provide to Executive (i)
accrued but unpaid Base Salary earned through the date of the Executive’s termination of employment (paid in accordance with the
normal practices of the Company or as otherwise required by law), (ii) expenses incurred by Executive prior to their termination of employment
for which Executive is entitled to reimbursement under (and paid in accordance with) Section 4 herein, and (iii) any vested benefits
earned by the Executive under any employee benefit plan of the Company or its affiliates under which he was participating immediately
prior to the termination date, which such benefits to be provided in accordance with the terms of the applicable employee benefit plan
(the “Accrued Obligations”), and Executive will be entitled to no severance or other post-termination benefits.
(c)
Termination by the Company for Good Cause, by Executive Other Than for Good Reason, or upon Non-Renewal of the Term by Company or
Executive. Notwithstanding any other provision of this Agreement, the Company may at any time terminate this Agreement and Executive’s
employment hereunder for Good Cause, Executive may at any time terminate her employment other than for Good Reason (as defined in Section
11(d) herein), Company may notify Executive that it will not renew the Term, or Executive may notify the Company that he will not renew
the Term. For this purpose, “Good Cause” will include the following: the current use of illegal drugs; conviction
of any crime which involves moral turpitude, fraud or misrepresentation; commission of any act which would constitute a felony or which
adversely impacts the business or reputation of the Company; fraud; misappropriation or embezzlement of Company funds or property; willful
misconduct or grossly negligent or reckless conduct which is materially injurious to the reputation, business or business relationships
of the Company; material violation or default on any of the provisions of this Agreement; or material and continuous failure to meet
reasonable performance criteria or reasonable standards of conduct as established from time to time by the Board, which failure continues
for at least thirty (30) days after written notice from the Company to Executive. Notice of a termination by the Company for Good Cause
will be delivered in writing to Executive stating the Good Cause for such action. If the employment of Executive is terminated by the
Company for Good Cause, if Executive terminates employment for any reason other than for Good Reason (including, but not limited to,
resignation or retirement), or if Executive notifies the Company he will not renew the Term, then, the Company will provide Executive
(i) accrued but unpaid salary through the termination date (paid in accordance with the normal practices of the Company or as otherwise
required by law), (ii) expenses incurred by Executive prior to their termination date for which Executive is entitled to reimbursement
under (and paid in accordance with) Section 4 herein and (iii) any vested benefits earned by the Executive under any employee benefit
plan of the Company or its affiliates under which he was participating immediately prior to the termination date, which such benefits
to be provided in accordance with the terms of the applicable employee benefit plan, and Executive will be entitled to no severance or
other post- termination benefits. For the sake of clarity, no election by the Company not to renew the Term will trigger any rights to
severance or other benefits.
(d)
Termination by the Company without Good Cause or by Executive for Good Reason. The Company may terminate this Agreement and Executive’s
employment at any time, including for reasons other than Good Cause (as “Good Cause” is defined in Section 11(c) above.
For the purposes herein, “Good Reason” will mean (i) a material diminution of Executive’s base salary; (ii)
a material diminution in Executive’s authority, duties, or responsibilities; or (iii) any other action or inaction that constitutes
a material breach of the terms of this Agreement; provided that Executive’s termination will not be treated as for Good Reason
unless Executive provides the Company with notice of the existence of the condition claimed to constitute Good Reason within ninety (90)
days of the initial existence of such condition and the Company fails to remedy such condition within thirty (30) days following the
Company’s receipt of such notice. In the event that (i) the Company terminates the employment of Executive during the Term for
reasons other than for Good Cause, death or Continued Disability or (ii) Executive terminates employment for Good Reason, then Executive
shall be entitled to the Accrued Obligations (as defined in Section 11(b)) and, subject to Executive’s signing, delivering and
not revoking a complete general release of all claims against the Company in a form acceptable to the Company (the “Release”),
which Release must be signed, delivered and not revoked within the period set forth in the Release, and provided that Executive is not
in default of her obligations under Section 7, 8, or 9 herein, the following:
(i)
Payment of an amount equal to six (6) months of Executive’s base salary in effect at the time of termination, payable in accordance
with the regular pay periods of the Company (but no less frequently than monthly and in equal installments) beginning on the first payroll
date following the date of termination of employment provided, however, that all payments otherwise due during the first sixty (60) days
following termination of employment shall be accumulated and, if the Release requirements have been met, paid on the sixtieth (60th)
day following termination of employment.
(ii)
Payment of the Annual Bonus (as defined in Exhibit A) at the rate of base pay and subject to attainment of annual performance goals specified
in Exhibit A for the fiscal year during which Executive terminates employment under this Section 11(d), prorated for the number of months
from the beginning of the fiscal year through the date of termination and payable at the same time the Annual Bonus (if any) is normally
payable as set forth in Exhibit A. For purposes of this provision, and by way of example, if Executive’s employment is terminated
under this Section 11(d)after the last day of a fiscal year but before the Annual Bonus (if any) for such completed fiscal year is paid,
Executive shall be entitled to receive the Annual Bonus (to the extent earned) for the full prior fiscal year period as well as any Annual
Bonus earned for any period within the new fiscal year prorated from the beginning of such fiscal year through the date of termination.
Any Annual Bonus payable under this Section 11(d) shall be paid in a lump sum in the normal course of bonus payouts, if the Company is
achieving the basic budgeted numbers through the date of termination (as determined by the Committee or Company in its sole discretion),
Executive will receive the Annual Bonus post-termination, accrued as is applicable. The “basic budgeted numbers” for purposes
of this provision are sales bookings, revenue and adjusted EBITDA.
(iii)
Payment of an amount equal to the product of six (6) times the monthly rate of the Company’s subsidy for coverage in its medical,
dental and vision plans for active employees (including any applicable coverage for spouses and dependents) in effect on the date of
termination, payable in a lump sum on the sixtieth (60th) day following termination of employment.
The
payments set forth in Section 11(d)(i), (ii) and (iii) are collectively referred to as the “Severance Payments.” All
other rights the Executive may have, other than as set forth in this Section, shall terminate upon such termination.
12.
NOTIFICATION TO PROSPECTIVE EMPLOYERS
If
Executive seeks or is offered employment by any other company, firm or person during their employment or during the post- termination
restricted periods, he will notify the prospective employer of the existence and terms of the Confidential Information and Trade Secrets
provision in Section 7 and the Protective Covenants provision in Section 9 of this Agreement. Executive may disclose the language of
Sections 7 and 9 but may not disclose the remainder of this Agreement.
13.
CHANGE IN CONTROL
(a)
In the event of a Change in Control (as defined herein) of the Company during the Term,
(i)
If Executive has remained continuously employed with the Company through the date of the Change in Control, all stock options, restricted
stock, and all other equity awards (if any) granted to Executive that are outstanding immediately prior to the Change in Control shall
immediately vest in full as of the date of the Change in Control.
(ii)
If, during the Term and within ninety (90) days prior to or twelve (12) months following a Change in Control, the Company terminates
the employment of Executive for reasons other than for Good Cause, death or Continued Disability, then, Executive shall receive the Accrued
Obligations (as defined in Section 6(a), and, subject to the Release requirements set forth in Section 11(d) and provided that Executive
is not in default of her obligations under Section 7, 8, or 9 herein, (A) Executive shall be entitled to the Severance Payments set forth
in and pursuant to Section 11(d) and (B) all stock options, restricted stock, and other equity awards (if any) granted to Executive that
are outstanding immediately prior to the date of termination shall immediately vest in full as of the date of termination and, with respect
to any outstanding options, will remain exercisable by Executive from such vesting date (i.e., the date of termination) until the earlier
of: (x) the end of the applicable option period or (y) one hundred and eighty (180) days from the date of Executive’s termination
of employment.
(b)
For purposes of this Agreement, “Change in Control” means any of the following events:
(i)
A change in control of the direction and administration of the Company’s business of a nature that would be required to be reported
in response to Item 6(e) of Schedule 14A of Regulation 14A promulgated under the Exchange Act, as in effect on the date hereof and any
successor provision of the regulations under the Exchange Act, whether or not the Company is then subject to such reporting requirements;
or
(ii)
Any “person” (as such term is used in Section 13(d) and Section 14(d)(2) of the Exchange Act but excluding any employee
benefit plan of the Company) is or becomes the “beneficial owner” (as defined in Rule 13d-3 under the Exchange Act),
directly or indirectly, of securities of the Company representing more than one half (1/2) of the combined voting power of the Company’s
outstanding securities then entitled to vote for the election of directors; or
(iii)
The Company sells all or substantially all of the assets of the Company; or
(iv)
The consummation of a merger, reorganization, consolidation or similar business combination that constitutes a change in control as defined
in the Company’s 2013 Second Amended and Restated Stock Incentive Plan or other successor stock plan or results in the occurrence
of any event described in Sections 13(b) (i), (ii) or (iii) above.
Notwithstanding
the foregoing, a Change in Control will not be deemed to have occurred unless such event would also be a Change in Control under Code
Section 409A or would otherwise be a permitted distribution event under Code Section 409A.
(c)
If any payment or distribution by the Company to or for the benefit of Executive, whether paid or payable or distributed or distributable
pursuant to the terms of this Agreement or otherwise pursuant to or by reason of any other agreement, policy, plan, program or arrangement
or the lapse or termination of any restriction on or the vesting or exercisability of any payment or benefit (each a “Payment”),
would be subject to the excise tax imposed by Section 4999 of the Code (or any successor provision thereto) or to any similar tax imposed
by state or local law (such tax or taxes are hereafter collectively referred to as the “Excise Tax”), then the aggregate
amount of Payments payable to Executive shall be reduced to the aggregate amount of Payments that may be made to the Executive without
incurring an excise tax (the “Safe-Harbor Amount”) in accordance with the immediately following sentence. Any such
reduction shall be made in the following order: (i) first, any future cash payments (if any) shall be reduced (if necessary, to zero);
(ii) second, any current cash payments shall be reduced (if necessary, to zero); (iii) third, all non-cash payments (other than equity
or equity derivative related payments) shall be reduced (if necessary, to zero); and (iv) fourth, all equity or equity derivative payments
shall be reduced.
14.
ACKNOWLEDGEMENTS
The
Company and Executive each hereby acknowledge and agree as follows:
(a)
The covenants, restrictions, agreements and obligations set forth herein are founded upon valuable consideration, and, with respect to
the covenants, restrictions, agreements and obligations set forth in Sections 7 and 9 hereof, are reasonable in duration, the activities
proscribed, and geographic scope;
(b)
In the event of a breach or threatened breach by Executive of any of the covenants, restrictions, agreements and obligations set forth
in Sections 7 or 9 hereof, monetary damages or the other remedies at law that may be available to the Company for such breach or threatened
breach will be inadequate and, without prejudice to the Company’s right to pursue any other remedies at law or in equity available
to it for such breach or threatened breach, including, without limitation, the recovery of damages from Executive, the Company will be
entitled to injunctive relief from a court of competent jurisdiction or the arbitrator; and
(c)
The time period, proscribed activities, and geographical area set forth in the Confidential Information and Trade Secrets provision in
Section 7 or the Protective Covenants provision in Section 9 hereof are each divisible and separable, and, in the event that they are
judicially held invalid or unenforceable as to such time period, scope of activities, or geographical area, they will be valid and enforceable
to such extent and in such geographical area(s) and for such time period(s) which the court or arbitrator determines to be reasonable
and enforceable. Executive agrees that in the event any court of competent jurisdiction or arbitrator determines that the covenants in
Sections 7 and 9 are invalid or unenforceable to join with the Company in requesting that court or arbitrator to construe the applicable
provision by limiting or reducing it so as to be enforceable to the extent compatible with the then applicable law. Furthermore, any
period of restriction or covenant herein stated will not include any period of violation or period of time required for litigation to
enforce such restriction or covenant and Executive agrees that the time periods for the covenants in Sections 7 and 9 of this Agreement
shall be tolled during any period in which Executive is in violation of either of those provisions.
15.
NOTICES
Any
notice or communication required or permitted hereunder will be given in writing and will be sufficiently given if delivered by email
or sent by overnight, nationally recognized courier to such party addressed as follows:
(a)
In the case of the Company, if addressed to it as follows:
Streamline
Health Solutions, Inc.
2400
Old Milton Parkway Box #1353
Alpharetta,
GA 30009
Attn:
Chief People Officer
Email:
wendy.lovvorn@streamlinehealth.net
(b)
In the case of Executive, if addressed to Executive at the most recent address on file with the Company.
Any
such notice delivered personally or sent via mail will be deemed to have been received on the date it is delivered. Any address for the
giving of notice hereunder may be changed by notice in writing.
16.
ASSIGNMENT, SUCCESSORS AND ASSIGNS
This
Agreement will inure to the benefit of and be binding upon the parties hereto and their respective legal representatives, successors
and assigns. The Company may assign or otherwise transfer its rights under this Agreement to any successor or affiliated business or
corporation (whether by sale of stock, merger, consolidation, sale of assets or otherwise), but this Agreement may not be assigned, nor
may her duties hereunder be delegated, by Executive. In the event that the Company assigns or otherwise transfers its rights under this
Agreement to any successor or affiliated business or corporation (whether by sale of stock, merger, consolidation, sale of assets or
otherwise), for all purposes of this Agreement, the “Company” will then be deemed to include the successor or affiliated
business or corporation to which the Company, assigned or otherwise transferred its rights hereunder.
17.
MODIFICATION
This
Agreement may not be released, discharged, abandoned, changed or modified by the parties in any manner, except by an instrument in writing
signed by each of the parties hereto.
18.
SEVERABILITY AND WAIVER
The
invalidity or unenforceability of any particular provision of this Agreement will not affect any other provisions hereof, and the parties
will use their best efforts to substitute a valid, legal and enforceable provision, which, insofar as practical, implements the purpose
of this Agreement. If the parties are unable to reach such agreement, then the provisions will be modified as set forth in Section 14(c)
above. Any failure to enforce any provision of this Agreement will not constitute a waiver thereof or of any other provision hereof.
19.
COUNTERPARTS
This
Agreement may be signed in counterparts (and delivered via facsimile transmission or by digitally scanned signature delivered electronically),
and each of such counterparts will constitute an original document and such counterparts, taken together, will constitute one and the
same instrument.
20.
ENTIRE AGREEMENT
This
constitutes the entire agreement among the parties with respect to the subject matter of this Agreement and supersedes all prior and
contemporaneous agreements, understandings, and negotiations, whether written or oral, with respect to such subject matter.
21.
DISPUTE RESOLUTION
Except
as set forth in Section 14 above, and excluding ERISA health and disability plan claims, workers’ compensation claims, unemployment
compensation claims, claims related to sexual harassment or assault, claims to enforce the Confidential Information and Trade Secrets
provision in Section 7 or the Protective Covenants provision in Section 9 , or any other claims that cannot be required to be arbitrated
as a matter of law, any and all disputes arising out of or in connection with the execution, interpretation, performance or non-performance
of this Agreement or any agreement or other instrument between, involving or affecting the parties (including the validity, scope and
enforceability of this arbitration clause) (“Covered Claims”), will be submitted to and resolved by arbitration. The arbitration
will be conducted pursuant to the terms of the Federal Arbitration Act and the Employment Arbitration Rules and Mediation Procedures
of the American Arbitration Association effective at the time of filing, as supplemented by the terms of this Agreement. This Agreement
means that Streamline and Executive agree to use binding arbitration, instead of going to court, for any Covered Claims that arise between
Executive and Streamline or any of Streamline’s employees or agents. Executive understands and agrees that arbitration is the only
forum for resolving Covered Claims and that both Streamline and he are waiving the right to a trial before a judge or a jury in federal
or state court in favor of arbitration for them. Streamline and Executive agree that Covered Claims will be arbitrated only on an individual
basis, and that both Streamline and Executive waive the right to participate in or receive money or any other relief from any class,
collective or representative proceeding of Covered Claims. No party may bring a claim on behalf of other individuals, and any arbitrator
hearing a Covered Claim may not: (i) combine more than one individual’s claim or claims into a single case; (ii) participate in
or facilitate notification of others of potential claims; or (iii) arbitrate any form of a class, collective or representative proceeding.
Streamline will pay the arbitrator’s fees and expenses, including but not limited to travel fees, per diem costs, and any administrative
fees. In the event that Executive initiates an arbitration proceeding under this Agreement, Executive shall be liable for the AAA-mandated
portion of the filing fee not to exceed $300.00; Streamline shall pay the remainder of any filing fee in excess of that amount as set
forth in the applicable AAA Employment/Workplace Fee Schedule. The arbitrator shall have the authority to award the same damages or other
relief that would have been available in court pursuant to applicable law. Streamline and Executive agree that the arbitrator shall have
the additional right to rule on motions to dismiss and/or motions for summary judgment, applying the standards governing such motions
under the Federal Rules of Civil Procedure. Executive understands that the ability of the parties to obtain documents, witness statements,
and other discovery is generally more limited in arbitration than in court proceedings. Executive also understands that arbitration awards
are generally final and binding, and a party’s ability to have a court reverse or modify an arbitration award is very limited.
The arbitrator must issue an award in writing, setting forth the reasons for the arbitrator’s determination. The arbitrator’s
authority shall be limited to deciding the case submitted by the party bringing the arbitration and any counterclaims filed therein.
Therefore, no decision by any arbitrator under this Agreement shall serve as precedent in other arbitrations. If the arbitrator makes
an award, a judgment on the award may be entered in any court having jurisdiction. Either party may notify the other party at any time
of the existence of a controversy potentially requiring arbitration by certified mail, and the parties will attempt in good faith to
resolve their differences within fifteen (15) days after the receipt of such notice. If the dispute cannot be resolved within the fifteen-day
period, either party may file a written demand for arbitration with the American Arbitration Association. The place of arbitration will
be Atlanta, Georgia.
/s/
Bryant James Reeves III |
|
/s/
Benjamin L. Stilwill |
Initial
by Executive |
|
Initial
by the Company |
22.
GOVERNING LAW; FORUM SELECTION
The
provisions of this Agreement will be governed by and interpreted in accordance with the internal laws of the State of Georgia and the
laws of the United States applicable therein. Executive acknowledges and agrees that Executive is subject to personal jurisdiction in
state and federal courts in Georgia, and waives any objection thereto.
23.
CODE SECTION 409A
Notwithstanding
any other provision in this Agreement to the contrary, if and to the extent that Code Section 409A is deemed to apply to any benefit
under this Agreement, it is the general intention of the Company that such benefits will, to the extent practicable, comply with, or
be exempt from, Code Section 409A, and this Agreement will, to the extent practicable, be construed in accordance therewith. To the maximum
extent permitted under Code Section 409A and its corresponding regulations, Severance Payments under this Agreement are intended to meet
the requirements of the short-term deferral exemption under Code Section 409A and the “separation pay exception” under Treas.
Reg. §1.409A-1(b)(9)(iii). For purposes of the application of Treas. Reg. § 1.409A-1(b)(4) (or any successor provision), each
payment in a series of payments to the Executive will be deemed a separate payment. Deferrals of benefits distributable pursuant to this
Agreement that are otherwise exempt from Code Section 409A in a manner that would cause Code Section 409A to apply will not be permitted
unless such deferrals follow Code Section 409A. In the event that the Company (or a successor thereto) has any stock which is publicly
traded on an established securities market or otherwise and Executive is determined to be a “specified employee” (as
defined under Code Section 409A), any payment that is deemed to be deferred compensation under Code Section 409A to be made to the Executive
upon a separation from service may not be made before the date that is six (6) months after Executive’s separation from service
(or death, if earlier). To the extent that Executive becomes subject to the six (6)-month delay rule, all payments that would have been
made to Executive during the six (6) months following her separation from service that are not otherwise exempt from Code Section 409A,
if any, will be accumulated and paid to Executive during the seventh (7th) month following her separation from service, and any remaining
payments due will be made in their ordinary course as described in this Agreement. For the purposes herein, the phrase “termination
of employment” or similar phrases will be interpreted in accordance with the term “separation from service”
as defined under Code Section 409A if and to the extent required under Code Section 409A. Further, (i) in the event that Code Section
409A requires that any special terms, provisions or conditions be included in this Agreement, then such terms, provisions and conditions
will, to the extent practicable, be deemed to be made a part of this Agreement, and (ii) terms used in this Agreement will be construed
in accordance with Code Section 409A if and to the extent required. Further, in the event that this Agreement or any benefit thereunder
will be deemed not to comply with Code Section 409A, then neither the Company, the Board, STRM, the Committee nor its or their affiliates
designees or agents will be liable to any participant or other person for actions, decisions or determinations made in good faith.
24.
WITHHOLDING.
The
Company may withhold from any amounts payable under this Agreement such federal, state, local or foreign taxes as will be required to
be withheld pursuant to any applicable law or regulation.
25.
ATTORNEYS’ FEES.
If
the Company successfully enforces any right under this Agreement through legal process of any kind, then the Company shall be entitled
to recover from Executive its costs of such enforcement, including reasonable attorneys’ fees.
[Signature
page follows.]
IN
WITNESS WHEREOF, this Agreement has been executed by the parties hereto as of the date first above written.
|
STREAMLINE HEALTH SOLUTIONS, INC. |
|
|
|
|
By: |
/s/
Benjamin L. Stilwill |
|
|
Benjamin
L. Stilwill |
|
|
President
& Chief Executive Officer |
|
|
|
|
EXECUTIVE |
|
|
|
|
By: |
/s/
Bryant James Reeves III |
|
|
Bryant
James Reeves III |
[Signature
Page to - Employment Agreement]
EXHIBIT
A TO EMPLOYMENT AGREEMENT (THE “AGREEMENT”) DATED AS OF December 04, 2023, BETWEEN STREAMLINE HEALTH LLC AND Bryant
James Reeves — COMPENSATION AND BENEFITS
1. |
Effective
Date. This agreement is dated December 4th, 2023 and is effective as of December 4, 2023. |
|
|
2. |
Base
Salary. Base Salary will be paid at an annualized rate of $185,000, which will be subject to annual review and adjustment by
the Committee but will not be reduced below $185,000 without the consent of Executive (“Base Salary”). Such amounts
will be payable to Executive in accordance with the normal payroll practices of the Company, but not less frequently than monthly. |
|
|
3. |
Annual
Bonus. During the term of employment, Executive will be eligible to participate in and earn an annual bonus of up to thirty percent
(25%) of Executive’s then current Base Salary, subject to attainment of annual performance goals determined by the Committee
or Board and in accordance with the terms of the Company’s or STRM’s executive bonus plan, as may be amended from time
to time. |
|
|
|
|
4. |
Benefits.
Executive will be eligible to participate in the Company’s or STRM’s benefit plans generally made available by the Company
or STRM to Company employees, subject to all terms and conditions of such plans as they may be amended from time to time. During
the Term, Executive will accrue vacation days and personal days totaling an aggregate of twenty (20) days per annum, prorated for
fiscal year ended January 31, 2023, in accordance with the Company’s vacation policies, as in effect from time to time. The
Company reserves the right to amend or cancel any employee benefit plans at any time in its sole discretion, subject to the terms
of such employee benefit plan and applicable law. |
|
|
5. |
Grant
of Restricted Stock. On or as soon as administratively feasible following the execution of this Agreement and subject to approval
of the Committee, Executive will receive a grant of 50,000 shares of restricted stock. The vesting of such shares will occur in three
(3) equal annual installments over the first three years of continuous employment under this Agreement. Such grant will be made pursuant
to, and otherwise subject to, the terms and conditions of the Streamline Health Solutions, Inc. Third Amended and Restated 2013 Stock
Incentive Plan and the related restricted stock grant agreement. |
Exhibit
31.1
CERTIFICATION
PURSUANT TO
SECTION
302 OF THE
SARBANES-OXLEY
ACT OF 2002
I,
Benjamin Louis Stilwill, certify that:
1. |
I
have reviewed this quarterly report on Form 10-Q of Streamline Health Solutions, Inc.; |
|
|
2. |
Based
on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to
the period covered by this report; |
|
|
3. |
Based
on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in
this report; |
|
|
4. |
The
registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange
Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
|
(a) |
designed
such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others
within those entities, particularly during the period in which this report is being prepared; |
|
|
|
|
(b) |
designed
such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our
supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements
for external purposes in accordance with generally accepted accounting principles; |
|
|
|
|
(c) |
evaluated
the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about
the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
and |
|
|
|
|
(d) |
disclosed
in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s
most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal
control over financial reporting; and |
5. |
The
registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing
the equivalent functions): |
|
(a) |
all
significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information;
and |
|
|
|
|
(b) |
any
fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s
internal control over financial reporting. |
Date:
December 14, 2023 |
/s/
Benjamin L. Stilwill |
|
President
and Chief Executive Officer |
Exhibit
31.2
CERTIFICATION
PURSUANT TO
SECTION
302 OF THE
SARBANES-OXLEY
ACT OF 2002
I,
Bryant J. Reeves III, certify that:
1. |
I
have reviewed this quarterly report on Form 10-Q of Streamline Health Solutions, Inc.; |
|
|
2. |
Based
on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to
the period covered by this report; |
|
|
3. |
Based
on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in
this report; |
|
|
4. |
The
registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange
Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
|
(a) |
designed
such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others
within those entities, particularly during the period in which this report is being prepared; |
|
|
|
|
(b) |
designed
such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our
supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements
for external purposes in accordance with generally accepted accounting principles; |
|
|
|
|
(c) |
evaluated
the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about
the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
and |
|
|
|
|
(d) |
disclosed
in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s
most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal
control over financial reporting; and |
5. |
The
registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing
the equivalent functions): |
|
(a) |
all
significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information;
and |
|
|
|
|
(b) |
any
fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s
internal control over financial reporting. |
Date:
December 14, 2023 |
/s/
Bryant J. Reeves III |
|
Interim
Chief Financial Officer |
Exhibit
32.1
CERTIFICATION
PURSUANT TO
18
U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
I,
Benjamin Louis Stilwill, President and Chief Executive Officer of Streamline Health Solutions, Inc. (the “Company”),
certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C Section 1350, that to my knowledge:
|
(1)
|
The
quarterly report on Form 10-Q of the Company for the quarter ended October 31, 2023 (the “Report”) fully complies with
the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
|
|
|
(2)
|
The
information contained in the Report fairly presents, in all material respects, the financial condition, and results of operations
of the Company. |
/s/
Benjamin L. Stilwill |
|
Benjamin
L. Stilwill |
|
President
and Chief Executive Officer |
|
|
|
December
14, 2023 |
|
A
signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company
and furnished to the Securities and Exchange Commission or its staff upon request.
Exhibit
32.2
CERTIFICATION
PURSUANT TO
18
U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
I,
Bryant J. Reeves III, Interim Chief Financial Officer of Streamline Health Solutions, Inc. (the “Company”), certify, pursuant
to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C Section 1350, that to my knowledge:
|
(1)
|
The
quarterly report on Form 10-Q of the Company for the quarter ended October 31, 2023 (the “Report”) fully complies with
the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
|
|
|
(2)
|
The
information contained in the Report fairly presents, in all material respects, the financial condition, and results of operations
of the Company. |
/s/
Bryant J. Reeves III |
|
Bryant
J. Reeves III |
|
Interim
Chief Financial Officer |
|
|
|
December
14, 2023 |
|
A
signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company
and furnished to the Securities and Exchange Commission or its staff upon request.
v3.23.3
Cover - shares
|
9 Months Ended |
|
Oct. 31, 2023 |
Dec. 11, 2023 |
Cover [Abstract] |
|
|
Document Type |
10-Q
|
|
Amendment Flag |
false
|
|
Document Quarterly Report |
true
|
|
Document Transition Report |
false
|
|
Document Period End Date |
Oct. 31, 2023
|
|
Document Fiscal Period Focus |
Q3
|
|
Document Fiscal Year Focus |
2024
|
|
Current Fiscal Year End Date |
--01-31
|
|
Entity File Number |
000-28132
|
|
Entity Registrant Name |
STREAMLINE
HEALTH SOLUTIONS, INC.
|
|
Entity Central Index Key |
0001008586
|
|
Entity Tax Identification Number |
31-1455414
|
|
Entity Incorporation, State or Country Code |
DE
|
|
Entity Address, Address Line One |
2400
Old Milton Pkwy.
|
|
Entity Address, Address Line Two |
Box 1353
|
|
Entity Address, City or Town |
Alpharetta
|
|
Entity Address, State or Province |
GA
|
|
Entity Address, Postal Zip Code |
30009
|
|
City Area Code |
(888)
|
|
Local Phone Number |
997-8732
|
|
Title of 12(b) Security |
Common
Stock, $0.01 par value per share
|
|
Trading Symbol |
STRM
|
|
Security Exchange Name |
NASDAQ
|
|
Entity Current Reporting Status |
Yes
|
|
Entity Interactive Data Current |
Yes
|
|
Entity Filer Category |
Non-accelerated Filer
|
|
Entity Small Business |
true
|
|
Entity Emerging Growth Company |
false
|
|
Entity Shell Company |
false
|
|
Entity Common Stock, Shares Outstanding |
|
58,829,461
|
X |
- DefinitionBoolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
+ Details
Name: |
dei_AmendmentFlag |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionEnd date of current fiscal year in the format --MM-DD.
+ References
+ Details
Name: |
dei_CurrentFiscalYearEndDate |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:gMonthDayItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionFiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.
+ References
+ Details
Name: |
dei_DocumentFiscalPeriodFocus |
Namespace Prefix: |
dei_ |
Data Type: |
dei:fiscalPeriodItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThis is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.
+ References
+ Details
Name: |
dei_DocumentFiscalYearFocus |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:gYearItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionFor the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
+ Details
Name: |
dei_DocumentPeriodEndDate |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:dateItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true only for a form used as an quarterly report.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Form 10-Q -Number 240 -Section 308 -Subsection a
+ Details
Name: |
dei_DocumentQuarterlyReport |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true only for a form used as a transition report.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Forms 10-K, 10-Q, 20-F -Number 240 -Section 13 -Subsection a-1
+ Details
Name: |
dei_DocumentTransitionReport |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
+ Details
Name: |
dei_DocumentType |
Namespace Prefix: |
dei_ |
Data Type: |
dei:submissionTypeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 1 such as Attn, Building Name, Street Name
+ References
+ Details
Name: |
dei_EntityAddressAddressLine1 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 2 such as Street or Suite number
+ References
+ Details
Name: |
dei_EntityAddressAddressLine2 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Definition
+ References
+ Details
Name: |
dei_EntityAddressCityOrTown |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCode for the postal or zip code
+ References
+ Details
Name: |
dei_EntityAddressPostalZipCode |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the state or province.
+ References
+ Details
Name: |
dei_EntityAddressStateOrProvince |
Namespace Prefix: |
dei_ |
Data Type: |
dei:stateOrProvinceItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityCentralIndexKey |
Namespace Prefix: |
dei_ |
Data Type: |
dei:centralIndexKeyItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionIndicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
+ References
+ Details
Name: |
dei_EntityCommonStockSharesOutstanding |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionIndicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
+ Details
Name: |
dei_EntityCurrentReportingStatus |
Namespace Prefix: |
dei_ |
Data Type: |
dei:yesNoItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionIndicate if registrant meets the emerging growth company criteria.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityEmergingGrowthCompany |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCommission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
+ Details
Name: |
dei_EntityFileNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:fileNumberItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionIndicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityFilerCategory |
Namespace Prefix: |
dei_ |
Data Type: |
dei:filerCategoryItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTwo-character EDGAR code representing the state or country of incorporation.
+ References
+ Details
Name: |
dei_EntityIncorporationStateCountryCode |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarStateCountryItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-T -Number 232 -Section 405
+ Details
Name: |
dei_EntityInteractiveDataCurrent |
Namespace Prefix: |
dei_ |
Data Type: |
dei:yesNoItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityRegistrantName |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityShellCompany |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionIndicates that the company is a Smaller Reporting Company (SRC).
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntitySmallBusiness |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityTaxIdentificationNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:employerIdItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionLocal phone number for entity.
+ References
+ Details
Name: |
dei_LocalPhoneNumber |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTitle of a 12(b) registered security.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b
+ Details
Name: |
dei_Security12bTitle |
Namespace Prefix: |
dei_ |
Data Type: |
dei:securityTitleItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the Exchange on which a security is registered.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection d1-1
+ Details
Name: |
dei_SecurityExchangeName |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarExchangeCodeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTrading symbol of an instrument as listed on an exchange.
+ References
+ Details
Name: |
dei_TradingSymbol |
Namespace Prefix: |
dei_ |
Data Type: |
dei:tradingSymbolItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
Condensed Consolidated Balance Sheets - USD ($)
|
Oct. 31, 2023 |
Jan. 31, 2023 |
Current assets: |
|
|
Cash and cash equivalents |
$ 2,557,000
|
$ 6,598,000
|
Accounts receivable, net of allowance for credit losses of $94,000 and $132,000, respectively |
3,653,000
|
7,719,000
|
Contract receivables |
763,000
|
960,000
|
Prepaid and other current assets |
742,000
|
710,000
|
Total current assets |
7,715,000
|
15,987,000
|
Non-current assets: |
|
|
Property and equipment, net of accumulated amortization of $278,000 and $246,000 respectively |
94,000
|
79,000
|
Right-of use asset for operating lease |
|
32,000
|
Capitalized software development costs, net of accumulated amortization of $7,560,000 and $6,224,000, respectively |
6,248,000
|
5,846,000
|
Intangible assets, net of accumulated amortization of $3,978,000 and $2,627,000, respectively |
12,479,000
|
14,793,000
|
Goodwill |
13,276,000
|
23,089,000
|
Other |
1,293,000
|
1,695,000
|
Total non-current assets |
33,390,000
|
45,534,000
|
Total assets |
41,105,000
|
61,521,000
|
Current liabilities: |
|
|
Accounts payable |
736,000
|
626,000
|
Accrued expenses |
2,883,000
|
3,265,000
|
Current portion of term loan |
1,250,000
|
750,000
|
Deferred revenues |
5,983,000
|
8,361,000
|
Current portion of operating lease obligation |
|
35,000
|
Acquisition earnout liability |
1,833,000
|
3,738,000
|
Total current liabilities |
12,685,000
|
16,775,000
|
Non-current liabilities: |
|
|
Term loan, net of current portion and deferred financing costs |
8,042,000
|
8,964,000
|
Line of credit |
500,000
|
|
Deferred revenues, less current portion |
127,000
|
167,000
|
Other non-current liabilities |
|
104,000
|
Total non-current liabilities |
8,669,000
|
9,235,000
|
Total liabilities |
21,354,000
|
26,010,000
|
Commitments and contingencies – Note 8 |
|
|
Stockholders’ equity: |
|
|
Common stock, $0.01 par value per share, 85,000,000 shares authorized; 58,793,990 and 57,567,210 shares issued and outstanding, respectively |
588,000
|
576,000
|
Additional paid in capital |
133,492,000
|
131,973,000
|
Accumulated deficit |
(114,329,000)
|
(97,038,000)
|
Total stockholders’ equity |
19,751,000
|
35,511,000
|
Total liabilities and stockholders’ equity |
$ 41,105,000
|
$ 61,521,000
|
X |
- DefinitionCarrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ ReferencesReference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(a)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_AccountsPayableCurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 310 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 310 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 9 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481990/310-10-45-9
+ Details
Name: |
us-gaap_AccountsReceivableNetCurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionCarrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.20) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_AccruedLiabilitiesCurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionValue received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(30)(a)(1)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_AdditionalPaidInCapitalCommonStock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount of liability recognized from contingent consideration in asset acquisition, classified as current.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 805 -SubTopic 50 -Name Accounting Standards Codification -Section 15 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480123/805-50-15-3
+ Details
Name: |
us-gaap_AssetAcquisitionContingentConsiderationLiabilityCurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionSum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (bb) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 25 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 28 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28
Reference 6: http://www.xbrl.org/2003/role/exampleRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10
Reference 7: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(12)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(8)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1
Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(18)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(ii)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B
Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B
Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(B)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B
Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B
Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B
Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7
Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 30 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30
Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32
Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(11)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1
+ Details
Name: |
us-gaap_Assets |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionSum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (bb) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 25 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 28 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28
Reference 6: http://www.xbrl.org/2003/role/exampleRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(9)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(ii)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B
Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B
Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(B)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B
Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B
Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B
Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7
+ Details
Name: |
us-gaap_AssetsCurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- References
+ Details
Name: |
us-gaap_AssetsCurrentAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionSum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (bb) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 25 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 28 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(ii)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B
Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B
Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(B)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B
Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B
Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B
Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7
+ Details
Name: |
us-gaap_AssetsNoncurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- References
+ Details
Name: |
us-gaap_AssetsNoncurrentAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe carrying amount of capitalized computer software costs net of accumulated amortization as of the balance sheet date.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 985 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1
+ Details
Name: |
us-gaap_CapitalizedComputerSoftwareNet |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionAmount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(1)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4
+ Details
Name: |
us-gaap_CashAndCashEquivalentsAtCarryingValue |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionRepresents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(19)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(15)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 942 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03.17) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1
Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.25) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_CommitmentsAndContingencies |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(22)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_CommonStockValue |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479837/606-10-45-3
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479837/606-10-45-1
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8
+ Details
Name: |
us-gaap_ContractWithCustomerAssetNetCurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionAmount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(20)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_DeferredRevenueCurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(26)(c)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_DeferredRevenueNoncurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10
Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 24 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(15)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1
Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1
Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 942 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(10)(1)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1
+ Details
Name: |
us-gaap_Goodwill |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionSum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph ((a)(1),(b)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482686/350-30-45-1
+ Details
Name: |
us-gaap_IntangibleAssetsNetExcludingGoodwill |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionSum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 25 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (bb) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 28 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28
Reference 7: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(14)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(ii)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B
Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B
Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(B)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B
Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B
Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B
Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7
Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7
Reference 21: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 30 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30
Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19-26) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_Liabilities |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(25)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1
Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1
Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3
Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 28 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28
Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(23)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1
Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(32)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_LiabilitiesAndStockholdersEquity |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionTotal obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 25 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (bb) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 28 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28
Reference 7: http://www.xbrl.org/2003/role/exampleRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(ii)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B
Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B
Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(B)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B
Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B
Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B
Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7
Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7
Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.21) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_LiabilitiesCurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- References
+ Details
Name: |
us-gaap_LiabilitiesCurrentAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAmount of obligation due after one year or beyond the normal operating cycle, if longer.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(22)) -SubTopic 10 -Topic 210 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 25 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (bb) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 28 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(ii)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B
Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B
Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(B)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B
Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B
Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B
Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7
Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7
Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(23)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 201.5-02(24)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 201.5-02(25)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
Reference 23: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 201.5-02(26)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_LiabilitiesNoncurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- References
+ Details
Name: |
us-gaap_LiabilitiesNoncurrentAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCarrying value as of the balance sheet date of portion of long-term loans payable due within one year or the operating cycle if longer.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.20) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_LoansPayableCurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionThe carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.22) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section 45 -Paragraph 13 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481573/470-10-45-13
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section 45 -Paragraph 14 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481573/470-10-45-14
+ Details
Name: |
us-gaap_LongTermLineOfCredit |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionCarrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.22) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_LongTermLoansPayable |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionPresent value of lessee's discounted obligation for lease payments from operating lease, classified as current.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 842 -SubTopic 20 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1
+ Details
Name: |
us-gaap_OperatingLeaseLiabilityCurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount of lessee's right to use underlying asset under operating lease.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 842 -SubTopic 20 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1
+ Details
Name: |
us-gaap_OperatingLeaseRightOfUseAsset |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionAmount of noncurrent assets classified as other.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(17)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_OtherAssetsNoncurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionAmount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.24) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_OtherLiabilitiesNoncurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(9)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_PrepaidExpenseAndOtherAssetsCurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionAmount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 1 -SubTopic 10 -Topic 360 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1
Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(8)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 942 -SubTopic 360 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1
+ Details
Name: |
us-gaap_PropertyPlantAndEquipmentNet |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionAmount of accumulated undistributed earnings (deficit).
+ ReferencesReference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 40 -Name Accounting Standards Codification -Section 65 -Paragraph 2 -Subparagraph (g)(2)(i) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 40 -Name Accounting Standards Codification -Section 65 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(23)(a)(4)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(17)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1
Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1
Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(30)(a)(3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_RetainedEarningsAccumulatedDeficit |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10
Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(19)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.6-05(4)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2
Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(4)(b)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(6)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(7)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3
Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1
Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3
Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 28 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28
Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(31)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(30)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 310 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 4.E) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2
+ Details
Name: |
us-gaap_StockholdersEquity |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- References
+ Details
Name: |
us-gaap_StockholdersEquityAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)
|
Oct. 31, 2023 |
Jan. 31, 2023 |
Statement of Financial Position [Abstract] |
|
|
Allowance for credit losses |
$ 94,000
|
$ 132,000
|
Accumulated amortization, property and equipment |
278,000
|
246,000
|
Accumulated amortization, capitalized software development costs |
7,560,000
|
6,224,000
|
Accumulated amortization, intangible assets |
$ 3,978,000
|
$ 2,627,000
|
Common stock, par value |
$ 0.01
|
$ 0.01
|
Common stock, shares authorized |
85,000,000
|
85,000,000
|
Common stock, shares issued |
58,793,990
|
57,567,210
|
Common stock, shares outstanding |
58,793,990
|
57,567,210
|
X |
- DefinitionAmount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(8)(b)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(14)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1
+ Details
Name: |
us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount of allowance for credit loss on accounts receivable, classified as current.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(4)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 326 -SubTopic 20 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479344/326-20-45-1
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 310 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481962/310-10-50-4
+ Details
Name: |
us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionFor each balance sheet presented, the amount of accumulated amortization for capitalized computer software costs.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 985 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1
+ Details
Name: |
us-gaap_CapitalizedComputerSoftwareAccumulatedAmortization |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionFace amount or stated value per share of common stock.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_CommonStockParOrStatedValuePerShare |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:perShareItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionThe maximum number of common shares permitted to be issued by an entity's charter and bylaws.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(16)(a)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_CommonStockSharesAuthorized |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionTotal number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_CommonStockSharesIssued |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionNumber of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.6-05(4)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2
Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(4)(b)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(16)(a)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1
Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(7)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3
Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_CommonStockSharesOutstanding |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionAccumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(16)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2
+ Details
Name: |
us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- References
+ Details
Name: |
us-gaap_StatementOfFinancialPositionAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
|
3 Months Ended |
9 Months Ended |
Oct. 31, 2023 |
Oct. 31, 2022 |
Oct. 31, 2023 |
Oct. 31, 2022 |
Revenues: |
|
|
|
|
|
Total revenues |
|
$ 6,133,000
|
$ 6,217,000
|
$ 17,235,000
|
$ 18,144,000
|
Operating expenses: |
|
|
|
|
|
Selling, general and administrative expense |
|
4,122,000
|
4,055,000
|
12,079,000
|
12,629,000
|
Research and development |
|
1,304,000
|
1,754,000
|
4,310,000
|
4,527,000
|
Impairment of goodwill |
|
9,813,000
|
|
9,813,000
|
|
Impairment of long-lived assets |
|
963,000
|
|
963,000
|
|
Total operating expenses |
|
19,080,000
|
9,379,000
|
35,776,000
|
27,139,000
|
Operating loss |
|
(12,947,000)
|
(3,162,000)
|
(18,541,000)
|
(8,995,000)
|
Other (expense) income: |
|
|
|
|
|
Interest expense |
|
(266,000)
|
(198,000)
|
(781,000)
|
(519,000)
|
Acquisition earnout valuation adjustments |
|
1,182,000
|
163,000
|
1,905,000
|
188,000
|
Other |
|
|
68,000
|
31,000
|
151,000
|
Loss before income taxes |
|
(12,031,000)
|
(3,129,000)
|
(17,386,000)
|
(9,175,000)
|
Income tax benefit (expense) |
|
120,000
|
(9,000)
|
59,000
|
(22,000)
|
Net loss |
|
$ (11,911,000)
|
$ (3,138,000)
|
$ (17,327,000)
|
$ (9,197,000)
|
Basic and Diluted Earnings Per Share: |
|
|
|
|
|
Net loss per common share - basic |
|
$ (0.21)
|
$ (0.07)
|
$ (0.31)
|
$ (0.19)
|
Net loss per common share - diluted |
|
$ (0.21)
|
$ (0.07)
|
$ (0.31)
|
$ (0.19)
|
Weighted average number of common shares - basic |
[1],[2] |
56,710,335
|
47,730,009
|
56,346,300
|
47,329,923
|
Weighted average number of common shares - diluted |
[1],[2] |
56,710,335
|
47,730,009
|
56,346,300
|
47,329,923
|
Software as a Service [Member] |
|
|
|
|
|
Revenues: |
|
|
|
|
|
Total revenues |
|
$ 3,924,000
|
$ 3,209,000
|
$ 10,630,000
|
$ 9,157,000
|
Operating expenses: |
|
|
|
|
|
Cost of goods and services |
|
1,677,000
|
1,742,000
|
5,159,000
|
4,771,000
|
Maintenance and Support [Member] |
|
|
|
|
|
Revenues: |
|
|
|
|
|
Total revenues |
|
1,070,000
|
1,120,000
|
3,327,000
|
3,348,000
|
Operating expenses: |
|
|
|
|
|
Cost of goods and services |
|
129,000
|
84,000
|
250,000
|
220,000
|
Professional Fees and Licenses [Member] |
|
|
|
|
|
Revenues: |
|
|
|
|
|
Total revenues |
|
1,139,000
|
1,888,000
|
3,278,000
|
5,639,000
|
Operating expenses: |
|
|
|
|
|
Cost of goods and services |
|
$ 1,072,000
|
$ 1,744,000
|
$ 3,202,000
|
$ 4,992,000
|
|
|
X |
- DefinitionAcquisition earnout valuation adjustments.
+ References
+ Details
Name: |
STRM_AcquisitionEarnoutValuationAdjustments |
Namespace Prefix: |
STRM_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionThe aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 924 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 11.L) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.2(a),(d)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2
+ Details
Name: |
us-gaap_CostOfGoodsAndServicesSold |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionTotal costs of sales and operating expenses for the period.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2
+ Details
Name: |
us-gaap_CostsAndExpenses |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_CostsAndExpensesAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_EarningsPerShareAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 15 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (e)(4) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 60B -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4
Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1
Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10
Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(25)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2
Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 942 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04(27)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1
Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(23)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1
Reference 16: http://www.xbrl.org/2003/role/exampleRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 52 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52
Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7
+ Details
Name: |
us-gaap_EarningsPerShareBasic |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:perShareItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 15 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (e)(4) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 60B -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4
Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1
Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(25)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2
Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 942 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04(27)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1
Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(23)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1
Reference 15: http://www.xbrl.org/2003/role/exampleRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 52 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52
Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7
+ Details
Name: |
us-gaap_EarningsPerShareDiluted |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:perShareItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAmount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Subparagraph (b) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28
Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 24 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482573/350-20-50-2
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 45 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482598/350-20-45-2
+ Details
Name: |
us-gaap_GoodwillImpairmentLoss |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionThe aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Subparagraph (b) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 360 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482099/360-10-50-2
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 45 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482130/360-10-45-4
+ Details
Name: |
us-gaap_ImpairmentOfLongLivedAssetsHeldForUse |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionAmount of the cost of borrowed funds accounted for as interest expense.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10
Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section 45 -Paragraph 3 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-07(3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22
Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 835 -SubTopic 30 -Section 45 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3
Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04.9) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (210.5-03(11)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 835 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1
+ Details
Name: |
us-gaap_InterestExpense |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionThe portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 28 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 9 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11
Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11
Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4
Reference 13: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10
Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section 45 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7
Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(18)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1
Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22
Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-07(9)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1
Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(1)(d)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3
Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(ii)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B
Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B
Reference 26: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(B)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B
Reference 27: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B
Reference 28: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B
Reference 29: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 30 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30
Reference 30: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32
Reference 31: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 60B -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B
Reference 32: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31
Reference 33: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32
Reference 34: http://www.xbrl.org/2003/role/disclosureRef -Topic 205 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7
Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28
Reference 36: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1A -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A
Reference 37: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1B -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B
Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(20)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2
Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04(22)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1
+ Details
Name: |
us-gaap_NetIncomeLoss |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_NonoperatingIncomeExpenseAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe net result for the period of deducting operating expenses from operating revenues.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 30 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32
Reference 4: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32
+ Details
Name: |
us-gaap_OperatingIncomeLoss |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionAmount of income (expense) related to nonoperating activities, classified as other.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.9) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2
+ Details
Name: |
us-gaap_OtherNonoperatingIncomeExpense |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionThe aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 730 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482916/730-10-50-1
Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 912 -SubTopic 730 -Name Accounting Standards Codification -Section 25 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482517/912-730-25-1
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 985 -SubTopic 20 -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1
+ Details
Name: |
us-gaap_ResearchAndDevelopmentExpense |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionAmount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 924 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 11.L) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 30 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 40 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41
Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4
+ Details
Name: |
us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_RevenuesAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.4) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2
+ Details
Name: |
us-gaap_SellingGeneralAndAdministrativeExpense |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionThe average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 16 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16
+ Details
Name: |
us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionNumber of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10
+ Details
Name: |
us-gaap_WeightedAverageNumberOfSharesOutstandingBasic |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Details
Name: |
srt_ProductOrServiceAxis=STRM_SoftwareAsAServiceMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
srt_ProductOrServiceAxis=STRM_MaintenanceAndSupportMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
srt_ProductOrServiceAxis=STRM_ProfessionalFeesAndLicensesMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
v3.23.3
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
|
Common Stock [Member] |
Additional Paid-in Capital [Member] |
Retained Earnings [Member] |
Total |
Balance at Jan. 31, 2022 |
$ 478,000
|
$ 119,225,000
|
$ (85,659,000)
|
$ 34,044,000
|
Balance, shares at Jan. 31, 2022 |
47,840,950
|
|
|
|
Restricted stock issued |
$ 4,000
|
(4,000)
|
|
|
Restricted stock issued, shares |
408,031
|
|
|
|
Restricted stock forfeited |
|
|
|
|
Restricted stock forfeited, shares |
(63,900)
|
|
|
|
Surrender of shares |
$ (1,000)
|
(140,000)
|
|
(141,000)
|
Surrender of shares, shares |
(95,701)
|
|
|
|
Share-based compensation |
|
326,000
|
|
326,000
|
Net loss |
|
|
(2,787,000)
|
(2,787,000)
|
Balance at Apr. 30, 2022 |
$ 481,000
|
119,407,000
|
(88,446,000)
|
31,442,000
|
Balance, shares at Apr. 30, 2022 |
48,089,380
|
|
|
|
Balance at Jan. 31, 2022 |
$ 478,000
|
119,225,000
|
(85,659,000)
|
34,044,000
|
Balance, shares at Jan. 31, 2022 |
47,840,950
|
|
|
|
Net loss |
|
|
|
(9,197,000)
|
Balance at Oct. 31, 2022 |
$ 551,000
|
128,469,000
|
(94,856,000)
|
34,164,000
|
Balance, shares at Oct. 31, 2022 |
55,130,334
|
|
|
|
Balance at Apr. 30, 2022 |
$ 481,000
|
119,407,000
|
(88,446,000)
|
31,442,000
|
Balance, shares at Apr. 30, 2022 |
48,089,380
|
|
|
|
Restricted stock issued |
$ 7,000
|
(7,000)
|
|
|
Restricted stock issued, shares |
726,801
|
|
|
|
Restricted stock forfeited |
|
|
|
|
Restricted stock forfeited, shares |
(20,000)
|
|
|
|
Share-based compensation |
|
331,000
|
|
331,000
|
Net loss |
|
|
(3,272,000)
|
(3,272,000)
|
Exercise of stock options |
|
6,000
|
|
6,000
|
Exercise of Stock Options, shares |
5,000
|
|
|
|
Balance at Jul. 31, 2022 |
$ 488,000
|
119,737,000
|
(91,718,000)
|
28,507,000
|
Balance, shares at Jul. 31, 2022 |
48,801,181
|
|
|
|
Restricted stock issued |
$ 1,000
|
(1,000)
|
|
|
Restricted stock issued, shares |
118,836
|
|
|
|
Restricted stock forfeited |
$ (1,000)
|
1,000
|
|
|
Restricted stock forfeited, shares |
(75,200)
|
|
|
|
Surrender of shares |
|
(24,000)
|
|
(24,000)
|
Surrender of shares, shares |
(14,472)
|
|
|
|
Share-based compensation |
|
555,000
|
|
555,000
|
Net loss |
|
|
(3,138,000)
|
(3,138,000)
|
Issuance of common stock |
$ 63,000
|
8,253,000
|
|
8,316,000
|
Issuance of Common Stock, shares |
6,299,989
|
|
|
|
Offering expenses |
|
(52,000)
|
|
(52,000)
|
Balance at Oct. 31, 2022 |
$ 551,000
|
128,469,000
|
(94,856,000)
|
34,164,000
|
Balance, shares at Oct. 31, 2022 |
55,130,334
|
|
|
|
Balance at Jan. 31, 2023 |
$ 576,000
|
131,973,000
|
(97,038,000)
|
35,511,000
|
Balance, shares at Jan. 31, 2023 |
57,567,210
|
|
|
|
Restricted stock issued |
$ 12,000
|
(12,000)
|
|
|
Restricted stock issued, shares |
1,185,927
|
|
|
|
Restricted stock forfeited |
$ (1,000)
|
1,000
|
|
|
Restricted stock forfeited, shares |
(28,400)
|
|
|
|
Surrender of shares |
$ (1,000)
|
(178,000)
|
|
(179,000)
|
Surrender of shares, shares |
(88,326)
|
|
|
|
Share-based compensation |
|
595,000
|
|
595,000
|
Adoption of ASU 2016-13 |
|
|
36,000
|
36,000
|
Net loss |
|
|
(2,901,000)
|
(2,901,000)
|
Balance at Apr. 30, 2023 |
$ 586,000
|
132,379,000
|
(99,903,000)
|
33,062,000
|
Balance, shares at Apr. 30, 2023 |
58,636,411
|
|
|
|
Balance at Jan. 31, 2023 |
$ 576,000
|
131,973,000
|
(97,038,000)
|
35,511,000
|
Balance, shares at Jan. 31, 2023 |
57,567,210
|
|
|
|
Net loss |
|
|
|
(17,327,000)
|
Balance at Oct. 31, 2023 |
$ 588,000
|
133,492,000
|
(114,329,000)
|
19,751,000
|
Balance, shares at Oct. 31, 2023 |
58,793,990
|
|
|
|
Balance at Apr. 30, 2023 |
$ 586,000
|
132,379,000
|
(99,903,000)
|
33,062,000
|
Balance, shares at Apr. 30, 2023 |
58,636,411
|
|
|
|
Restricted stock issued |
$ 4,000
|
(4,000)
|
|
|
Restricted stock issued, shares |
385,720
|
|
|
|
Restricted stock forfeited |
$ (1,000)
|
1,000
|
|
|
Restricted stock forfeited, shares |
(77,000)
|
|
|
|
Surrender of shares |
|
(73,000)
|
|
(73,000)
|
Surrender of shares, shares |
(50,060)
|
|
|
|
Share-based compensation |
|
630,000
|
|
630,000
|
Net loss |
|
|
(2,515,000)
|
(2,515,000)
|
Balance at Jul. 31, 2023 |
$ 589,000
|
132,933,000
|
(102,418,000)
|
31,104,000
|
Balance, shares at Jul. 31, 2023 |
58,895,071
|
|
|
|
Restricted stock issued |
$ 2,000
|
(2,000)
|
|
|
Restricted stock issued, shares |
176,054
|
|
|
|
Restricted stock forfeited |
$ (2,000)
|
2,000
|
|
|
Restricted stock forfeited, shares |
(239,100)
|
|
|
|
Surrender of shares |
$ (1,000)
|
(18,000)
|
|
(19,000)
|
Surrender of shares, shares |
(38,035)
|
|
|
|
Share-based compensation |
|
577,000
|
|
577,000
|
Net loss |
|
|
(11,911,000)
|
(11,911,000)
|
Balance at Oct. 31, 2023 |
$ 588,000
|
$ 133,492,000
|
$ (114,329,000)
|
$ 19,751,000
|
Balance, shares at Oct. 31, 2023 |
58,793,990
|
|
|
|
X |
- DefinitionStock issued during period shares surrender of shares.
+ References
+ Details
Name: |
STRM_StockIssuedDuringPeriodSharesSurrenderOfShares |
Namespace Prefix: |
STRM_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionStock issued during period value surrender of shares.
+ References
+ Details
Name: |
STRM_StockIssuedDuringPeriodValueSurrenderOfShares |
Namespace Prefix: |
STRM_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionAmount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 35 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480483/718-10-35-2
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 20 -Section 55 -Paragraph 13 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481089/718-20-55-13
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 20 -Section 55 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481089/718-20-55-12
+ Details
Name: |
us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionAmount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1
+ Details
Name: |
us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionThe portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 28 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 9 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11
Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11
Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4
Reference 13: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10
Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section 45 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7
Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(18)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1
Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22
Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-07(9)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1
Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(1)(d)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3
Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(ii)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B
Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B
Reference 26: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(B)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B
Reference 27: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B
Reference 28: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B
Reference 29: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 30 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30
Reference 30: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32
Reference 31: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 60B -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B
Reference 32: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31
Reference 33: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32
Reference 34: http://www.xbrl.org/2003/role/disclosureRef -Topic 205 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7
Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28
Reference 36: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1A -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A
Reference 37: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1B -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B
Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(20)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2
Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04(22)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1
+ Details
Name: |
us-gaap_NetIncomeLoss |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionNumber of shares issued which are neither cancelled nor held in the treasury.
+ References
+ Details
Name: |
us-gaap_SharesOutstanding |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionNumber of new stock issued during the period.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(4)(b)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(i)(1)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3
Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1
Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_StockIssuedDuringPeriodSharesNewIssues |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionNumber of shares related to Restricted Stock Award forfeited during the period.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1
Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTotal number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1
+ Details
Name: |
us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionNumber of share options (or share units) exercised during the current period.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(02) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1
Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionEquity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2
Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 11 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 205 -Name Accounting Standards Codification -Section 45 -Paragraph 4 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(4)(b)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3
Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1
Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_StockIssuedDuringPeriodValueNewIssues |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionValue of stock related to Restricted Stock Awards forfeited during the period.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1
Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionAggregate value of stock related to Restricted Stock Awards issued during the period.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1
Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionValue of stock issued as a result of the exercise of stock options.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29-31) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionAmount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10
Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(19)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.6-05(4)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2
Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(4)(b)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(6)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(7)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3
Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1
Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3
Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 28 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28
Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(31)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(30)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 310 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 4.E) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2
+ Details
Name: |
us-gaap_StockholdersEquity |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionThis element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.
+ References
+ Details
Name: |
us-gaap_StockholdersEquityOther |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
v3.23.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
|
9 Months Ended |
Oct. 31, 2023 |
Oct. 31, 2022 |
Statement of Cash Flows [Abstract] |
|
|
Net loss |
$ (17,327,000)
|
$ (9,197,000)
|
Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
Depreciation and amortization |
3,264,000
|
3,272,000
|
Acquisition earnout valuation adjustments |
(1,905,000)
|
(188,000)
|
Benefit for deferred income taxes |
(104,000)
|
|
Share-based compensation expense |
1,626,000
|
1,212,000
|
Impairment of goodwill |
9,813,000
|
|
Impairment of long-lived assets |
963,000
|
|
Provision for credit losses |
|
21,000
|
Changes in assets and liabilities: |
|
|
Accounts and contract receivables |
4,299,000
|
492,000
|
Other assets |
(65,000)
|
(868,000)
|
Accounts payable |
109,000
|
(373,000)
|
Accrued expenses and other liabilities |
(417,000)
|
1,159,000
|
Deferred revenue |
(2,417,000)
|
(251,000)
|
Net cash used in operating activities |
(2,161,000)
|
(4,721,000)
|
Cash flows from investing activities: |
|
|
Purchases of property and equipment |
(47,000)
|
(10,000)
|
Capitalization of software development costs |
(1,562,000)
|
(1,435,000)
|
Net cash used in investing activities |
(1,609,000)
|
(1,445,000)
|
Cash flows from financing activities: |
|
|
Repayment of bank term loan |
(500,000)
|
(125,000)
|
Proceeds from line of credit |
500,000
|
|
Proceeds from issuance of common stock |
|
8,316,000
|
Payments for costs directly attributable to the issuance of common stock |
|
(52,000)
|
Payments related to settlement of employee share-based awards |
(271,000)
|
(165,000)
|
Other |
|
6,000
|
Net cash (used in) provided by financing activities |
(271,000)
|
7,980,000
|
Net (decrease) increase in cash and cash equivalents |
(4,041,000)
|
1,814,000
|
Cash and cash equivalents at beginning of period |
6,598,000
|
9,885,000
|
Cash and cash equivalents at end of period |
$ 2,557,000
|
$ 11,699,000
|
X |
- DefinitionAcquisition earnout valuation adjustments.
+ References
+ Details
Name: |
STRM_AcquisitionEarnoutValuationAdjustments |
Namespace Prefix: |
STRM_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAmount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 24 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4
+ Details
Name: |
us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionAmount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 24 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 1 -SubTopic 230 -Topic 830 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1
+ Details
Name: |
us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionThe current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Subparagraph (b) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1
+ Details
Name: |
us-gaap_DepreciationAndAmortization |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionAmount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Subparagraph (b) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28
Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 24 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482573/350-20-50-2
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 45 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482598/350-20-45-2
+ Details
Name: |
us-gaap_GoodwillImpairmentLoss |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionThe aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Subparagraph (b) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 360 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482099/360-10-50-2
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 45 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482130/360-10-45-4
+ Details
Name: |
us-gaap_ImpairmentOfLongLivedAssetsHeldForUse |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionThe increase (decrease) during the reporting period in the amount due from customers for the credit sale of goods and services; includes accounts receivable and other types of receivables.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Subparagraph (a) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28
+ Details
Name: |
us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionThe increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Subparagraph (a) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28
+ Details
Name: |
us-gaap_IncreaseDecreaseInAccountsPayable |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionThe increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Subparagraph (a) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28
+ Details
Name: |
us-gaap_IncreaseDecreaseInAccruedLiabilities |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionAmount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/exampleRef -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Subparagraph (a) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28
+ Details
Name: |
us-gaap_IncreaseDecreaseInDeferredRevenue |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_IncreaseDecreaseInOperatingCapitalAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAmount of increase (decrease) in operating assets classified as other.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Subparagraph (a) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28
+ Details
Name: |
us-gaap_IncreaseDecreaseInOtherOperatingAssets |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionAmount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 24 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24
+ Details
Name: |
us-gaap_NetCashProvidedByUsedInFinancingActivities |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAmount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 24 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24
+ Details
Name: |
us-gaap_NetCashProvidedByUsedInInvestingActivities |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAmount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 24 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25
+ Details
Name: |
us-gaap_NetCashProvidedByUsedInOperatingActivities |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 28 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 9 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11
Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11
Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4
Reference 13: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10
Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section 45 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7
Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(18)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1
Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22
Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-07(9)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1
Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(1)(d)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3
Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(ii)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B
Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B
Reference 26: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(B)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B
Reference 27: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B
Reference 28: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B
Reference 29: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 30 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30
Reference 30: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32
Reference 31: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 60B -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B
Reference 32: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31
Reference 33: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32
Reference 34: http://www.xbrl.org/2003/role/disclosureRef -Topic 205 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7
Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28
Reference 36: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1A -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A
Reference 37: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1B -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B
Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(20)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2
Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04(22)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1
+ Details
Name: |
us-gaap_NetIncomeLoss |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionThe cash outflow for cost incurred directly with the issuance of an equity security.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 15 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15
+ Details
Name: |
us-gaap_PaymentsOfStockIssuanceCosts |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionThe cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 13 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13
+ Details
Name: |
us-gaap_PaymentsToAcquirePropertyPlantAndEquipment |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionThe cash outflow associated with the development or modification of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 13 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13
+ Details
Name: |
us-gaap_PaymentsToDevelopSoftware |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionThe cash inflow from the additional capital contribution to the entity.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 14 -Subparagraph (a) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14
+ Details
Name: |
us-gaap_ProceedsFromIssuanceOfCommonStock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionAmount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(f)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 14 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14
+ Details
Name: |
us-gaap_ProceedsFromLinesOfCredit |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionAmount of cash inflow (outflow) from financing activities classified as other.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 14 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14
Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Name Accounting Standards Codification -Section 45 -Paragraph 15 -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15
+ Details
Name: |
us-gaap_ProceedsFromPaymentsForOtherFinancingActivities |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionAmount of expense (reversal of expense) for expected credit loss on accounts receivable.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 326 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(5)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2
+ Details
Name: |
us-gaap_ProvisionForDoubtfulAccounts |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionThe cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(i)(2)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 15 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15
+ Details
Name: |
us-gaap_RepaymentsOfLongTermDebt |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionAmount of noncash expense for share-based payment arrangement.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Subparagraph (a) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28
+ Details
Name: |
us-gaap_ShareBasedCompensation |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_StatementOfCashFlowsAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
Pay vs Performance Disclosure - USD ($)
|
3 Months Ended |
9 Months Ended |
Oct. 31, 2023 |
Jul. 31, 2023 |
Apr. 30, 2023 |
Oct. 31, 2022 |
Jul. 31, 2022 |
Apr. 30, 2022 |
Oct. 31, 2023 |
Oct. 31, 2022 |
Pay vs Performance Disclosure [Table] |
|
|
|
|
|
|
|
|
Net Income (Loss) Attributable to Parent |
$ (11,911,000)
|
$ (2,515,000)
|
$ (2,901,000)
|
$ (3,138,000)
|
$ (3,272,000)
|
$ (2,787,000)
|
$ (17,327,000)
|
$ (9,197,000)
|
X |
- ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 1
+ Details
Name: |
ecd_PvpTable |
Namespace Prefix: |
ecd_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 28 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 9 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11
Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11
Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4
Reference 13: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10
Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section 45 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7
Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(18)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1
Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22
Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-07(9)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1
Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(1)(d)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3
Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(ii)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B
Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B
Reference 26: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(B)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B
Reference 27: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B
Reference 28: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B
Reference 29: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 30 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30
Reference 30: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32
Reference 31: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 60B -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B
Reference 32: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31
Reference 33: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32
Reference 34: http://www.xbrl.org/2003/role/disclosureRef -Topic 205 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7
Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28
Reference 36: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1A -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A
Reference 37: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1B -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B
Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(20)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2
Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04(22)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1
+ Details
Name: |
us-gaap_NetIncomeLoss |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
v3.23.3
X |
- ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 408 -Subsection a
+ Details
Name: |
ecd_InsiderTradingArrLineItems |
Namespace Prefix: |
ecd_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 408 -Subsection a -Paragraph 1
+ Details
Name: |
ecd_NonRule10b51ArrAdoptedFlag |
Namespace Prefix: |
ecd_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 408 -Subsection a -Paragraph 1
+ Details
Name: |
ecd_NonRule10b51ArrTrmntdFlag |
Namespace Prefix: |
ecd_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 408 -Subsection a -Paragraph 1
+ Details
Name: |
ecd_Rule10b51ArrAdoptedFlag |
Namespace Prefix: |
ecd_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 408 -Subsection a -Paragraph 1
+ Details
Name: |
ecd_Rule10b51ArrTrmntdFlag |
Namespace Prefix: |
ecd_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
BASIS OF PRESENTATION
|
9 Months Ended |
Oct. 31, 2023 |
Accounting Policies [Abstract] |
|
BASIS OF PRESENTATION |
NOTE
1 — BASIS OF PRESENTATION
Streamline
Health Solutions, Inc. and each of its wholly-owned subsidiaries, Streamline Health, LLC, Avelead Consulting, LLC, Streamline Consulting
Solutions, LLC and Streamline Pay & Benefits, LLC, (collectively, unless the context requires otherwise, “we,” “us,”
“our,” “Streamline,” or the “Company”), operate in one segment as a provider of healthcare information
technology solutions and associated services. The Company provides these capabilities through the licensing of its Coding & Clinical
Documentation Improvement (CDI) solutions, eValuator coding analysis platform, RevID, and other workflow software applications and the
use of such applications by software as a service (“SaaS”). The Company also provides audit services to help clients optimize
their internal clinical documentation and coding functions, as well as implementation and consulting services to complement its software
solutions. The Company’s software and services enable hospitals and integrated healthcare delivery systems in the United States
and Canada to capture, store, manage, route, retrieve and process patient clinical, financial and other healthcare provider information
related to the patient revenue cycle.
The
accompanying unaudited condensed consolidated financial statements have been prepared by us pursuant to the rules and regulations applicable
to quarterly reports on Form 10-Q of the U.S. Securities and Exchange Commission (the “SEC”). Certain information and note
disclosures normally included in annual financial statements prepared in accordance with U.S. generally accepted accounting principles
(“GAAP”) have been condensed or omitted pursuant to those rules and regulations, although we believe that the disclosures
made are adequate to make the information not misleading. The condensed consolidated financial statements include the accounts of Streamline
Health Solutions, Inc. and each of its wholly-owned subsidiaries. In the opinion of the Company’s management, all adjustments (consisting
of normal recurring accruals) considered necessary for a fair presentation of the condensed consolidated financial statements have been
included. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements
and notes thereto included in the Company’s most recent annual report on Form 10-K. Operating results for the three and nine months
ended October 31, 2023 are not necessarily indicative of the results that may be expected
for the fiscal year ending January 31, 2024.
The
Company has one operating segment and one reporting unit due to the singular nature of our products, product development and distribution
process, and client base as a provider of computer software-based solutions and services for acute-care healthcare providers.
All
amounts in the condensed consolidated financial statements, notes and tables have been rounded to the nearest thousand dollars, except
share and per share amounts, unless otherwise indicated. All references to a fiscal year refer to the fiscal year commencing February
1 in that calendar year and ending on January 31 of the following calendar year.
Going
Concern
The
Company’s financial statements are prepared on a going concern basis, which contemplates the realization of assets and the satisfaction
of obligations in the normal course of business. To date, the Company has not generated sufficient revenues to allow it to generate cash
flow from operations. The Company has historically accumulated losses and used cash from its financing activities to supplement its operations.
Further, the Company’s current forecast projects the Company will not be able to maintain compliance with certain of its
financial covenants under its current credit agreement in the next twelve months. These
conditions raise substantial doubt about the ability of the Company to continue as a going concern within one year after the date that
the financial statements are issued.
In
view of these matters, continuation as a going concern is dependent upon the Company’s ability to achieve cash from operations
and raise additional debt or equity capital to fund its ongoing operations. The Company expects to generate positive operating cash
flow in the next two fiscal quarters based upon executed contracts which it expects to be fully implemented.
As of October 31, 2023, the Company had approximately $9.75 million of total
outstanding debt associated with its term loan and revolver, $1.25 million of which is classified as a current liability. The Company
is engaged in ongoing discussions with its current banking partner, Western Alliance Bank, with whom it maintains a good working relationship;
however, the Company does not have written or executed agreements as of the issuance of this Form 10-Q. The Company’s ability to
refinance its existing debt is based upon credit markets and economic forces that are outside of its control. There can be no assurance
that the Company will be successful in raising additional capital or that such capital, if available, will be on terms that are acceptable
to the Company.
The
financial statements do not include any adjustments to the amount and classification of assets and liabilities that may be necessary
should the Company not continue as a going concern.
|
X |
- References
+ Details
Name: |
us-gaap_AccountingPoliciesAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 235 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//235/tableOfContent
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 275 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//275/tableOfContent
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 810 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//810/tableOfContent
Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 250 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//250/tableOfContent
+ Details
Name: |
us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
|
9 Months Ended |
Oct. 31, 2023 |
Accounting Policies [Abstract] |
|
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES |
NOTE
2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Our
significant accounting policies are presented in “Note 2 – Significant Accounting Policies” in the fiscal year 2022
Annual Report on Form 10-K. Users of financial information for interim periods are encouraged to refer to the notes to the consolidated
financial statements contained in the Annual Report on Form 10-K when reviewing interim financial results.
Use
of Estimates
The
preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts
reported in the financial statements and accompanying notes. On an ongoing basis, management evaluates its estimates and judgments, including
those related to the recognition of revenue, share-based compensation, capitalization of software development costs, intangible assets,
the allowance for credit losses, contingent consideration, and income taxes. Actual results could differ from those estimates.
Reclassification
Certain amounts for the three and nine months ended October 31, 2022 were reclassified to conform to the current
period classification. For the three and nine months ended October 31, 2023, the Company incurred certain acquisition-related costs related
to the acquisition of Avelead totaling $0 and $44,000, respectively, consisting primarily of professional service fees. For the three and nine months ended October 31,
2022, the Company incurred acquisition-related costs totaling $2,000 and $141,000, respectively, consisting primarily of professional service fees. The
aforementioned acquisition-related costs for the three and nine months ended October 31, 2022 were previously presented in a separate,
single caption and are now included in selling, general, and administrative expense in the accompanying condensed consolidated statements
of operations, which is consistent with the presentation for the current period.
Fair
Value of Financial Instruments
The
Financial Accounting Standards Board’s (“FASB”) authoritative guidance on fair value measurements establishes a framework
for measuring fair value. This guidance enables the reader of the financial statements to assess the inputs used to develop those measurements
by establishing a hierarchy for ranking the quality and reliability of the information used to determine fair values. Under this guidance,
assets and liabilities carried at fair value must be classified and disclosed in one of the following three categories:
Level
1: Quoted market prices in active markets for identical assets or liabilities.
Level
2: Observable market-based inputs or unobservable inputs that are corroborated by market data.
Level
3: Unobservable inputs that are not corroborated by market data.
The
carrying amounts of cash and cash equivalents, accounts receivable, accounts payable and accrued expenses approximate fair value based
on the short-term maturity of these instruments. Cash and cash equivalents are classified as Level 1. There were no transfers of assets
or liabilities between Levels 1, 2, or 3 during the nine months ended October 31, 2023 and
2022.
The
table below provides information on the fair value of our liabilities:
SCHEDULE
OF FAIR VALUE OF LIABILITIES
| |
Total Fair | | |
Quoted Prices in Active Markets | | |
Significant Other Observable Inputs | | |
Significant Unobservable
Inputs | |
| |
Value | | |
(Level 1) | | |
(Level 2) | | |
(Level 3) | |
At January 31, 2023 | |
| | | |
| | | |
| | | |
| | |
Acquisition earnout liability (1) | |
$ | 3,738,000 | | |
$ | — | | |
$ | — | | |
$ | 3,738,000 | |
At October 31, 2023 | |
| | | |
| | | |
| | | |
| | |
Acquisition earnout liability (1) | |
$ | 1,833,000 | | |
$ | — | | |
$ | — | | |
$ | 1,833,333 | |
(1) |
The
fair value of the acquisition earnout liability is based upon a probability-weighted discounted cash flow that was completed at the
date of acquisition and updated as of October 31, 2023. The change in the fair value of the acquisition earnout liability decreased
$1,182,000 and
$1,905,000 for
the three and nine months ended October 31, 2023, respectively. The change in the fair value is recognized in “Acquisition earnout valuation
adjustments” in the accompanying condensed consolidated statement of operations.
The probability-weighted discounted cash flow
is calculated using a Monte Carlo valuation method. The valuation model provides numerous outcomes. The outcomes are averaged and
discounted to present value, which provides the current value point estimate. A range of possible outcomes is not available under
the specific valuation method that was used in determining fair value of the acquisition earnout liability. The significant inputs
include recorded Avelead SaaS revenue, the probabilities associated with each of (i) a change in control or (ii) a certain client
termination, as well as other normal and customary inputs to financial models, including but not limited to, risk factors and
interest rates. |
The
fair value of the Company’s term loan and outstanding balance of the revolving line of credit under its Second Amended and
Restated Loan and Security Agreement (as amended and modified, the “Second Amended and Restated Loan Agreement”) was
determined through an analysis of the interest rate spread from the date of closing the loan (August 2021) to the date of the most
recent balance sheets, October 31, 2023 and January 31, 2023. The
term loan bears interest at a per annum rate equal to the Prime Rate (as published in The Wall Street Journal) plus 1.5%,
with a Prime “floor” rate of 3.25%.
The prime rate is variable and, thus accommodates changes in the market interest rate. However, the interest rate spread (the 1.5%
added to the Prime Rate) is fixed. We estimated the impact of the changes in the interest rate spread by analogizing the effect of
the change in the published “Corporate Bond Rates,” reduced for any changes in the market interest rate. This
provided us with an estimated change to the interest rate spread of approximately 0.5%
from (i) the date we entered the Second Amended and Restated Loan Agreement for the term loan or (ii) the date of each draw on the
revolving line of credit to the end of the fiscal third quarter, October 31, 2023, and end of the fiscal year, January 31, 2023. The
fair value of the debt as of October 31, 2023 and January 31, 2023 was estimated to be $9,054,000 and
$9,550,000,
respectively, or a discount to book value of $196,000 and
$200,000,
respectively. The fair value of the line of credit as of October 31, 2023 and January 31, 2023 was estimated to be $488,000
and $0,
respectively, or a discount to book value of $12,000
and $0,
respectively. Long-term debt is classified as Level 2.
Revenue
Recognition
We
derive revenue from the sale of internally-developed software, either by licensing for local installation or by a SaaS delivery model,
through the Company’s direct sales force or through third-party resellers. Licensed, locally-installed customers on a perpetual
model utilize the Company’s support and maintenance services for a separate fee, whereas term-based locally installed license fees
and SaaS fees include support and maintenance. We also derive revenue from professional services that support the implementation, configuration,
training and optimization of the applications, as well as audit services and consulting services.
We
recognize revenue in accordance with Accounting Standards Codification (ASC) 606, Revenue from Contracts with Customers, under
the core principle of recognizing revenue to depict the transfer of promised goods or services to customers in an amount that reflects
the consideration to which the entity expects to be entitled in exchange for those goods or services.
Disaggregation
of Revenue
The
following table provides information about disaggregated revenue by type and nature of revenue stream:
SCHEDULE OF DISAGGREGATION OF REVENUE
| |
October 31, 2023 | | |
October 31, 2022 | | |
October 31, 2023 | | |
October 31, 2022 | |
| |
Three Months Ended | | |
Nine Months Ended | |
| |
October 31, 2023 | | |
October 31, 2022 | | |
October 31, 2023 | | |
October 31, 2022 | |
Over time revenue | |
$ | 6,133,000 | | |
$ | 6,217,000 | | |
$ | 17,161,000 | | |
$ | 18,021,000 | |
Point in time revenue | |
| — | | |
| — | | |
| 74,000 | | |
| 123,000 | |
Total revenue | |
$ | 6,133,000 | | |
$ | 6,217,000 | | |
$ | 17,235,000 | | |
$ | 18,144,000 | |
The
Company includes revenue categories of (i) over time and (ii) point in time revenue. The Company includes revenue categories of (i) SaaS,
(ii) maintenance and support, (iii) professional services, and (iv) audit services as over time revenue. For point in time revenue, the
performance obligation is recognized as the point in time when the obligation is fully satisfied. The Company includes (i) software licenses
as point in time revenue.
Contract
Receivables and Deferred Revenues
The
Company receives payments from customers based upon contractual billing schedules. Contract receivables include amounts related to the
Company’s contractual right to consideration for completed performance obligations not yet invoiced. Deferred revenue includes
payments received in advance of performance under the contract. The Company’s contract receivables and deferred revenue are reported
on an individual contract basis at the end of each reporting period. Contract receivables are classified as current or noncurrent based
on the timing of when we expect to bill the customer. Deferred revenue is classified as current or noncurrent based on the timing of
when we expect to recognize revenue. During the nine months ended October 31, 2023, the
Company recognized approximately $6,772,000 in revenue from deferred revenues outstanding as of January 31, 2023. Revenue allocated to
remaining performance obligations was $23,045,000 as of October 31, 2023, of which the Company
expects to recognize approximately 56% over the next 12 months and the remainder thereafter.
Deferred
costs (costs to fulfill a contract and contract acquisition costs)
The
Company defers the direct costs, which include salaries and benefits, for professional services related to SaaS contracts as a cost to
fulfill a contract. These deferred costs will be amortized on a straight-line basis over the period of expected benefit which is the
contractual term. As of October 31, 2023 and January 31, 2023, the Company had deferred
costs of $98,000 and $94,000, respectively, net of accumulated amortization of $235,000 and $176,000, respectively. Amortization expense
of these costs was $24,000 and $22,000 for the three months ended October 31, 2023 and 2022,
respectively, and $59,000 and $62,000 for the nine months ended October 31, 2023 and 2022,
respectively, and is included in cost of SaaS in the condensed consolidated statements of operations.
Contract
acquisition costs, which consist of sales commissions paid or payable, are considered incremental and recoverable costs of obtaining
a contract with a customer. Sales commissions for initial and renewal contracts are deferred and then amortized on a straight-line basis
over the contract term. As a practical expedient, the Company expenses sales commissions as incurred when the amortization period of
related deferred commission costs is expected to be one year or less.
As
of October 31, 2023 and January 31, 2023, deferred commission costs paid and payable,
which are included on the consolidated balance sheets within other non-current assets totaled $1,195,000
and $1,534,000,
respectively, net of accumulated amortization and impairment totaling $1,238,000
and $820,000,
respectively. Amortization expense associated with deferred sales commissions, which is included in selling,
general and administrative expense in the condensed consolidated statements of operations, was $129,000
and $110,000
for the three months ended October 31, 2023 and 2022, respectively. Amortization
expense for the nine months ended October 31, 2023 and 2022 was $383,000
and $298,000,
respectively. For the three and nine months ended October 31, 2023, the Company recorded an impairment of $35,000
for deferred commission costs related to the client termination notification received in October 2023. There were no impairment
charges recorded for the three and nine months ended October 31, 2022.
Equity
Awards
The
Company accounts for share-based payments based on the grant-date fair value of the awards with compensation cost recognized as expense
over the requisite service period, and forfeitures are recognized as incurred. For awards to non-employees, the Company recognizes compensation
expense in the same manner as if the entity had paid cash for the goods or services. The Company incurred total compensation expense
related to share-based awards for the three and nine months ended October 31, 2023 of $517,000
and $1,626,000, respectively, which includes $60,000 and $176,000, respectively, of capitalized non-employee stock compensation, compared
to share-based compensation expense of $555,000 and $1,212,000, respectively, for the three and nine months ended October
31, 2022. During third quarter of fiscal year 2023, the Company accelerated the vesting of approximately 260,000 previously outstanding and unvested
shares of restricted common stock of the Company.
The
fair value of stock options granted are estimated at the date of grant using a Black-Scholes option pricing model. Option pricing model
input assumptions such as expected term, expected volatility and risk-free interest rate impact the fair value estimate. These assumptions
are subjective and are generally derived from external (such as, risk-free rate of interest) and historical data (such as, volatility
factor and expected term). Future grants of equity awards accounted for as share-based compensation could have a material impact on reported
expenses depending upon the number, value and vesting period of future awards.
The
Company issues restricted stock awards in the form of Company common stock. The fair value of these awards is based on the market closing
price per share on the grant date. For the three and nine months ended October 31, 2023,
the Company issued 45,000
and 1,130,000
shares of restricted common stock to employees,
respectively, compared to 65,000
and 865,000
shares of restricted common stock for the three
and nine months ended October 31, 2022, respectively. The Company expenses the compensation
cost of these awards as the restriction period lapses, which is typically a three-year period. For the three and nine months ended October
31, 2023, the Company issued 0
and 258,621
shares of restricted common stock to the Board
of Directors, respectively, compared to 0
and 200,731
shares of restricted common stock for the three
and nine months ended October 31, 2022, respectively. For the three and nine months ended
October 31, 2023, the Company issued 131,054
and 359,080
shares of restricted common stock to consultants,
respectively, compared to 53,836
and 187,937
shares of restricted common stock for the three
and nine months ended October 31, 2022, respectively.
Income
Taxes
Income
taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences
attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective
tax bases and for tax credit and loss carry-forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected
to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. In assessing net
deferred tax assets, the Company considers whether it is more likely than not that some or all of the deferred tax assets will not be
realized. The Company establishes a valuation allowance when it is more likely than not that all or a portion of deferred tax assets
will not be realized. Refer to Note 6 – Income Taxes for further details.
The
Company provides for uncertain tax positions and the related interest and penalties based upon management’s assessment of whether
certain tax positions are more likely than not to be sustained upon examination by tax authorities. The Company believes it has appropriately
accounted for any uncertain tax positions as of October 31, 2023.
Net
Loss Per Common Share
The
Company presents basic and diluted earnings per share (“EPS”) data for the Company’s common stock.
The
Company’s unvested restricted stock awards are considered non-participating securities because holders are not entitled to non-forfeitable
rights to dividends or dividend equivalents during the vesting term. Diluted EPS for the Company’s common stock is computed using
the treasury stock method.
The
following is the calculation of the basic and diluted net loss per share of common stock for the three and nine months ended October
31, 2023 and 2022:
SCHEDULE OF BASIC AND DILUTED NET LOSS PER SHARE OF COMMON STOCK
| |
October 31, 2023 | | |
October 31, 2022 | | |
October 31, 2023 | | |
October 31, 2022 | |
| |
Three Months Ended | | |
Nine Months Ended | |
| |
October 31, 2023 | | |
October 31, 2022 | | |
October 31, 2023 | | |
October 31, 2022 | |
Basic and diluted loss per share: | |
| | | |
| | | |
| | | |
| | |
Net loss | |
$ | (11,911,000 | ) | |
$ | (3,138,000 | ) | |
$ | (17,327,000 | ) | |
$ | (9,197,000 | ) |
Basic and diluted net loss per share of common stock from operations | |
$ | (0.21 | ) | |
$ | (0.07 | ) | |
$ | (0.31 | ) | |
$ | (0.19 | ) |
Weighted average shares outstanding – basic and diluted (1)(2) | |
| 56,710,335 | | |
| 47,730,009 | | |
| 56,346,300 | | |
| 47,329,923 | |
Weighted average shares outstanding - basic | |
| 56,710,335 | | |
| 47,730,009 | | |
| 56,346,300 | | |
| 47,329,923 | |
(1) |
Includes
the effect of vested and excludes the effect of unvested restricted shares of common stock, which are considered non-participating
securities. As of October 31, 2023 and 2022, there were 1,980,471 and 1,501,031 unvested restricted shares of common stock outstanding,
respectively. |
|
|
(2) |
Diluted
net loss per share excludes the effect of shares that are anti-dilutive. For the three and nine months ended October 31, 2023, diluted
earnings per share excludes 418,836 outstanding stock options and 1,980,471 unvested restricted shares of common stock. For the three
and nine months ended October 31, 2022, diluted earnings per share excludes 628,958 outstanding stock options and 1,501,031
unvested restricted shares of common stock. |
Restructuring
On
October 16, 2023, the Company announced it was executing a strategic restructuring designed to reduce expenses while maintaining the
Company’s ability to expand its SaaS business. The strategic restructuring initiatives included a reduction in force,
resulting in the termination of 26 employees,
approximately 24%
of the Company’s workforce. To execute the strategic restructuring, the Company estimates the one-time restructuring costs
associated with the workforce reduction to be approximately $900,000, and
the Company expects the expenses associated with the strategic restructuring to be substantially recognized by the end of fiscal
year 2023. The estimated costs pertain to severance and other employee termination-related costs and various professional fees the
Company may require to assist with execution of the strategic restructuring. The following is a reconciliation of the strategic
restructuring liability that is reflected on the Company’s condensed consolidated balance sheet under “Accrued
expenses”.
SCHEDULE OF RECONCILIATION OF THE
RESTRUCTURING LIABILITY
| |
(in
thousands) | |
| |
| | |
| | |
| | |
| | |
As
of October 31, 2023 | |
| |
Accrued
Balance as of January 31, 2023 | | |
2023
Expenses to Date | | |
2023
Cash Payments | | |
Accrued
Balance as of October 31, 2023 | | |
Total
Costs Incurred to Date | | |
Total
Expected Costs | |
Severance
expense | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Cost
of sales | |
$ | — | | |
$ | 154 | | |
$ | — | | |
$ | 154 | | |
$ | 154 | | |
$ | 154 | |
Selling,
general, and administrative | |
| — | | |
| 350 | | |
| — | | |
| 350 | | |
| 350 | | |
| 350 | |
Research
and development | |
| — | | |
| 227 | | |
| — | | |
| 227 | | |
| 227 | | |
| 227 | |
Total
severance expense | |
$ | — | | |
$ | 731 | | |
$ | — | | |
$ | 731 | | |
$ | 731 | | |
$ | 731 | |
Professional
fees | |
| — | | |
| 18 | | |
| — | | |
| 18 | | |
| 18 | | |
$ | 169 | |
Total | |
$ | — | | |
$ | 749 | | |
$ | — | | |
$ | 749 | | |
$ | 749 | | |
| 900 | |
Non-Cash
Items
For
the three and nine months ended October 31, 2023, the Company recorded capitalized software purchased with stock, totaling $60,000
and $176,000,
respectively, as non-cash items as it relates to non-cash investing activities in the condensed consolidated statements of cash
flow.
Accounting
Pronouncements Recently Adopted
On
February 1, 2023, the Company adopted ASU No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit
Losses on Financial Instruments (“ASU 2016-13”), as amended. ASU 2016-13 requires an allowance for expected credit losses
to be applied to financial assets at inception and reflect the risk of credit loss over the life of the asset. The Company estimated
current expected credit losses based on historical credit loss rates and applied an increase to account for future economic conditions.
The Company’s allowance for doubtful accounts as of January 31, 2023, prior to the adoption of ASU 216-13, was $132,000. The Company
estimated the current expected credit loss related to accounts receivable as of the adoption date of February 1, 2023 to be $96,000.
The Company recorded the adjustment in accounting policy change of $36,000 to the opening accumulated deficit balance for the year of
adoption.
SCHEDULE OF ACCOUNTING PRONOUNCEMENTS RECENTLY ADOPTED
| |
January 31, 2023 | | |
CECL Adoption | | |
Provision adjustments | | |
Write-offs & Recoveries | | |
October 31, 2023 | |
Allowance for credit losses | |
$ | (132,000 | ) | |
$ | 36,000 | | |
| — | | |
| — | | |
$ | (96,000 | ) |
For
the period ended October 31, 2023, the Company estimated the current expected credit loss
related to accounts receivable using historical credit loss rates and applied an adjustment to account for future economic conditions
in accordance with ASU 2016-13. The Company had no further impact on the allowance for credit losses during the nine-month period ended
October 31, 2023.
Recent
Accounting Pronouncements Not Yet Adopted
The
Company does not believe there are any other new accounting pronouncements that have been issued that might have a material impact on
its financial position or results of operations.
|
X |
- References
+ Details
Name: |
us-gaap_AccountingPoliciesAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe entire disclosure for all significant accounting policies of the reporting entity.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483426/235-10-50-1
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 235 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//235/tableOfContent
+ Details
Name: |
us-gaap_SignificantAccountingPoliciesTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
BUSINESS COMBINATION
|
9 Months Ended |
Oct. 31, 2023 |
Business Combination and Asset Acquisition [Abstract] |
|
BUSINESS COMBINATION |
NOTE
3 — BUSINESS COMBINATION
Avelead
Acquisition
The
Company acquired all the equity interests of Avelead Consulting, LLC (“Avelead”) as part of the Company’s strategic
expansion into the acute-care health care revenue cycle management industry (the “Transaction”). The Transaction was completed
on August 16, 2021.
On
November 21, 2022, the Company made cash payments of $2,012,000
and issued 1,871,037
unregistered securities in the form of restricted common stock, par value $0.01
per share, with respect to the first year earnout consideration. The estimated aggregate value of the first year earnout payment was
$5,000,000.
The second (and final) year earnout payment is expected to be paid during the quarter ending January 31, 2024 and consists of
$1,214,000 of cash payments and 1,589,342 unregistered securities in the form of restricted common stock, par value $0.01 per share.
These liabilities are reflected at the estimated fair value of the future commitment on the Company’s condensed consolidated
balance sheet as “Acquisition Earnout Liability” and totaled $1,833,000
as of October 31, 2023.
|
X |
- References
+ Details
Name: |
us-gaap_BusinessCombinationAndAssetAcquisitionAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 805 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 805 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//805/tableOfContent
+ Details
Name: |
us-gaap_BusinessCombinationDisclosureTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
OPERATING LEASES
|
9 Months Ended |
Oct. 31, 2023 |
Operating Leases |
|
OPERATING LEASES |
NOTE
4 — OPERATING LEASES
We
determine whether an arrangement is a lease at inception. Right-of-use assets represent our right to use an underlying asset for the
lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease right-of-use
assets and liabilities are recognized at commencement date based on the present value of lease payments over the expected lease term.
Since our lease arrangements do not provide an implicit rate, we use our incremental borrowing rate for the expected remaining lease
term at commencement date for new and existing leases in determining the present value of future lease payments. Operating lease expense
is recognized on a straight-line basis over the lease term.
Alpharetta
Office Lease
On
October 1, 2021, the Company entered into an agreement with a third-party to sublease its office space in Alpharetta, Georgia. The
sublease term was for 18
months, which coincided with the Company’s underlying lease (see below). The Company received $292,000
from the sublessee over the term of the sublease. The sublease did not relieve the Company of its original obligation under the
lease, and therefore the Company did not adjust the operating lease right-of-use asset and related liability. The sublease
terminated on March 31, 2023. For the three and nine months ended October 31, 2023, the Company recorded $0 and $32,000, respectively,
as other income related to the sublease. For the three and nine months ended October 31, 2022, the Company recorded
$49,000 and $145,000, respectively, as other income related to the sublease.
The
Company entered into a lease for office space in Alpharetta, Georgia, on March 1, 2020. The lease terminated on March 31, 2023. At inception,
the Company recorded a right-of use asset of $540,000,
and related current and long-term operating lease obligation in the accompanying consolidated balance sheet. The Company used a discount
rate of 6.5%
to determine the lease liability. For the three and nine months ended October 31, 2023, the Company had lease operating costs of approximately
$0 and $32,000, respectively. For the three and nine months ended October 31, 2022, the Company had lease
operating costs of approximately $48,000 and $145,000, respectively.
Suwanee
Office Lease
Upon
acquiring Avelead on August 16, 2021 (refer to Note 3 – Business Combination), the Company assumed an operating lease
agreement for the corporate office space of Avelead. The lessor is an entity controlled by one of the sellers of Avelead and that
seller is a former employee of the Company. The initial 36-month term lease commenced March 1, 2019 and expired on February
28, 2022. The Company previously renewed the lease for an additional 12-month term which expired February 28, 2023 and was
not renewed. For the three and nine months ended October 31, 2023, the Company recorded rent expense of $0 and $6,000,
respectively. For the three and nine months ended October 31, 2022, the Company recorded
rent expense of $18,000 and $55,000, respectively.
|
X |
- References
+ Details
Name: |
STRM_DisclosureOperatingLeasesAbstract |
Namespace Prefix: |
STRM_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 842 -SubTopic 20 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//842-20/tableOfContent
+ Details
Name: |
us-gaap_LesseeOperatingLeasesTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
DEBT
|
9 Months Ended |
Oct. 31, 2023 |
Debt Disclosure [Abstract] |
|
DEBT |
NOTE
5 — DEBT
Outstanding
principal balances consisted of the following at:
SCHEDULE
OF OUTSTANDING PRINCIPAL BALANCES
| |
October 31, 2023 | | |
January 31, 2023 | |
Term loan | |
$ | 9,250,000 | | |
$ | 9,750,000 | |
Financing cost payable | |
| 120,000 | | |
| 69,000 | |
Deferred financing cost | |
| (78,000 | ) | |
| (105,000 | ) |
Total | |
| 9,292,000 | | |
| 9,714,000 | |
Less: Current portion of term loan | |
| (1,250,000 | ) | |
| (750,000 | ) |
Non-current portion of term loan | |
| 8,042,000 | | |
| 8,964,000 | |
Non-current portion of line of credit | |
| 500,000 | | |
| — | |
Total non-current portion of debt | |
$ | 8,542,000 | | |
$ | 8,964,000 | |
Term
Loan and Revolving Line of Credit
On
November 29, 2022, the Company executed a Second Modification to Second Amended and Restated Loan Agreement (the “Second Modification”).
The Second Modification includes an expansion of the Company’s total borrowing to include a $2,000,000 non-formula revolving line
of credit. The revolving line of credit will be co-terminus with the term loan and matures on August 26, 2026. There are no requirements
to draw on the line of credit. Amounts outstanding under the line of credit portion of the Second Amended and Restated Loan Agreement
bear interest at a per annum rate equal to the Prime Rate (as published in The Wall Street Journal) plus 1.5%, with a Prime “floor”
rate of 3.25%. The Second Modification amended certain financial covenants in the Second Amended and Restated Loan Agreement. At January
31, 2023 and October 31, 2023, there was $0 and $500,000 outstanding on the revolving
line of credit, respectively.
Under
the Second Amended and Restated Loan Agreement, the Company has a term loan facility with an initial maximum principal amount of $10,000,000.
Amounts outstanding under the Second Amended and Restated Loan Agreement bear interest at a per annum rate equal to the Prime Rate (as
published in The Wall Street Journal) plus 1.5%, with a Prime “floor” rate of 3.25%. The Second Amended and Restated Loan
Agreement has a five-year term, and the maximum principal amount was advanced in a single-cash advance on or about the original closing
date (August 2021). Interest is due monthly, and the Company shall make monthly interest-only payments through the one-year anniversary
of the original closing date. Under the Second Amended and Restated Loan Agreement, principal repayments are required of $500,000 in
the second year, $1,000,000 in the third year, $2,000,000 in the fourth year, and $3,000,000 in the fifth year with the remaining outstanding
principal balance and all accrued but unpaid interest due in full on the maturity date. The Second Amended and Restated Loan Agreement
may also require early repayments if certain conditions are met.
The
Second Amended and Restated Loan Agreement includes customary financial covenants as follows:
|
● |
Minimum
Cash. Borrowers shall, at all times, maintain unrestricted cash of Borrowers at Bank in an amount not less than Two Million
Dollars ($2,000,000). |
|
|
|
|
● |
Maximum
Debt to ARR Ratio. Borrowers’ Maximum Debt to ARR Ratio, measured on a quarterly basis as of the last day of each fiscal
quarter, shall not be greater than the amount set forth under the heading “Maximum Debt to ARR Ratio” as of, and for
each of the dates appearing adjacent to such “Maximum Debt to ARR Ratio”. |
SCHEDULE OF MAXIMUM DEBT TO ARR RATIO
Quarter Ending | |
Maximum Debt to ARR Ratio |
October 31, 2022 | |
0.80 to 1.00 |
January 31, 2023 | |
0.70 to 1.00 |
April 30, 2023 | |
0.65 to 1.00 |
July 31, 2023 | |
0.60 to 1.00 |
October 31, 2023 | |
0.55 to 1.00 |
January 31, 2024 | |
0.50 to 1.00 |
|
● |
Maximum
Debt to Adjusted EBITDA Ratio. Commencing with the quarter ending April 30, 2024, Borrowers’ Maximum Debt to Adjusted
EBITDA Ratio, measured on a quarterly basis as of the last day of each fiscal quarter for the trailing four (4) quarter period then
ended, shall not be greater than the amount set forth under the heading “Maximum Debt to Adjusted EBITDA Ratio” as of,
and for each of the dates appearing adjacent to such “Maximum Debt to Adjusted EBITDA Ratio”. |
SCHEDULE OF MAXIMUM DEBT TO ADJUSTED EBITDA RATIO
Quarter Ending | |
Maximum
Debt to Adjusted
EBITDA Ratio |
April 30, 2024 | |
3.50 to 1.00 |
July 31, 2024 and on the last day of each quarter thereafter | |
2.00 to 1.00 |
|
● |
Fixed
Charge Coverage Ratio. Commencing with the quarter ending April 30, 2024, Borrowers shall maintain a Fixed Charge Coverage
Ratio of not less than 1.20 to 1.00, measured on a quarterly basis as of the last day of each fiscal quarter for the trailing four
(4) quarter period then ended. |
The
Second Amended and Restated Loan Agreement also includes customary negative covenants, subject to exceptions, which limit transfers,
capital expenditures, indebtedness, certain liens, investments, acquisitions, dispositions of assets, restricted payments, and the business
activities of the Company, as well as customary representations and warranties, affirmative covenants and events of default, including
cross defaults and a change of control default. The line of credit also is subject to customary prepayment requirements. Substantially
all the assets of the Company are collateralized by the Second Amended and Restated Loan Agreement. For the periods ended January 31,
2023 and October 31, 2023, the Company was in compliance with the Second Amended and Restated Loan Agreement covenants. However, the Company’s current forecast projects the Company may not be able to maintain compliance with certain
of its financial covenants under the Second Amended and Restated Loan Agreement in the future. The Company is
forecasted to miss certain future covenants. See Note 1 – Basis of Presentation for detail regarding the Company’s assessment
as a going concern.
The
Company records costs related to the maintenance of the Second Amended and Restated Loan Agreement as deferred financing costs, net of
the term loan. These deferred financing costs are being amortized over the remaining term of the loan. The Company has incurred $250,000
in financing costs which becomes payable at the earlier of the term date of the loan, or pre-payment. These costs are being accreted,
through interest expense, to the full value of the $250,000 over the remaining term of the loan.
|
X |
- References
+ Details
Name: |
us-gaap_DebtDisclosureAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1B -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(c)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 470 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//470/tableOfContent
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1B -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1B -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1B -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1C -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1C -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1C -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1E -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E
Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1I -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I
Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1I -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I
Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1I -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I
+ Details
Name: |
us-gaap_DebtDisclosureTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
INCOME TAXES
|
9 Months Ended |
Oct. 31, 2023 |
Income Tax Disclosure [Abstract] |
|
INCOME TAXES |
NOTE
6 — INCOME TAXES
Income
tax benefit increased to $59,000 for
the nine months ended October 31, 2023 compared to expense of $22,000 in the prior year
comparable period. The effective income tax rate on continuing operations of approximately -0-% differs from our combined federal
and state statutory rate of 25% primarily due to the full valuation allowance the Company currently maintains on its net deferred tax
asset.
The
Company has recorded $340,000 and $333,000 in reserves for uncertain tax positions as of October
31, 2023 and January 31, 2023, respectively.
The
Company and its subsidiaries are subject to U.S. federal income tax as well as income taxes in multiple state and local jurisdictions.
The Company has concluded all U.S. federal tax matters for years through January 31, 2019. All material state and local income tax matters
have been concluded for years through January 31, 2018. The Company is no longer subject to IRS examination for periods prior to the
tax year ended January 31, 2019; however, carryforward losses that were generated prior to the tax year ended January 31, 2019 may still
be adjusted by the IRS if they are used in a future period.
|
X |
- DefinitionThe entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480990/946-20-50-13
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(h)(2)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//740/tableOfContent
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482685/740-10-50-14
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482685/740-10-50-21
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 270 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482526/740-270-50-1
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 17 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 6.I.5.Q1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 11.C) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-2
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482603/740-30-50-2
+ Details
Name: |
us-gaap_IncomeTaxDisclosureTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
EQUITY
|
9 Months Ended |
Oct. 31, 2023 |
Equity [Abstract] |
|
EQUITY |
NOTE
7 — EQUITY
Capital
Raise
On
October 24, 2022, the Company entered into purchase agreements with certain investors pursuant to which the Company agreed to issue and
sell in a registered direct offering (the “2022 Offering”) an aggregate of 6,299,989 shares of common stock, par value $0.01
per share, at a purchase price of $1.32 per share. The gross proceeds to the Company from the 2022 Offering were approximately $8,316,000.
The Company used the proceeds of the 2022 Offering for general corporate purposes. The 2022 Offering closed on October 26, 2022.
Registration
of Shares Issued to 180 Consulting
On
June 22, 2022, the Company filed a Registration Statement on Form S-3 (Registration No. 333-265773) for the purpose of registering for
resale 272,653 shares of common stock issued to 180 Consulting, LLC (“180 Consulting”). The Registration Statement was declared
effective by the SEC on July 1, 2022.
On
June 28, 2023, the Company filed a Registration Statement on Form S-3 (Registration No. 333-272993) for purpose of registering for resale
394,127 shares of common stock issued to 180 Consulting, LLC (“180 Consulting”). The Registration Statement was declared
effective by the SEC on July 10, 2023.
Authorized
Shares Increase
At
the Annual Meeting of Stockholders held on June 7, 2022, the Company’s stockholders approved an amendment to the Streamline Health
Solutions, Inc. Third Amended and Restated 2013 Stock Incentive Plan to increase the number of shares of the Company’s common stock
authorized for issuance thereunder by 2,000,000 shares, from 8,223,246 shares to 10,223,246 shares. The Company’s stockholders
also approved an amendment to the Company’s Certificate of Incorporation, as amended, to increase the total number of authorized
shares of the Company’s common stock from 65,000,000 shares to 85,000,000 shares.
At
the Annual Meeting of Stockholders held on June 15, 2023, the Company’s stockholders approved an amendment to the Streamline Health
Solutions, Inc. Third Amended and Restated 2013 Stock Incentive Plan to increase the available number of shares of the Company’s
common stock authorized for issuance thereunder by 1,000,000 shares, from 10,223,246 shares to 11,223,246 shares.
|
X |
- References
+ Details
Name: |
us-gaap_EquityAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe entire disclosure for equity.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 235 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 235 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481004/946-505-50-6
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480237/815-40-50-6
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(e)(1)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1
Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//505/tableOfContent
Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13
Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13
Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13
Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14
Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14
Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 16 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-16
Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18
Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18
Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 18 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18
+ Details
Name: |
us-gaap_StockholdersEquityNoteDisclosureTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
COMMITMENTS AND CONTINGENCIES
|
9 Months Ended |
Oct. 31, 2023 |
Commitments and Contingencies Disclosure [Abstract] |
|
COMMITMENTS AND CONTINGENCIES |
NOTE
8 — COMMITMENTS AND CONTINGENCIES
Consulting
Agreement with 180 Consulting, LLC
On
March 19, 2020, the Company entered into a Master Services Agreement (the “MSA”) with 180 Consulting, pursuant to which 180
Consulting has provided and will continue to provide a variety of consulting services in support of eValuator products including product
management, operational consulting, staff augmentation, internal systems platform integration and software engineering services, among
others, through separate executed statements of work (“SOWs”). On September 20, 2021, the Company entered into a separate
MSA in support of Avelead products. Certain of the SOWs include the ability of 180 Consulting to earn common stock of the company at
a conversion rate to be calculated 20 days after the execution of the related SOW. The MSA includes a termination clause upon a 90-day
written notice. While no related party has a direct or indirect material interest in this MSA or the related SOWs, individuals providing
services to the Company under the MSA and the SOWs may share workspace and administrative costs with 121G Consulting, LLC (“121G”).
Mr. Green is a “member” of 121G, and, accordingly, has a financial interest in that entity. 180 Consulting earned 100,037
and 358,190 shares for the three and nine months ended October 31, 2023, respectively, and has earned an aggregate of 1,273,394 shares
of the Company’s common stock through October 31, 2023. 180 Consulting earned 183,284 and 293,190 shares for the three and nine
months ended October 31, 2022, respectively. For services rendered by 180 Consulting during the three and nine months ended October 31,
2023, the Company incurred fees of $639,000 and $2,558,000, respectively, and capitalized non-employee stock compensation of $60,000
and $176,000, respectively. The Company paid fees of $751,000 and $1,781,000 for services rendered by 180 Consulting during the three
and nine months ended October 31, 2022.
Inclusive
of the MSA executed with 180 Consulting are SOWs that provide for the Company to sublicense software through 180 Consulting that is owned
by 121G. This is a services agreement for access to software that assists the Company in implementing and integrating with our clients’
technology. The license agreement is designed such that there is no material financial benefit that accrues to 121G. 180 Consulting licenses
the software from 121G at cost. The Company paid approximately $87,000 and $468,000 for the SOWs that include the sublicense agreement
for the three and nine months ended October 31, 2023, respectively, which are included in the aforementioned totals above.
|
X |
- References
+ Details
Name: |
us-gaap_CommitmentsAndContingenciesDisclosureAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe entire disclosure for commitments and contingencies.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 440 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4
Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 450 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//450/tableOfContent
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 954 -SubTopic 440 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480327/954-440-50-1
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 440 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4
Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 440 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//440/tableOfContent
+ Details
Name: |
us-gaap_CommitmentsAndContingenciesDisclosureTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
GOODWILL AND INTANGIBLE ASSETS
|
9 Months Ended |
Oct. 31, 2023 |
Goodwill and Intangible Assets Disclosure [Abstract] |
|
GOODWILL AND INTANGIBLE ASSETS |
NOTE
9 — GOODWILL AND INTANGIBLE ASSETS
Goodwill
represents the excess cost over fair value of the net assets of acquired businesses and is not amortized. The Company performs an impairment
assessment of goodwill annually during the fourth quarter of its fiscal year with a valuation date of November 1, or more
frequently if a triggering event occurs.
The
Company’s intangible assets consist of client relationships, acquired and developed technology, and trade names. These
assets are recorded at cost, less accumulated amortization and impairment, if any. All the Company’s intangible assets are
definite lived and amortized on a straight-line basis over their estimated useful lives. Subsequent testing of intangible assets is
conducted when a triggering event occurs that would indicate impairment may exist.
In
October 2023, the Company was notified by a legacy client of its intent to not renew its contract as of its end date on December 31,
2023. At that time, the Company elected to accelerate the execution of a planned strategic restructuring that was designed to reduce
costs while maintaining the Company’s ability to expand its SaaS business. Both the client termination and the execution of the
strategic restructuring were announced on October 16, 2023. Following these announcements, the Company’s share price declined significantly.
Based on these events (collectively, the “Triggering Events”), the Company identified indicators of possible impairment and
initiated testing using a valuation date of October 31, 2023. The impairment tests were conducted under guidance of ASC Topic 360, Impairment
and Disposal of Long-Lived Assets (“ASC 360”) for certain long-lived assets, including capitalized contract costs, developed
technology, client relationships and trade names, and in accordance with ASC Topic 350, Intangibles – Goodwill and Other (“ASC
350”) with respect to the reporting unit’s goodwill.
Goodwill
The
changes in the carrying amount of goodwill were as follows:
SCHEDULE
OF CARRYING AMOUNT OF GOODWILL
| |
Nine Months Ended | |
| |
October 31, 2023 | |
Balance as of January 31, 2023 | |
$ | 23,089,000 | |
Impairment | |
| (9,813,000 | ) |
Balance as of October 31, 2023 | |
$ | 13,276,000 | |
The
Company determined that effective January 31, 2023, it had one reporting unit for purposes of evaluation of goodwill. Based on the Triggering
Events and in conjunction with its preparation of its financial statements for the three and nine months ended October 31, 2023, the
Company tested the reporting unit’s goodwill for possible impairment as of October 31, 2023. The testing for impairment was performed
under the guidance of ASC 360. The testing utilized a discounted debt-free net cash flow (“DCF”) method under the income
approach and the market capitalization method (“MCM”) under the market approach. The sum of the weighted values of each method
was used to derive the fair value of the Company’s equity.
The MCM calculates the aggregate market value of
the Company based on the total number of shares outstanding and the current market price of the shares as of the valuation date. Data
on similar mergers and acquisitions within healthcare technology are observed to determine control premium that represents a stock premium
percentage offered by an acquirer to a public company. The control premium applied to the aggregate market value represents MCM calculated
fair value.
The DCF incorporates the use of projected financial information and a discount
rate using a weighted average cost of capital with cost of equity estimated based on the capital asset pricing model. The cash-flow projections
are based on financial forecasts developed by management that include forecasts of future operating results based on internal budgets
and strategic plans to invest in working capital to support anticipated revenue growth. External factors and business conditions are considered
by management when setting the long-term growth rates. The selected discount rate considers the risk and nature of the reporting unit’s
cash flows and the rates of return market participants would require to invest their capital in the Company.
The
Company concluded that its goodwill was impaired based on the weighted combination of the DCF and MCM value estimates which resulted in a
calculated fair value lower than the equity carrying value. The Company recorded an impairment of goodwill in the amount of $9,813,000
reported as “Goodwill Impairment” on its Condensed Consolidated Statement of Operations for the period ended October 31, 2023.
Intangible
Assets
The
changes in the carrying amounts of the Company’s finite-lived assets were as follows:
SCHEDULE
OF FINITE-LIVED INTANGIBLE ASSETS
| |
| |
October 31, 2023 | |
| |
Estimated Useful Life | |
Gross Assets | | |
Accumulated Amortization | | |
Impairment | | |
Net Assets | |
Finite-lived assets: | |
| |
| | | |
| | | |
| | | |
| | |
Client relationships | |
8-10 years | |
$ | 9,700,000 | | |
$ | 2,216,000 | | |
$ | 963,000 | | |
$ | 6,521,000 | |
Internally developed software | |
9 years | |
| 6,380,000 | | |
| 1,565,000 | | |
| — | | |
$ | 4,815,000 | |
Trademarks and tradenames | |
15 years | |
| 1,340,000 | | |
| 197,000 | | |
| — | | |
$ | 1,143,000 | |
Total | |
| |
$ | 17,420,000 | | |
$ | 3,978,000 | | |
| 963,000 | | |
$ | 12,479,000 | |
ASC
360 defines a multi-step process to test long-lived assets, including intangible assets, for recoverability that if failed would indicate
impairment. First, the Company must consider whether indicators of impairment of long-lived assets are present, which the Company determined
the Triggering Events in conjunction with preparation of its financial statements for the three
and nine months ended October 31, 2023 provided such indication.
Next, the Company must review the long-lived assets to define asset group(s)
that would reflect the lowest level of assets to which discrete cash flows are identifiable. In performing this review, the Company identified
that the long-lived asset “client relationships” related to Avelead should be classified as abandoned (the “Abandoned
Asset”) with the Company determining that it no longer has plans to provide the corresponding consulting service. The Abandoned
Asset’s carrying value would need to be set to its salvage value which would be zero given no future cash flows.
The Company determined the lowest level of discrete cash flows is at the
reporting unit level, and all remaining long-lived assets (excluding the Abandoned Asset) and goodwill would represent its only asset
group. Recoverability is assessed by comparing that the sum of the discrete undiscounted cash flows exceeds the carrying value of the
asset group. The undiscounted cash flow projections are based on 8-year (representing the useful life of the primary asset in the asset
group) financial forecasts developed by management that include forecasts of future operating results based on internal budgets and strategic
plans to investment in working capital to support anticipated revenue growth.
The
undiscounted cash flows for the long-lived assets were above the carrying amounts indicating that the long-lived asset group is
recoverable and no further impairment to long-lived assets exists as of October 31, 2023. For the three-month period ended October
31, 2023, the Company recorded $963,000
as “Impairment of long-lived assets” on its Condensed Consolidated Statement of Operations to adjust the Abandoned Asset
to its salvage value of zero.
|
X |
- References
+ Details
Name: |
us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe entire disclosure for goodwill and intangible assets.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 350 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//350/tableOfContent
+ Details
Name: |
us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
RELATED PARTY TRANSACTIONS
|
9 Months Ended |
Oct. 31, 2023 |
Related Party Transactions [Abstract] |
|
RELATED PARTY TRANSACTIONS |
NOTE
10 - RELATED PARTY TRANSACTIONS
Refer
to Note 3 – Business Combination. The Company acquired Avelead on August 16, 2021. Accordingly, the Company assumed a lease for
corporate office space from a selling equity-holder of Avelead that is a former employee of the Company. This lease term ended February
2023. For the three and nine months ended October 31, 2023, the Company recorded rent expense of $0 and $6,000, respectively. For the
three and nine months ended October 31, 2022, the Company recorded rent expense of $18,000 and $55,000, respectively (refer to Note 4
– Operating Leases).
|
X |
- DefinitionThe entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480990/946-20-50-2
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480990/946-20-50-5
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480990/946-20-50-6
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 235 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 235 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 850 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-07(2)(g)(3)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-07(2)(c)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-07(2)(e)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 850 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//850/tableOfContent
Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 850 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483326/850-10-50-6
Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 850 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1
Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 850 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483326/850-10-50-1
+ Details
Name: |
us-gaap_RelatedPartyTransactionsDisclosureTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
|
9 Months Ended |
Oct. 31, 2023 |
Accounting Policies [Abstract] |
|
Use of Estimates |
Use
of Estimates
The
preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts
reported in the financial statements and accompanying notes. On an ongoing basis, management evaluates its estimates and judgments, including
those related to the recognition of revenue, share-based compensation, capitalization of software development costs, intangible assets,
the allowance for credit losses, contingent consideration, and income taxes. Actual results could differ from those estimates.
|
Reclassification |
Reclassification
Certain amounts for the three and nine months ended October 31, 2022 were reclassified to conform to the current
period classification. For the three and nine months ended October 31, 2023, the Company incurred certain acquisition-related costs related
to the acquisition of Avelead totaling $0 and $44,000, respectively, consisting primarily of professional service fees. For the three and nine months ended October 31,
2022, the Company incurred acquisition-related costs totaling $2,000 and $141,000, respectively, consisting primarily of professional service fees. The
aforementioned acquisition-related costs for the three and nine months ended October 31, 2022 were previously presented in a separate,
single caption and are now included in selling, general, and administrative expense in the accompanying condensed consolidated statements
of operations, which is consistent with the presentation for the current period.
|
Fair Value of Financial Instruments |
Fair
Value of Financial Instruments
The
Financial Accounting Standards Board’s (“FASB”) authoritative guidance on fair value measurements establishes a framework
for measuring fair value. This guidance enables the reader of the financial statements to assess the inputs used to develop those measurements
by establishing a hierarchy for ranking the quality and reliability of the information used to determine fair values. Under this guidance,
assets and liabilities carried at fair value must be classified and disclosed in one of the following three categories:
Level
1: Quoted market prices in active markets for identical assets or liabilities.
Level
2: Observable market-based inputs or unobservable inputs that are corroborated by market data.
Level
3: Unobservable inputs that are not corroborated by market data.
The
carrying amounts of cash and cash equivalents, accounts receivable, accounts payable and accrued expenses approximate fair value based
on the short-term maturity of these instruments. Cash and cash equivalents are classified as Level 1. There were no transfers of assets
or liabilities between Levels 1, 2, or 3 during the nine months ended October 31, 2023 and
2022.
The
table below provides information on the fair value of our liabilities:
SCHEDULE
OF FAIR VALUE OF LIABILITIES
| |
Total Fair | | |
Quoted Prices in Active Markets | | |
Significant Other Observable Inputs | | |
Significant Unobservable
Inputs | |
| |
Value | | |
(Level 1) | | |
(Level 2) | | |
(Level 3) | |
At January 31, 2023 | |
| | | |
| | | |
| | | |
| | |
Acquisition earnout liability (1) | |
$ | 3,738,000 | | |
$ | — | | |
$ | — | | |
$ | 3,738,000 | |
At October 31, 2023 | |
| | | |
| | | |
| | | |
| | |
Acquisition earnout liability (1) | |
$ | 1,833,000 | | |
$ | — | | |
$ | — | | |
$ | 1,833,333 | |
(1) |
The
fair value of the acquisition earnout liability is based upon a probability-weighted discounted cash flow that was completed at the
date of acquisition and updated as of October 31, 2023. The change in the fair value of the acquisition earnout liability decreased
$1,182,000 and
$1,905,000 for
the three and nine months ended October 31, 2023, respectively. The change in the fair value is recognized in “Acquisition earnout valuation
adjustments” in the accompanying condensed consolidated statement of operations.
The probability-weighted discounted cash flow
is calculated using a Monte Carlo valuation method. The valuation model provides numerous outcomes. The outcomes are averaged and
discounted to present value, which provides the current value point estimate. A range of possible outcomes is not available under
the specific valuation method that was used in determining fair value of the acquisition earnout liability. The significant inputs
include recorded Avelead SaaS revenue, the probabilities associated with each of (i) a change in control or (ii) a certain client
termination, as well as other normal and customary inputs to financial models, including but not limited to, risk factors and
interest rates. |
The
fair value of the Company’s term loan and outstanding balance of the revolving line of credit under its Second Amended and
Restated Loan and Security Agreement (as amended and modified, the “Second Amended and Restated Loan Agreement”) was
determined through an analysis of the interest rate spread from the date of closing the loan (August 2021) to the date of the most
recent balance sheets, October 31, 2023 and January 31, 2023. The
term loan bears interest at a per annum rate equal to the Prime Rate (as published in The Wall Street Journal) plus 1.5%,
with a Prime “floor” rate of 3.25%.
The prime rate is variable and, thus accommodates changes in the market interest rate. However, the interest rate spread (the 1.5%
added to the Prime Rate) is fixed. We estimated the impact of the changes in the interest rate spread by analogizing the effect of
the change in the published “Corporate Bond Rates,” reduced for any changes in the market interest rate. This
provided us with an estimated change to the interest rate spread of approximately 0.5%
from (i) the date we entered the Second Amended and Restated Loan Agreement for the term loan or (ii) the date of each draw on the
revolving line of credit to the end of the fiscal third quarter, October 31, 2023, and end of the fiscal year, January 31, 2023. The
fair value of the debt as of October 31, 2023 and January 31, 2023 was estimated to be $9,054,000 and
$9,550,000,
respectively, or a discount to book value of $196,000 and
$200,000,
respectively. The fair value of the line of credit as of October 31, 2023 and January 31, 2023 was estimated to be $488,000
and $0,
respectively, or a discount to book value of $12,000
and $0,
respectively. Long-term debt is classified as Level 2.
|
Revenue Recognition |
Revenue
Recognition
We
derive revenue from the sale of internally-developed software, either by licensing for local installation or by a SaaS delivery model,
through the Company’s direct sales force or through third-party resellers. Licensed, locally-installed customers on a perpetual
model utilize the Company’s support and maintenance services for a separate fee, whereas term-based locally installed license fees
and SaaS fees include support and maintenance. We also derive revenue from professional services that support the implementation, configuration,
training and optimization of the applications, as well as audit services and consulting services.
We
recognize revenue in accordance with Accounting Standards Codification (ASC) 606, Revenue from Contracts with Customers, under
the core principle of recognizing revenue to depict the transfer of promised goods or services to customers in an amount that reflects
the consideration to which the entity expects to be entitled in exchange for those goods or services.
Disaggregation
of Revenue
The
following table provides information about disaggregated revenue by type and nature of revenue stream:
SCHEDULE OF DISAGGREGATION OF REVENUE
| |
October 31, 2023 | | |
October 31, 2022 | | |
October 31, 2023 | | |
October 31, 2022 | |
| |
Three Months Ended | | |
Nine Months Ended | |
| |
October 31, 2023 | | |
October 31, 2022 | | |
October 31, 2023 | | |
October 31, 2022 | |
Over time revenue | |
$ | 6,133,000 | | |
$ | 6,217,000 | | |
$ | 17,161,000 | | |
$ | 18,021,000 | |
Point in time revenue | |
| — | | |
| — | | |
| 74,000 | | |
| 123,000 | |
Total revenue | |
$ | 6,133,000 | | |
$ | 6,217,000 | | |
$ | 17,235,000 | | |
$ | 18,144,000 | |
The
Company includes revenue categories of (i) over time and (ii) point in time revenue. The Company includes revenue categories of (i) SaaS,
(ii) maintenance and support, (iii) professional services, and (iv) audit services as over time revenue. For point in time revenue, the
performance obligation is recognized as the point in time when the obligation is fully satisfied. The Company includes (i) software licenses
as point in time revenue.
Contract
Receivables and Deferred Revenues
The
Company receives payments from customers based upon contractual billing schedules. Contract receivables include amounts related to the
Company’s contractual right to consideration for completed performance obligations not yet invoiced. Deferred revenue includes
payments received in advance of performance under the contract. The Company’s contract receivables and deferred revenue are reported
on an individual contract basis at the end of each reporting period. Contract receivables are classified as current or noncurrent based
on the timing of when we expect to bill the customer. Deferred revenue is classified as current or noncurrent based on the timing of
when we expect to recognize revenue. During the nine months ended October 31, 2023, the
Company recognized approximately $6,772,000 in revenue from deferred revenues outstanding as of January 31, 2023. Revenue allocated to
remaining performance obligations was $23,045,000 as of October 31, 2023, of which the Company
expects to recognize approximately 56% over the next 12 months and the remainder thereafter.
Deferred
costs (costs to fulfill a contract and contract acquisition costs)
The
Company defers the direct costs, which include salaries and benefits, for professional services related to SaaS contracts as a cost to
fulfill a contract. These deferred costs will be amortized on a straight-line basis over the period of expected benefit which is the
contractual term. As of October 31, 2023 and January 31, 2023, the Company had deferred
costs of $98,000 and $94,000, respectively, net of accumulated amortization of $235,000 and $176,000, respectively. Amortization expense
of these costs was $24,000 and $22,000 for the three months ended October 31, 2023 and 2022,
respectively, and $59,000 and $62,000 for the nine months ended October 31, 2023 and 2022,
respectively, and is included in cost of SaaS in the condensed consolidated statements of operations.
Contract
acquisition costs, which consist of sales commissions paid or payable, are considered incremental and recoverable costs of obtaining
a contract with a customer. Sales commissions for initial and renewal contracts are deferred and then amortized on a straight-line basis
over the contract term. As a practical expedient, the Company expenses sales commissions as incurred when the amortization period of
related deferred commission costs is expected to be one year or less.
As
of October 31, 2023 and January 31, 2023, deferred commission costs paid and payable,
which are included on the consolidated balance sheets within other non-current assets totaled $1,195,000
and $1,534,000,
respectively, net of accumulated amortization and impairment totaling $1,238,000
and $820,000,
respectively. Amortization expense associated with deferred sales commissions, which is included in selling,
general and administrative expense in the condensed consolidated statements of operations, was $129,000
and $110,000
for the three months ended October 31, 2023 and 2022, respectively. Amortization
expense for the nine months ended October 31, 2023 and 2022 was $383,000
and $298,000,
respectively. For the three and nine months ended October 31, 2023, the Company recorded an impairment of $35,000
for deferred commission costs related to the client termination notification received in October 2023. There were no impairment
charges recorded for the three and nine months ended October 31, 2022.
|
Equity Awards |
Equity
Awards
The
Company accounts for share-based payments based on the grant-date fair value of the awards with compensation cost recognized as expense
over the requisite service period, and forfeitures are recognized as incurred. For awards to non-employees, the Company recognizes compensation
expense in the same manner as if the entity had paid cash for the goods or services. The Company incurred total compensation expense
related to share-based awards for the three and nine months ended October 31, 2023 of $517,000
and $1,626,000, respectively, which includes $60,000 and $176,000, respectively, of capitalized non-employee stock compensation, compared
to share-based compensation expense of $555,000 and $1,212,000, respectively, for the three and nine months ended October
31, 2022. During third quarter of fiscal year 2023, the Company accelerated the vesting of approximately 260,000 previously outstanding and unvested
shares of restricted common stock of the Company.
The
fair value of stock options granted are estimated at the date of grant using a Black-Scholes option pricing model. Option pricing model
input assumptions such as expected term, expected volatility and risk-free interest rate impact the fair value estimate. These assumptions
are subjective and are generally derived from external (such as, risk-free rate of interest) and historical data (such as, volatility
factor and expected term). Future grants of equity awards accounted for as share-based compensation could have a material impact on reported
expenses depending upon the number, value and vesting period of future awards.
The
Company issues restricted stock awards in the form of Company common stock. The fair value of these awards is based on the market closing
price per share on the grant date. For the three and nine months ended October 31, 2023,
the Company issued 45,000
and 1,130,000
shares of restricted common stock to employees,
respectively, compared to 65,000
and 865,000
shares of restricted common stock for the three
and nine months ended October 31, 2022, respectively. The Company expenses the compensation
cost of these awards as the restriction period lapses, which is typically a three-year period. For the three and nine months ended October
31, 2023, the Company issued 0
and 258,621
shares of restricted common stock to the Board
of Directors, respectively, compared to 0
and 200,731
shares of restricted common stock for the three
and nine months ended October 31, 2022, respectively. For the three and nine months ended
October 31, 2023, the Company issued 131,054
and 359,080
shares of restricted common stock to consultants,
respectively, compared to 53,836
and 187,937
shares of restricted common stock for the three
and nine months ended October 31, 2022, respectively.
|
Income Taxes |
Income
Taxes
Income
taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences
attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective
tax bases and for tax credit and loss carry-forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected
to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. In assessing net
deferred tax assets, the Company considers whether it is more likely than not that some or all of the deferred tax assets will not be
realized. The Company establishes a valuation allowance when it is more likely than not that all or a portion of deferred tax assets
will not be realized. Refer to Note 6 – Income Taxes for further details.
The
Company provides for uncertain tax positions and the related interest and penalties based upon management’s assessment of whether
certain tax positions are more likely than not to be sustained upon examination by tax authorities. The Company believes it has appropriately
accounted for any uncertain tax positions as of October 31, 2023.
|
Net Loss Per Common Share |
Net
Loss Per Common Share
The
Company presents basic and diluted earnings per share (“EPS”) data for the Company’s common stock.
The
Company’s unvested restricted stock awards are considered non-participating securities because holders are not entitled to non-forfeitable
rights to dividends or dividend equivalents during the vesting term. Diluted EPS for the Company’s common stock is computed using
the treasury stock method.
The
following is the calculation of the basic and diluted net loss per share of common stock for the three and nine months ended October
31, 2023 and 2022:
SCHEDULE OF BASIC AND DILUTED NET LOSS PER SHARE OF COMMON STOCK
| |
October 31, 2023 | | |
October 31, 2022 | | |
October 31, 2023 | | |
October 31, 2022 | |
| |
Three Months Ended | | |
Nine Months Ended | |
| |
October 31, 2023 | | |
October 31, 2022 | | |
October 31, 2023 | | |
October 31, 2022 | |
Basic and diluted loss per share: | |
| | | |
| | | |
| | | |
| | |
Net loss | |
$ | (11,911,000 | ) | |
$ | (3,138,000 | ) | |
$ | (17,327,000 | ) | |
$ | (9,197,000 | ) |
Basic and diluted net loss per share of common stock from operations | |
$ | (0.21 | ) | |
$ | (0.07 | ) | |
$ | (0.31 | ) | |
$ | (0.19 | ) |
Weighted average shares outstanding – basic and diluted (1)(2) | |
| 56,710,335 | | |
| 47,730,009 | | |
| 56,346,300 | | |
| 47,329,923 | |
Weighted average shares outstanding - basic | |
| 56,710,335 | | |
| 47,730,009 | | |
| 56,346,300 | | |
| 47,329,923 | |
(1) |
Includes
the effect of vested and excludes the effect of unvested restricted shares of common stock, which are considered non-participating
securities. As of October 31, 2023 and 2022, there were 1,980,471 and 1,501,031 unvested restricted shares of common stock outstanding,
respectively. |
|
|
(2) |
Diluted
net loss per share excludes the effect of shares that are anti-dilutive. For the three and nine months ended October 31, 2023, diluted
earnings per share excludes 418,836 outstanding stock options and 1,980,471 unvested restricted shares of common stock. For the three
and nine months ended October 31, 2022, diluted earnings per share excludes 628,958 outstanding stock options and 1,501,031
unvested restricted shares of common stock. |
|
Restructuring |
Restructuring
On
October 16, 2023, the Company announced it was executing a strategic restructuring designed to reduce expenses while maintaining the
Company’s ability to expand its SaaS business. The strategic restructuring initiatives included a reduction in force,
resulting in the termination of 26 employees,
approximately 24%
of the Company’s workforce. To execute the strategic restructuring, the Company estimates the one-time restructuring costs
associated with the workforce reduction to be approximately $900,000, and
the Company expects the expenses associated with the strategic restructuring to be substantially recognized by the end of fiscal
year 2023. The estimated costs pertain to severance and other employee termination-related costs and various professional fees the
Company may require to assist with execution of the strategic restructuring. The following is a reconciliation of the strategic
restructuring liability that is reflected on the Company’s condensed consolidated balance sheet under “Accrued
expenses”.
SCHEDULE OF RECONCILIATION OF THE
RESTRUCTURING LIABILITY
| |
(in
thousands) | |
| |
| | |
| | |
| | |
| | |
As
of October 31, 2023 | |
| |
Accrued
Balance as of January 31, 2023 | | |
2023
Expenses to Date | | |
2023
Cash Payments | | |
Accrued
Balance as of October 31, 2023 | | |
Total
Costs Incurred to Date | | |
Total
Expected Costs | |
Severance
expense | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Cost
of sales | |
$ | — | | |
$ | 154 | | |
$ | — | | |
$ | 154 | | |
$ | 154 | | |
$ | 154 | |
Selling,
general, and administrative | |
| — | | |
| 350 | | |
| — | | |
| 350 | | |
| 350 | | |
| 350 | |
Research
and development | |
| — | | |
| 227 | | |
| — | | |
| 227 | | |
| 227 | | |
| 227 | |
Total
severance expense | |
$ | — | | |
$ | 731 | | |
$ | — | | |
$ | 731 | | |
$ | 731 | | |
$ | 731 | |
Professional
fees | |
| — | | |
| 18 | | |
| — | | |
| 18 | | |
| 18 | | |
$ | 169 | |
Total | |
$ | — | | |
$ | 749 | | |
$ | — | | |
$ | 749 | | |
$ | 749 | | |
| 900 | |
|
Non-Cash Items |
Non-Cash
Items
For
the three and nine months ended October 31, 2023, the Company recorded capitalized software purchased with stock, totaling $60,000
and $176,000,
respectively, as non-cash items as it relates to non-cash investing activities in the condensed consolidated statements of cash
flow.
|
Accounting Pronouncements Recently Adopted |
Accounting
Pronouncements Recently Adopted
On
February 1, 2023, the Company adopted ASU No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit
Losses on Financial Instruments (“ASU 2016-13”), as amended. ASU 2016-13 requires an allowance for expected credit losses
to be applied to financial assets at inception and reflect the risk of credit loss over the life of the asset. The Company estimated
current expected credit losses based on historical credit loss rates and applied an increase to account for future economic conditions.
The Company’s allowance for doubtful accounts as of January 31, 2023, prior to the adoption of ASU 216-13, was $132,000. The Company
estimated the current expected credit loss related to accounts receivable as of the adoption date of February 1, 2023 to be $96,000.
The Company recorded the adjustment in accounting policy change of $36,000 to the opening accumulated deficit balance for the year of
adoption.
SCHEDULE OF ACCOUNTING PRONOUNCEMENTS RECENTLY ADOPTED
| |
January 31, 2023 | | |
CECL Adoption | | |
Provision adjustments | | |
Write-offs & Recoveries | | |
October 31, 2023 | |
Allowance for credit losses | |
$ | (132,000 | ) | |
$ | 36,000 | | |
| — | | |
| — | | |
$ | (96,000 | ) |
For
the period ended October 31, 2023, the Company estimated the current expected credit loss
related to accounts receivable using historical credit loss rates and applied an adjustment to account for future economic conditions
in accordance with ASU 2016-13. The Company had no further impact on the allowance for credit losses during the nine-month period ended
October 31, 2023.
|
Recent Accounting Pronouncements Not Yet Adopted |
Recent
Accounting Pronouncements Not Yet Adopted
The
Company does not believe there are any other new accounting pronouncements that have been issued that might have a material impact on
its financial position or results of operations.
|
X |
- DefinitionNoncash Items [Policy Text Block]
+ References
+ Details
Name: |
STRM_NoncashItemsPolicyTextBlock |
Namespace Prefix: |
STRM_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionRecent accounting pronouncements not yet adopted [Policy text block].
+ References
+ Details
Name: |
STRM_RecentAccountingPronouncementsNotYetAdoptedPolicyTextBlock |
Namespace Prefix: |
STRM_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_AccountingPoliciesAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionDisclosure of accounting policy for cost associated with exit or disposal activity or restructuring. Excludes entity newly acquired in business combination and discontinued operation.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 5.P.4) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 5.P.3) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-1
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 5.P.3,4) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-1
+ Details
Name: |
us-gaap_CostsAssociatedWithExitOrDisposalActivitiesOrRestructuringsPolicy |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionDisclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2
+ Details
Name: |
us-gaap_EarningsPerSharePolicyTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionDisclosure of accounting policy for determining the fair value of financial instruments.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 60 -Paragraph 1 -SubTopic 10 -Topic 820 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482053/820-10-60-1
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 1 -SubTopic 10 -Topic 825 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482907/825-10-50-1
+ Details
Name: |
us-gaap_FairValueOfFinancialInstrumentsPolicy |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionDisclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(h)(1)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 17 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 9 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482525/740-10-45-25
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482525/740-10-45-28
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 19 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482685/740-10-50-19
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482765/220-10-50-1
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 20 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482685/740-10-50-20
+ Details
Name: |
us-gaap_IncomeTaxPolicyTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionDisclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.
+ References
+ Details
Name: |
us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionDisclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 205 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483504/205-10-50-1
+ Details
Name: |
us-gaap_PriorPeriodReclassificationAdjustmentDescription |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionDisclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-07(1)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1
Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4
Reference 3: http://www.xbrl.org/2003/role/exampleRef -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (e) -SubTopic 10 -Topic 235 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4
+ Details
Name: |
us-gaap_RevenueRecognitionPolicyTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionDisclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (f)(2)(i) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (f)(2)(ii) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (f)(2)(v) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 14.C.Q3) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 14.D.1.Q5) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 14.D.3.Q2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 14.D.2.Q6) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//718/tableOfContent
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (f)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2
Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (f)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2
+ Details
Name: |
us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionDisclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 9 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482861/275-10-50-9
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482861/275-10-50-4
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b) -SubTopic 10 -Topic 275 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -SubTopic 10 -Topic 275 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Name Accounting Standards Codification -Section 50 -Paragraph 11 -SubTopic 10 -Topic 275 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482861/275-10-50-11
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Name Accounting Standards Codification -Section 50 -Paragraph 12 -SubTopic 10 -Topic 275 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482861/275-10-50-12
Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 8 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482861/275-10-50-8
+ Details
Name: |
us-gaap_UseOfEstimates |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
|
9 Months Ended |
Oct. 31, 2023 |
Accounting Policies [Abstract] |
|
SCHEDULE OF FAIR VALUE OF LIABILITIES |
The
table below provides information on the fair value of our liabilities:
SCHEDULE
OF FAIR VALUE OF LIABILITIES
| |
Total Fair | | |
Quoted Prices in Active Markets | | |
Significant Other Observable Inputs | | |
Significant Unobservable
Inputs | |
| |
Value | | |
(Level 1) | | |
(Level 2) | | |
(Level 3) | |
At January 31, 2023 | |
| | | |
| | | |
| | | |
| | |
Acquisition earnout liability (1) | |
$ | 3,738,000 | | |
$ | — | | |
$ | — | | |
$ | 3,738,000 | |
At October 31, 2023 | |
| | | |
| | | |
| | | |
| | |
Acquisition earnout liability (1) | |
$ | 1,833,000 | | |
$ | — | | |
$ | — | | |
$ | 1,833,333 | |
(1) |
The
fair value of the acquisition earnout liability is based upon a probability-weighted discounted cash flow that was completed at the
date of acquisition and updated as of October 31, 2023. The change in the fair value of the acquisition earnout liability decreased
$1,182,000 and
$1,905,000 for
the three and nine months ended October 31, 2023, respectively. The change in the fair value is recognized in “Acquisition earnout valuation
adjustments” in the accompanying condensed consolidated statement of operations.
The probability-weighted discounted cash flow
is calculated using a Monte Carlo valuation method. The valuation model provides numerous outcomes. The outcomes are averaged and
discounted to present value, which provides the current value point estimate. A range of possible outcomes is not available under
the specific valuation method that was used in determining fair value of the acquisition earnout liability. The significant inputs
include recorded Avelead SaaS revenue, the probabilities associated with each of (i) a change in control or (ii) a certain client
termination, as well as other normal and customary inputs to financial models, including but not limited to, risk factors and
interest rates. |
|
SCHEDULE OF DISAGGREGATION OF REVENUE |
The
following table provides information about disaggregated revenue by type and nature of revenue stream:
SCHEDULE OF DISAGGREGATION OF REVENUE
| |
October 31, 2023 | | |
October 31, 2022 | | |
October 31, 2023 | | |
October 31, 2022 | |
| |
Three Months Ended | | |
Nine Months Ended | |
| |
October 31, 2023 | | |
October 31, 2022 | | |
October 31, 2023 | | |
October 31, 2022 | |
Over time revenue | |
$ | 6,133,000 | | |
$ | 6,217,000 | | |
$ | 17,161,000 | | |
$ | 18,021,000 | |
Point in time revenue | |
| — | | |
| — | | |
| 74,000 | | |
| 123,000 | |
Total revenue | |
$ | 6,133,000 | | |
$ | 6,217,000 | | |
$ | 17,235,000 | | |
$ | 18,144,000 | |
|
SCHEDULE OF BASIC AND DILUTED NET LOSS PER SHARE OF COMMON STOCK |
The
following is the calculation of the basic and diluted net loss per share of common stock for the three and nine months ended October
31, 2023 and 2022:
SCHEDULE OF BASIC AND DILUTED NET LOSS PER SHARE OF COMMON STOCK
| |
October 31, 2023 | | |
October 31, 2022 | | |
October 31, 2023 | | |
October 31, 2022 | |
| |
Three Months Ended | | |
Nine Months Ended | |
| |
October 31, 2023 | | |
October 31, 2022 | | |
October 31, 2023 | | |
October 31, 2022 | |
Basic and diluted loss per share: | |
| | | |
| | | |
| | | |
| | |
Net loss | |
$ | (11,911,000 | ) | |
$ | (3,138,000 | ) | |
$ | (17,327,000 | ) | |
$ | (9,197,000 | ) |
Basic and diluted net loss per share of common stock from operations | |
$ | (0.21 | ) | |
$ | (0.07 | ) | |
$ | (0.31 | ) | |
$ | (0.19 | ) |
Weighted average shares outstanding – basic and diluted (1)(2) | |
| 56,710,335 | | |
| 47,730,009 | | |
| 56,346,300 | | |
| 47,329,923 | |
Weighted average shares outstanding - basic | |
| 56,710,335 | | |
| 47,730,009 | | |
| 56,346,300 | | |
| 47,329,923 | |
(1) |
Includes
the effect of vested and excludes the effect of unvested restricted shares of common stock, which are considered non-participating
securities. As of October 31, 2023 and 2022, there were 1,980,471 and 1,501,031 unvested restricted shares of common stock outstanding,
respectively. |
|
|
(2) |
Diluted
net loss per share excludes the effect of shares that are anti-dilutive. For the three and nine months ended October 31, 2023, diluted
earnings per share excludes 418,836 outstanding stock options and 1,980,471 unvested restricted shares of common stock. For the three
and nine months ended October 31, 2022, diluted earnings per share excludes 628,958 outstanding stock options and 1,501,031
unvested restricted shares of common stock. |
|
SCHEDULE OF RECONCILIATION OF THE RESTRUCTURING LIABILITY |
SCHEDULE OF RECONCILIATION OF THE
RESTRUCTURING LIABILITY
| |
(in
thousands) | |
| |
| | |
| | |
| | |
| | |
As
of October 31, 2023 | |
| |
Accrued
Balance as of January 31, 2023 | | |
2023
Expenses to Date | | |
2023
Cash Payments | | |
Accrued
Balance as of October 31, 2023 | | |
Total
Costs Incurred to Date | | |
Total
Expected Costs | |
Severance
expense | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | |
Cost
of sales | |
$ | — | | |
$ | 154 | | |
$ | — | | |
$ | 154 | | |
$ | 154 | | |
$ | 154 | |
Selling,
general, and administrative | |
| — | | |
| 350 | | |
| — | | |
| 350 | | |
| 350 | | |
| 350 | |
Research
and development | |
| — | | |
| 227 | | |
| — | | |
| 227 | | |
| 227 | | |
| 227 | |
Total
severance expense | |
$ | — | | |
$ | 731 | | |
$ | — | | |
$ | 731 | | |
$ | 731 | | |
$ | 731 | |
Professional
fees | |
| — | | |
| 18 | | |
| — | | |
| 18 | | |
| 18 | | |
$ | 169 | |
Total | |
$ | — | | |
$ | 749 | | |
$ | — | | |
$ | 749 | | |
$ | 749 | | |
| 900 | |
|
SCHEDULE OF ACCOUNTING PRONOUNCEMENTS RECENTLY ADOPTED |
SCHEDULE OF ACCOUNTING PRONOUNCEMENTS RECENTLY ADOPTED
| |
January 31, 2023 | | |
CECL Adoption | | |
Provision adjustments | | |
Write-offs & Recoveries | | |
October 31, 2023 | |
Allowance for credit losses | |
$ | (132,000 | ) | |
$ | 36,000 | | |
| — | | |
| — | | |
$ | (96,000 | ) |
|
X |
- References
+ Details
Name: |
us-gaap_AccountingPoliciesAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5
+ Details
Name: |
us-gaap_DisaggregationOfRevenueTableTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2C -SubTopic 10 -Topic 820 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2C
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-3
Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2
+ Details
Name: |
us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.3,4) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1
+ Details
Name: |
us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 5.P.3) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-1
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB TOPIC 5.P.4) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2
+ Details
Name: |
us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
DEBT (Tables)
|
9 Months Ended |
Oct. 31, 2023 |
Debt Disclosure [Abstract] |
|
SCHEDULE OF OUTSTANDING PRINCIPAL BALANCES |
Outstanding
principal balances consisted of the following at:
SCHEDULE
OF OUTSTANDING PRINCIPAL BALANCES
| |
October 31, 2023 | | |
January 31, 2023 | |
Term loan | |
$ | 9,250,000 | | |
$ | 9,750,000 | |
Financing cost payable | |
| 120,000 | | |
| 69,000 | |
Deferred financing cost | |
| (78,000 | ) | |
| (105,000 | ) |
Total | |
| 9,292,000 | | |
| 9,714,000 | |
Less: Current portion of term loan | |
| (1,250,000 | ) | |
| (750,000 | ) |
Non-current portion of term loan | |
| 8,042,000 | | |
| 8,964,000 | |
Non-current portion of line of credit | |
| 500,000 | | |
| — | |
Total non-current portion of debt | |
$ | 8,542,000 | | |
$ | 8,964,000 | |
|
SCHEDULE OF MAXIMUM DEBT TO ARR RATIO |
SCHEDULE OF MAXIMUM DEBT TO ARR RATIO
Quarter Ending | |
Maximum Debt to ARR Ratio |
October 31, 2022 | |
0.80 to 1.00 |
January 31, 2023 | |
0.70 to 1.00 |
April 30, 2023 | |
0.65 to 1.00 |
July 31, 2023 | |
0.60 to 1.00 |
October 31, 2023 | |
0.55 to 1.00 |
January 31, 2024 | |
0.50 to 1.00 |
|
SCHEDULE OF MAXIMUM DEBT TO ADJUSTED EBITDA RATIO |
SCHEDULE OF MAXIMUM DEBT TO ADJUSTED EBITDA RATIO
Quarter Ending | |
Maximum
Debt to Adjusted
EBITDA Ratio |
April 30, 2024 | |
3.50 to 1.00 |
July 31, 2024 and on the last day of each quarter thereafter | |
2.00 to 1.00 |
|
X |
- DefinitionSchedule Of Maximum Debt To ARR Ratio [Table Text Block]
+ References
+ Details
Name: |
STRM_ScheduleOfMaximumDebtToARRRatioTableTextBlock |
Namespace Prefix: |
STRM_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionSchedule Of Maximum Debt To Adjusted EBITDA Ratio [Table Text Block]
+ References
+ Details
Name: |
STRM_ScheduleOfMaximumDebtToAdjustedEBITDARatioTableTextBlock |
Namespace Prefix: |
STRM_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_DebtDisclosureAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.
+ References
+ Details
Name: |
us-gaap_ScheduleOfDebtTableTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
GOODWILL AND INTANGIBLE ASSETS (Tables)
|
9 Months Ended |
Oct. 31, 2023 |
Goodwill and Intangible Assets Disclosure [Abstract] |
|
SCHEDULE OF CARRYING AMOUNT OF GOODWILL |
The
changes in the carrying amount of goodwill were as follows:
SCHEDULE
OF CARRYING AMOUNT OF GOODWILL
| |
Nine Months Ended | |
| |
October 31, 2023 | |
Balance as of January 31, 2023 | |
$ | 23,089,000 | |
Impairment | |
| (9,813,000 | ) |
Balance as of October 31, 2023 | |
$ | 13,276,000 | |
|
SCHEDULE OF FINITE-LIVED INTANGIBLE ASSETS |
The
changes in the carrying amounts of the Company’s finite-lived assets were as follows:
SCHEDULE
OF FINITE-LIVED INTANGIBLE ASSETS
| |
| |
October 31, 2023 | |
| |
Estimated Useful Life | |
Gross Assets | | |
Accumulated Amortization | | |
Impairment | | |
Net Assets | |
Finite-lived assets: | |
| |
| | | |
| | | |
| | | |
| | |
Client relationships | |
8-10 years | |
$ | 9,700,000 | | |
$ | 2,216,000 | | |
$ | 963,000 | | |
$ | 6,521,000 | |
Internally developed software | |
9 years | |
| 6,380,000 | | |
| 1,565,000 | | |
| — | | |
$ | 4,815,000 | |
Trademarks and tradenames | |
15 years | |
| 1,340,000 | | |
| 197,000 | | |
| — | | |
$ | 1,143,000 | |
Total | |
| |
$ | 17,420,000 | | |
$ | 3,978,000 | | |
| 963,000 | | |
$ | 12,479,000 | |
|
X |
- References
+ Details
Name: |
us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482665/350-30-50-1
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2
+ Details
Name: |
us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 24 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24
Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1
Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1
Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1
Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1
Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1
Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1
Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1
Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1
Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1
Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1A -Publisher FASB -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1A
Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482573/350-20-50-2
+ Details
Name: |
us-gaap_ScheduleOfGoodwillTextBlock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:textBlockItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
X |
- References
+ Details
Name: |
us-gaap_AccountingPoliciesAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionIncluding the current and noncurrent portions, aggregate carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer).
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(22)) -SubTopic 10 -Topic 210 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 944 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(16)(a)(2)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(16)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1
+ Details
Name: |
us-gaap_LoansPayable |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionCarrying value as of the balance sheet date of portion of long-term loans payable due within one year or the operating cycle if longer.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.20) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_LoansPayableCurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
v3.23.3
SCHEDULE OF FAIR VALUE OF LIABILITIES (Details) - USD ($)
|
Oct. 31, 2023 |
Jan. 31, 2023 |
Platform Operator, Crypto-Asset [Line Items] |
|
|
|
Acquisition earn out liability fair value, observable inputs |
[1] |
$ 1,833,000
|
$ 3,738,000
|
Fair Value, Inputs, Level 1 [Member] |
|
|
|
Platform Operator, Crypto-Asset [Line Items] |
|
|
|
Acquisition earn out liability fair value, observable inputs |
[1] |
|
|
Fair Value, Inputs, Level 2 [Member] |
|
|
|
Platform Operator, Crypto-Asset [Line Items] |
|
|
|
Acquisition earn out liability fair value, observable inputs |
[1] |
|
|
Fair Value, Inputs, Level 3 [Member] |
|
|
|
Platform Operator, Crypto-Asset [Line Items] |
|
|
|
Acquisition earn out liability fair value, observable inputs |
[1] |
$ 1,833,333
|
$ 3,738,000
|
|
|
X |
- DefinitionAcquisition earnout liability, fair value.
+ References
+ Details
Name: |
STRM_AcquisitionEarnoutLiabilityFairValue |
Namespace Prefix: |
STRM_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
v3.23.3
X |
- DefinitionAcquisition earnout liability, change in valuation.
+ References
+ Details
Name: |
STRM_AcquisitionEarnoutLiabilityChangeInValuation |
Namespace Prefix: |
STRM_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_AccountingPoliciesAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
SCHEDULE OF DISAGGREGATION OF REVENUE (Details) - USD ($)
|
3 Months Ended |
9 Months Ended |
Oct. 31, 2023 |
Oct. 31, 2022 |
Oct. 31, 2023 |
Oct. 31, 2022 |
Disaggregation of Revenue [Line Items] |
|
|
|
|
Total revenue |
$ 6,133,000
|
$ 6,217,000
|
$ 17,235,000
|
$ 18,144,000
|
Transferred over Time [Member] |
|
|
|
|
Disaggregation of Revenue [Line Items] |
|
|
|
|
Total revenue |
6,133,000
|
6,217,000
|
17,161,000
|
18,021,000
|
Transferred at Point in Time [Member] |
|
|
|
|
Disaggregation of Revenue [Line Items] |
|
|
|
|
Total revenue |
|
|
$ 74,000
|
$ 123,000
|
X |
- DefinitionLine items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5
Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91
Reference 3: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91
Reference 4: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91
Reference 5: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91
Reference 6: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91
Reference 7: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91
Reference 8: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91
+ Details
Name: |
us-gaap_DisaggregationOfRevenueLineItems |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAmount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 924 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 11.L) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 30 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 40 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41
Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4
+ Details
Name: |
us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- Details
Name: |
us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredOverTimeMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredAtPointInTimeMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
v3.23.3
SCHEDULE OF BASIC AND DILUTED NET LOSS PER SHARE OF COMMON STOCK (Details) - USD ($)
|
3 Months Ended |
9 Months Ended |
Oct. 31, 2023 |
Jul. 31, 2023 |
Apr. 30, 2023 |
Oct. 31, 2022 |
Jul. 31, 2022 |
Apr. 30, 2022 |
Oct. 31, 2023 |
Oct. 31, 2022 |
Accounting Policies [Abstract] |
|
|
|
|
|
|
|
|
|
Net loss |
|
$ (11,911,000)
|
$ (2,515,000)
|
$ (2,901,000)
|
$ (3,138,000)
|
$ (3,272,000)
|
$ (2,787,000)
|
$ (17,327,000)
|
$ (9,197,000)
|
Basic net loss per share of common stock from operations |
|
$ (0.21)
|
|
|
$ (0.07)
|
|
|
$ (0.31)
|
$ (0.19)
|
Diluted net loss per share of common stock from operations |
|
$ (0.21)
|
|
|
$ (0.07)
|
|
|
$ (0.31)
|
$ (0.19)
|
Weighted average shares outstanding - basic |
[1],[2] |
56,710,335
|
|
|
47,730,009
|
|
|
56,346,300
|
47,329,923
|
Weighted average shares outstanding - diluted |
[1],[2] |
56,710,335
|
|
|
47,730,009
|
|
|
56,346,300
|
47,329,923
|
|
|
X |
- References
+ Details
Name: |
us-gaap_AccountingPoliciesAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 60B -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4
Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 944 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(23)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(25)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2
Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 942 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04(27)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1
Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7
Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-03(13)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-1
Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04(20)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1
Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(19)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1
+ Details
Name: |
us-gaap_IncomeLossFromContinuingOperationsPerBasicShare |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:perShareItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 60B -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4
Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 944 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(23)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1
Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(25)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2
Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 942 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04(27)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1
Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7
Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-03(13)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-1
+ Details
Name: |
us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:perShareItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 28 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1
Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 9 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11
Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11
Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4
Reference 13: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10
Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section 45 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7
Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(18)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1
Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22
Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-07(9)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1
Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(1)(d)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3
Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(ii)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A
Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B
Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(A)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B
Reference 26: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(B)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B
Reference 27: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B
Reference 28: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B
Reference 29: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 30 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30
Reference 30: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32
Reference 31: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 60B -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B
Reference 32: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31
Reference 33: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32
Reference 34: http://www.xbrl.org/2003/role/disclosureRef -Topic 205 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7
Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28
Reference 36: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1A -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A
Reference 37: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1B -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B
Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(20)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2
Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04(22)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1
+ Details
Name: |
us-gaap_NetIncomeLoss |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionThe average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 16 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16
+ Details
Name: |
us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionNumber of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10
+ Details
Name: |
us-gaap_WeightedAverageNumberOfSharesOutstandingBasic |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
duration |
|
v3.23.3
SCHEDULE OF BASIC AND DILUTED NET LOSS PER SHARE OF COMMON STOCK (Details) (Parenthetical) - shares
|
3 Months Ended |
9 Months Ended |
Oct. 31, 2023 |
Oct. 31, 2022 |
Oct. 31, 2023 |
Oct. 31, 2022 |
Unvested Restricted Stock [Member] |
|
|
|
|
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] |
|
|
|
|
Diluted earnings per share |
|
|
1,980,471
|
1,501,031
|
Share-Based Payment Arrangement, Option [Member] |
|
|
|
|
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] |
|
|
|
|
Diluted earnings per share |
418,836
|
628,958
|
418,836
|
628,958
|
Unvested Restricted Shares [Member] |
|
|
|
|
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] |
|
|
|
|
Diluted earnings per share |
1,980,471
|
1,501,031
|
1,980,471
|
1,501,031
|
X |
- DefinitionSecurities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1
+ Details
Name: |
us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionLine items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
+ Details
Name: |
us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Details
Name: |
us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=STRM_UnvestedRestrictedStockMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=STRM_UnvestedRestrictedSharesMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
v3.23.3
SCHEDULE OF RECONCILIATION OF THE RESTRUCTURING LIABILITY (Details) - USD ($)
|
9 Months Ended |
Oct. 31, 2023 |
Oct. 31, 2022 |
Accrued Balance as of January 31, 2023 |
$ 3,265,000
|
|
2023 Expenses to Date |
(417,000)
|
$ 1,159,000
|
Accrued Balance as of October 31, 2023 |
2,883,000
|
|
Total Costs Incurred to Date |
2,883,000
|
|
Cost of Sales [Member] |
|
|
Accrued Balance as of January 31, 2023 |
|
|
2023 Expenses to Date |
154
|
|
2023 Cash Payments |
|
|
Accrued Balance as of October 31, 2023 |
154
|
|
Total Costs Incurred to Date |
154
|
|
Total Expected Costs |
154
|
|
Selling, General and Administrative Expenses [Member] |
|
|
Accrued Balance as of January 31, 2023 |
|
|
2023 Expenses to Date |
350
|
|
2023 Cash Payments |
|
|
Accrued Balance as of October 31, 2023 |
350
|
|
Total Costs Incurred to Date |
350
|
|
Total Expected Costs |
350
|
|
Research and Development Expense [Member] |
|
|
Accrued Balance as of January 31, 2023 |
|
|
2023 Expenses to Date |
227
|
|
2023 Cash Payments |
|
|
Accrued Balance as of October 31, 2023 |
227
|
|
Total Costs Incurred to Date |
227
|
|
Total Expected Costs |
227
|
|
Severance Expenses [Member] |
|
|
Accrued Balance as of January 31, 2023 |
|
|
2023 Expenses to Date |
731
|
|
2023 Cash Payments |
|
|
Accrued Balance as of October 31, 2023 |
731
|
|
Total Costs Incurred to Date |
731
|
|
Total Expected Costs |
731
|
|
Professional Fees [Member] |
|
|
Accrued Balance as of January 31, 2023 |
|
|
2023 Expenses to Date |
18
|
|
2023 Cash Payments |
|
|
Accrued Balance as of October 31, 2023 |
18
|
|
Total Costs Incurred to Date |
18
|
|
Total Expected Costs |
169
|
|
Accrued Expenses [Member] |
|
|
Accrued Balance as of January 31, 2023 |
|
|
2023 Expenses to Date |
749
|
|
2023 Cash Payments |
|
|
Accrued Balance as of October 31, 2023 |
749
|
|
Total Costs Incurred to Date |
749
|
|
Total Expected Costs |
$ 900
|
|
X |
- DefinitionCarrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.20) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_AccruedLiabilitiesCurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionThe increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Subparagraph (a) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28
+ Details
Name: |
us-gaap_IncreaseDecreaseInAccruedLiabilities |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- Details
Name: |
us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_IncomeStatementLocationAxis=STRM_SeveranceExpensesMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_IncomeStatementLocationAxis=STRM_ProfessionalFeesMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_IncomeStatementLocationAxis=STRM_AccruedExpensesMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
v3.23.3
X |
- DefinitionAllowance for doubtful accounts receivable adoption of asu.
+ References
+ Details
Name: |
STRM_AllowanceForDoubtfulAccountsReceivableAdoptionOfASU |
Namespace Prefix: |
STRM_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- References
+ Details
Name: |
us-gaap_AccountingPoliciesAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAmount of allowance for credit loss on accounts receivable.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 944 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(5)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(4)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 326 -SubTopic 20 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479344/326-20-45-1
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 310 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481962/310-10-50-4
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 326 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 326 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13
+ Details
Name: |
us-gaap_AllowanceForDoubtfulAccountsReceivable |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount of increase (decrease) in allowance for credit loss on accounts receivable.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 326 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13
+ Details
Name: |
us-gaap_AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAmount of direct write-downs of accounts receivable charged against the allowance.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 326 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13
+ Details
Name: |
us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
v3.23.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)
|
|
3 Months Ended |
9 Months Ended |
|
|
Oct. 16, 2023
USD ($)
Integer
|
Oct. 31, 2023
USD ($)
shares
|
Jul. 31, 2023
shares
|
Apr. 30, 2023
shares
|
Oct. 31, 2022
USD ($)
shares
|
Jul. 31, 2022
shares
|
Apr. 30, 2022
shares
|
Oct. 31, 2023
USD ($)
shares
|
Oct. 31, 2022
USD ($)
shares
|
Feb. 01, 2023
USD ($)
|
Jan. 31, 2023
USD ($)
|
Acquisition related costs |
|
$ 0
|
|
|
$ 2,000
|
|
|
$ 44,000
|
$ 141,000
|
|
|
Debt Instrument, Interest Rate, Stated Percentage |
|
0.50%
|
|
|
|
|
|
0.50%
|
|
|
|
Long-Term Debt, Gross |
|
$ 9,250,000
|
|
|
|
|
|
$ 9,250,000
|
|
|
$ 9,750,000
|
Discount book value |
|
12,000
|
|
|
|
|
|
12,000
|
|
|
0
|
Deferred revenue, revenue recognized |
|
|
|
|
|
|
|
6,772,000
|
|
|
|
Revenue remaining performance obligation |
|
23,045,000
|
|
|
|
|
|
$ 23,045,000
|
|
|
|
Revenue, remaining performance obligation, expected timing of satisfaction, explanation |
|
|
|
|
|
|
|
the Company
expects to recognize approximately 56% over the next 12 months and the remainder thereafter.
|
|
|
|
Deferred costs, net |
|
98,000
|
|
|
|
|
|
$ 98,000
|
|
|
94,000
|
Accumulated amortization of deferred costs |
|
235,000
|
|
|
|
|
|
235,000
|
|
|
176,000
|
Deferred costs, amortization expense |
|
24,000
|
|
|
22,000
|
|
|
59,000
|
62,000
|
|
|
Accumulated amortization |
|
1,238,000
|
|
|
|
|
|
1,238,000
|
|
|
820,000
|
Deferred commission costs |
|
35,000
|
|
|
|
|
|
|
|
|
|
Compensation expense related to stock-based award |
|
517,000
|
|
|
$ 555,000
|
|
|
1,626,000
|
$ 1,212,000
|
|
|
[custom:NumberOfEmployeesTerminated-0] | Integer |
26
|
|
|
|
|
|
|
|
|
|
|
[custom:PercentageOfWorkforceTerminated] |
24.00%
|
|
|
|
|
|
|
|
|
|
|
Restructuring Costs |
$ 900,000
|
|
|
|
|
|
|
|
|
|
|
Capitalized software purchased with stock |
|
60,000
|
|
|
|
|
|
176,000
|
|
|
|
Alllowance for credit losses |
|
$ 96,000
|
|
|
|
|
|
96,000
|
|
$ 96,000
|
132,000
|
Adjustment in accounting policy change due to adoption |
|
|
|
|
|
|
|
$ 36,000
|
|
|
|
Employees [Member] |
|
|
|
|
|
|
|
|
|
|
|
Stock Issued During Period, Shares, Restricted Stock Award, Gross | shares |
|
45,000
|
|
|
65,000
|
|
|
1,130,000
|
865,000
|
|
|
Consultants [Member] |
|
|
|
|
|
|
|
|
|
|
|
Stock Issued During Period, Shares, Restricted Stock Award, Gross | shares |
|
131,054
|
|
|
53,836
|
|
|
359,080
|
187,937
|
|
|
Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
Outstanding and unvested shares of restricted common stock | shares |
|
260,000
|
|
|
|
|
|
260,000
|
|
|
|
Stock Issued During Period, Shares, Restricted Stock Award, Gross | shares |
|
176,054
|
385,720
|
1,185,927
|
118,836
|
726,801
|
408,031
|
|
|
|
|
Common Stock [Member] | Board Of Directors [Member] |
|
|
|
|
|
|
|
|
|
|
|
Stock Issued During Period, Shares, Restricted Stock Award, Gross | shares |
|
0
|
|
|
0
|
|
|
258,621
|
200,731
|
|
|
Equity Award [Member] | Share-Based Payment Arrangement, Nonemployee [Member] |
|
|
|
|
|
|
|
|
|
|
|
Compensation expense related to stock-based award |
|
$ 60,000
|
|
|
|
|
|
$ 176,000
|
|
|
|
Selling, General and Administrative Expenses [Member] |
|
|
|
|
|
|
|
|
|
|
|
Deferred sales commissions |
|
129,000
|
|
|
$ 110,000
|
|
|
383,000
|
$ 298,000
|
|
|
Deferred commission costs |
|
|
|
|
|
|
|
35,000
|
|
|
|
Other Noncurrent Assets [Member] |
|
|
|
|
|
|
|
|
|
|
|
Deferred commissions costs paid and payable |
|
1,195,000
|
|
|
|
|
|
1,195,000
|
|
|
1,534,000
|
Line of Credit [Member] |
|
|
|
|
|
|
|
|
|
|
|
Fair value of line of credit |
|
$ 488,000
|
|
|
|
|
|
$ 488,000
|
|
|
0
|
Second Amended and Restated Loan and Security Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument, Description of Variable Rate Basis |
|
|
|
|
|
|
|
The
term loan bears interest at a per annum rate equal to the Prime Rate (as published in The Wall Street Journal) plus
|
|
|
|
Debt Instrument, Interest Rate, Stated Percentage |
|
1.50%
|
|
|
|
|
|
1.50%
|
|
|
|
Long-Term Debt, Gross |
|
$ 9,054,000
|
|
|
|
|
|
$ 9,054,000
|
|
|
9,550,000
|
Debt Instrument, Face Amount |
|
$ 196,000
|
|
|
|
|
|
$ 196,000
|
|
|
$ 200,000
|
Second Amended and Restated Loan and Security Agreement [Member] | Prime Rate [Member] |
|
|
|
|
|
|
|
|
|
|
|
Debt Instrument, Interest Rate, Stated Percentage |
|
3.25%
|
|
|
|
|
|
3.25%
|
|
|
|
Debt Instrument, Basis Spread on Variable Rate |
|
|
|
|
|
|
|
1.50%
|
|
|
|
X |
- DefinitionAllowance for doubtful accounts receivable adoption of asu.
+ References
+ Details
Name: |
STRM_AllowanceForDoubtfulAccountsReceivableAdoptionOfASU |
Namespace Prefix: |
STRM_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionDeferred commission costs.
+ References
+ Details
Name: |
STRM_DeferredCommissionCosts |
Namespace Prefix: |
STRM_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionDeferred commission costs accumulated amortization.
+ References
+ Details
Name: |
STRM_DeferredCommissionCostsAccumulatedAmortization |
Namespace Prefix: |
STRM_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionDeferred commissions costs paid and payable.
+ References
+ Details
Name: |
STRM_DeferredCommissionsCostsPaidAndPayable |
Namespace Prefix: |
STRM_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionDeferred costs, amortization expense.
+ References
+ Details
Name: |
STRM_DeferredCostsAmortizationExpenses |
Namespace Prefix: |
STRM_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionNumber of employees terminated.
+ References
+ Details
Name: |
STRM_NumberOfEmployeesTerminated |
Namespace Prefix: |
STRM_ |
Data Type: |
xbrli:integerItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionPercentage of workforce terminated.
+ References
+ Details
Name: |
STRM_PercentageOfWorkforceTerminated |
Namespace Prefix: |
STRM_ |
Data Type: |
dtr-types:percentItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAccumulated amortization of other deferred costs capitalized at the end of the reporting period. Does not include deferred finance costs, deferred acquisition costs of insurance companies, or deferred leasing costs for real estate operations.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(17)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_AccumulatedAmortizationOfOtherDeferredCosts |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount of expense for award under share-based payment arrangement. Excludes amount capitalized.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 14.F) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(1)(i) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2
+ Details
Name: |
us-gaap_AllocatedShareBasedCompensationExpense |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionAmount of allowance for credit loss on accounts receivable.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 944 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(5)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(4)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 326 -SubTopic 20 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479344/326-20-45-1
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 310 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481962/310-10-50-4
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 326 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13
Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 326 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13
+ Details
Name: |
us-gaap_AllowanceForDoubtfulAccountsReceivable |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionThe amount of expense recognized in the current period for the periodic realization of capitalized fees that were paid to salespeople, distributors, brokers, and agents at the time of the conclusion of the sale. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Subparagraph (b) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.3) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2
+ Details
Name: |
us-gaap_AmortizationOfDeferredSalesCommissions |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionAmount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-8
+ Details
Name: |
us-gaap_ContractWithCustomerLiabilityRevenueRecognized |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionPercentage points added to the reference rate to compute the variable rate on the debt instrument.
+ References
+ Details
Name: |
us-gaap_DebtInstrumentBasisSpreadOnVariableRate1 |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:percentItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAmount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(22)) -SubTopic 10 -Topic 210 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(16)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (b)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-4
+ Details
Name: |
us-gaap_DebtInstrumentCarryingAmount |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionDescription of reference rate used for variable rate of debt instrument.
+ References
+ Details
Name: |
us-gaap_DebtInstrumentDescriptionOfVariableRateBasis |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionFace (par) amount of debt instrument at time of issuance.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 835 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1B -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B
Reference 3: http://www.xbrl.org/2003/role/exampleRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 69B -Publisher FASB -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B
Reference 4: http://www.xbrl.org/2003/role/exampleRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 69C -Publisher FASB -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C
Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 835 -SubTopic 30 -Section 45 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2
Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 835 -SubTopic 30 -Section 55 -Paragraph 8 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8
+ Details
Name: |
us-gaap_DebtInstrumentFaceAmount |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionContractual interest rate for funds borrowed, under the debt agreement.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1B -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.22(a)(1)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_DebtInstrumentInterestRateStatedPercentage |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:percentItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionAmount, after accumulated amortization, of debt discount (premium).
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 835 -SubTopic 30 -Section 45 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 835 -SubTopic 30 -Section 45 -Paragraph 1A -Publisher FASB -URI https://asc.fasb.org//1943274/2147482925/835-30-45-1A
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 835 -SubTopic 30 -Section 45 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482925/835-30-45-4
Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 835 -SubTopic 30 -Section 45 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3
Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 835 -SubTopic 30 -Section 55 -Paragraph 8 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8
Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1D -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D
+ Details
Name: |
us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionThe carrying amount of deferred costs.
+ References
+ Details
Name: |
us-gaap_DeferredCostsCurrentAndNoncurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionFair value of the amount outstanding under the credit facility.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482907/825-10-50-10
+ Details
Name: |
us-gaap_LineOfCreditFacilityFairValueOfAmountOutstanding |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Subparagraph (b) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28
+ Details
Name: |
us-gaap_RestructuringCosts |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionAmount of transaction price allocated to performance obligation that has not been recognized as revenue.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (a) -SubTopic 10 -Topic 606 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-13
+ Details
Name: |
us-gaap_RevenueRemainingPerformanceObligation |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionDescription of when remaining performance obligation is expected to be recognized as revenue.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-13
+ Details
Name: |
us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionNumber of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2
+ Details
Name: |
us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionThe fair value of stock issued in noncash financing activities.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5
+ Details
Name: |
us-gaap_StockIssued1 |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionTotal number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1
+ Details
Name: |
us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Details
Name: |
srt_TitleOfIndividualAxis=STRM_EmployeesMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
srt_TitleOfIndividualAxis=STRM_ConsultantsMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
srt_TitleOfIndividualAxis=STRM_BoardOfDirectorsMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_AwardTypeAxis=STRM_EquityAwardMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementNonemployeeMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_ShortTermDebtTypeAxis=us-gaap_LineOfCreditMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_TypeOfArrangementAxis=STRM_SecondAmendedAndRestatedLoanAndSecurityAgreementMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_VariableRateAxis=us-gaap_PrimeRateMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
v3.23.3
BUSINESS COMBINATION (Details Narrative) - USD ($)
|
Jan. 31, 2024 |
Nov. 21, 2022 |
Oct. 31, 2023 |
Jan. 31, 2023 |
Business Acquisition [Line Items] |
|
|
|
|
Common stock, par value |
|
|
$ 0.01
|
$ 0.01
|
Acquisition earnout liability |
|
|
$ 1,833,000
|
$ 3,738,000
|
Avelead [Member] |
|
|
|
|
Business Acquisition [Line Items] |
|
|
|
|
Cash payments |
|
$ 2,012,000
|
|
|
Restricted common stock, shares |
|
1,871,037
|
|
|
Common stock, par value |
|
$ 0.01
|
|
|
Estimated aggregate value of first year earnout payment |
|
$ 5,000,000
|
|
|
Avelead [Member] | Forecast [Member] |
|
|
|
|
Business Acquisition [Line Items] |
|
|
|
|
Cash payments |
$ 1,214,000
|
|
|
|
Restricted common stock, shares |
1,589,342
|
|
|
|
Common stock, par value |
$ 0.01
|
|
|
|
X |
- DefinitionAmount of liability recognized from contingent consideration in asset acquisition, classified as current.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 805 -SubTopic 50 -Name Accounting Standards Codification -Section 15 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480123/805-50-15-3
+ Details
Name: |
us-gaap_AssetAcquisitionContingentConsiderationLiabilityCurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionNumber of shares of equity interests issued or issuable to acquire entity.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 805 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(4) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1
+ Details
Name: |
us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionLine items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 805 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5
+ Details
Name: |
us-gaap_BusinessAcquisitionLineItems |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAmount of liability recognized arising from contingent consideration in a business combination.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 805 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 25 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479668/805-30-25-6
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 35 -Paragraph 1 -Subparagraph (b) -SubTopic 30 -Topic 805 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479613/805-30-35-1
+ Details
Name: |
us-gaap_BusinessCombinationContingentConsiderationLiability |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionFace amount or stated value per share of common stock.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_CommonStockParOrStatedValuePerShare |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:perShareItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionThe cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 805 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13
+ Details
Name: |
us-gaap_PaymentsToAcquireBusinessesGross |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- Details
Name: |
us-gaap_BusinessAcquisitionAxis=STRM_AveleadMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
srt_StatementScenarioAxis=srt_ScenarioForecastMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
v3.23.3
OPERATING LEASES (Details Narrative) - USD ($)
|
|
|
3 Months Ended |
9 Months Ended |
|
|
Oct. 02, 2021 |
Aug. 16, 2021 |
Oct. 31, 2023 |
Oct. 31, 2022 |
Oct. 31, 2023 |
Oct. 31, 2022 |
Jan. 31, 2023 |
Oct. 31, 2021 |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |
|
|
|
|
|
|
|
|
Other income related to sublease |
|
|
|
$ 49,000
|
|
$ 145,000
|
|
|
Operating Lease, Right-of-Use Asset |
|
|
|
|
|
|
$ 32,000
|
$ 540,000
|
Lessee, Operating Lease, Discount Rate |
|
|
6.50%
|
|
6.50%
|
|
|
|
Operating lease cost |
|
|
$ 0
|
48,000
|
$ 32,000
|
145,000
|
|
|
Rent expenes |
|
|
0
|
$ 18,000
|
6,000
|
$ 55,000
|
|
|
Sublease Agreement [Member] |
|
|
|
|
|
|
|
|
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |
|
|
|
|
|
|
|
|
Sublease, term |
18 months
|
|
|
|
|
|
|
|
Other income related to sublease |
$ 292,000
|
|
|
|
|
|
|
|
Other income related to sublease |
|
|
0
|
|
32,000
|
|
|
|
Suwanee Office Lease [Member] |
|
|
|
|
|
|
|
|
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |
|
|
|
|
|
|
|
|
Lease expiration date |
|
Feb. 28, 2022
|
|
|
|
|
|
|
Rent expenes |
|
|
$ 0
|
|
$ 6,000
|
|
|
|
X |
- DefinitionLine items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 808 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479402/808-10-50-1
+ Details
Name: |
us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionDate which lease or group of leases is set to expire, in YYYY-MM-DD format.
+ References
+ Details
Name: |
us-gaap_LeaseExpirationDate1 |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:dateItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionDiscount rate used by lessee to determine present value of operating lease payments.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 842 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c)(3) -Publisher FASB -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3
+ Details
Name: |
us-gaap_LesseeOperatingLeaseDiscountRate |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:percentItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionAmount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 842 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 53 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 842 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4
+ Details
Name: |
us-gaap_OperatingLeaseCost |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionAmount of lessee's right to use underlying asset under operating lease.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 842 -SubTopic 20 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1
+ Details
Name: |
us-gaap_OperatingLeaseRightOfUseAsset |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionAmount of revenue and income classified as other.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column E)(2)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column E)(Footnote 4)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column E)(Footnote 6)(b)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(4)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-07(1)(c)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1
+ Details
Name: |
us-gaap_OtherIncome |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionCash payments to lessor's for use of assets under operating leases.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 25 -Subparagraph (g) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25
+ Details
Name: |
us-gaap_PaymentsForRent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- DefinitionAmount of sublease income excluding finance and operating lease expense.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 842 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 53 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 842 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4
+ Details
Name: |
us-gaap_SubleaseIncome |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
X |
- Details
Name: |
us-gaap_TypeOfArrangementAxis=STRM_SubleaseAgreementMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_TypeOfArrangementAxis=STRM_SuwaneeOfficeLeaseMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
v3.23.3
SCHEDULE OF OUTSTANDING PRINCIPAL BALANCES (Details) - USD ($)
|
Oct. 31, 2023 |
Jan. 31, 2023 |
Debt Disclosure [Abstract] |
|
|
Term loan |
$ 9,250,000
|
$ 9,750,000
|
Financing cost payable |
120,000
|
69,000
|
Deferred financing cost |
(78,000)
|
(105,000)
|
Total |
9,292,000
|
9,714,000
|
Less: Current portion of term loan |
(1,250,000)
|
(750,000)
|
Non-current portion of term loan |
8,042,000
|
8,964,000
|
Non-current portion of line of credit |
500,000
|
|
Total non-current portion of debt |
$ 8,542,000
|
$ 8,964,000
|
X |
- References
+ Details
Name: |
us-gaap_DebtDisclosureAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAmount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(22)) -SubTopic 10 -Topic 210 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(16)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (b)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-4
+ Details
Name: |
us-gaap_DebtInstrumentCarryingAmount |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 835 -SubTopic 30 -Section 45 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3
Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1D -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D
+ Details
Name: |
us-gaap_DeferredFinanceCostsNet |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionAmount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(22)) -SubTopic 10 -Topic 210 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 69B -Publisher FASB -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B
Reference 3: http://www.xbrl.org/2003/role/exampleRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 69C -Publisher FASB -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1D -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D
Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 944 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(16)(a)(2)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1
Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 942 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(16)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (b)(3) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-4
+ Details
Name: |
us-gaap_LongTermDebt |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(20)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_LongTermDebtCurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(22)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_LongTermDebtNoncurrent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionThe carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.22) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section 45 -Paragraph 13 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481573/470-10-45-13
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section 45 -Paragraph 14 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481573/470-10-45-14
+ Details
Name: |
us-gaap_LongTermLineOfCredit |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionCarrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.22) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_LongTermLoansPayable |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
v3.23.3
SCHEDULE OF MAXIMUM DEBT TO ARR RATIO (Details)
|
Oct. 31, 2023 |
October 31, 2022 [Member] | Minimum [Member] |
|
Debt Instrument [Line Items] |
|
Maximum Debt to ARR Ratio |
0.80%
|
October 31, 2022 [Member] | Maximum [Member] |
|
Debt Instrument [Line Items] |
|
Maximum Debt to ARR Ratio |
1.00%
|
January 31, 2023 [Member] | Minimum [Member] |
|
Debt Instrument [Line Items] |
|
Maximum Debt to ARR Ratio |
0.70%
|
January 31, 2023 [Member] | Maximum [Member] |
|
Debt Instrument [Line Items] |
|
Maximum Debt to ARR Ratio |
1.00%
|
April 30, 2023 [Member] | Minimum [Member] |
|
Debt Instrument [Line Items] |
|
Maximum Debt to ARR Ratio |
0.65%
|
April 30, 2023 [Member] | Maximum [Member] |
|
Debt Instrument [Line Items] |
|
Maximum Debt to ARR Ratio |
1.00%
|
July 31, 2023 [Member] | Minimum [Member] |
|
Debt Instrument [Line Items] |
|
Maximum Debt to ARR Ratio |
0.60%
|
July 31, 2023 [Member] | Maximum [Member] |
|
Debt Instrument [Line Items] |
|
Maximum Debt to ARR Ratio |
1.00%
|
October 31, 2023 [Member] | Minimum [Member] |
|
Debt Instrument [Line Items] |
|
Maximum Debt to ARR Ratio |
0.55%
|
October 31, 2023 [Member] | Maximum [Member] |
|
Debt Instrument [Line Items] |
|
Maximum Debt to ARR Ratio |
1.00%
|
January 31, 2024 [Member] | Minimum [Member] |
|
Debt Instrument [Line Items] |
|
Maximum Debt to ARR Ratio |
0.50%
|
January 31, 2024 [Member] | Maximum [Member] |
|
Debt Instrument [Line Items] |
|
Maximum Debt to ARR Ratio |
1.00%
|
X |
- DefinitionMaximum Debt to ARR Ratio.
+ References
+ Details
Name: |
STRM_MaximumDebtToArrRatio |
Namespace Prefix: |
STRM_ |
Data Type: |
dtr-types:percentItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionLine items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 835 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1
Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(f)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-04(a)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1B -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B
Reference 5: http://www.xbrl.org/2003/role/exampleRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 69B -Publisher FASB -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B
Reference 6: http://www.xbrl.org/2003/role/exampleRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 69C -Publisher FASB -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C
Reference 7: http://www.xbrl.org/2003/role/exampleRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 69E -Publisher FASB -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E
Reference 8: http://www.xbrl.org/2003/role/exampleRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 69F -Publisher FASB -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1B -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1B -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B
Reference 11: http://www.xbrl.org/2003/role/exampleRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1B -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B
Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1B -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B
Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1B -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B
Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1B -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B
Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1D -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D
Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1D -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D
Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1D -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D
Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1E -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E
Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1E -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E
Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1E -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E
Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1F -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F
Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1F -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F
Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1F -Subparagraph (b)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F
Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1F -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F
Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1I -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I
+ Details
Name: |
us-gaap_DebtInstrumentLineItems |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Details
Name: |
srt_StatementScenarioAxis=STRM_OctoberThirtyOneTwoThousandAndTwentyTwoMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
srt_RangeAxis=srt_MinimumMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
srt_RangeAxis=srt_MaximumMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
srt_StatementScenarioAxis=STRM_JanuaryThirtyOneTwoThousandTwentyThreeMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
srt_StatementScenarioAxis=STRM_AprilThirtyTwoThousandTwentyThreeMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
srt_StatementScenarioAxis=STRM_JulyThirtyOneTwoThousandTwentyThreeMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
srt_StatementScenarioAxis=STRM_OctoberThirtyOneTwoThousandTwentyThreeMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
srt_StatementScenarioAxis=STRM_JanuaryThirtyOneTwoThousandTwentyFourMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
v3.23.3
X |
- DefinitionMaximum Debt to Adjusted EBITDA Ratio.
+ References
+ Details
Name: |
STRM_MaximumDebtToAdjustedEbitdaRatio |
Namespace Prefix: |
STRM_ |
Data Type: |
dtr-types:percentItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionLine items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 835 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1
Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(f)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-04(a)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1B -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B
Reference 5: http://www.xbrl.org/2003/role/exampleRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 69B -Publisher FASB -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B
Reference 6: http://www.xbrl.org/2003/role/exampleRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 69C -Publisher FASB -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C
Reference 7: http://www.xbrl.org/2003/role/exampleRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 69E -Publisher FASB -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E
Reference 8: http://www.xbrl.org/2003/role/exampleRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 69F -Publisher FASB -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1B -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1B -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B
Reference 11: http://www.xbrl.org/2003/role/exampleRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1B -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B
Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1B -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B
Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1B -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B
Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1B -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B
Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1D -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D
Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1D -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D
Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1D -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D
Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1E -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E
Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1E -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E
Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1E -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E
Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1F -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F
Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1F -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F
Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1F -Subparagraph (b)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F
Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1F -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F
Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1I -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I
+ Details
Name: |
us-gaap_DebtInstrumentLineItems |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Details
Name: |
srt_StatementScenarioAxis=STRM_AprilThirtyTwoThousandTwentyFourMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
srt_RangeAxis=srt_MaximumMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
srt_RangeAxis=srt_MinimumMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
srt_StatementScenarioAxis=STRM_JulyThirtyOneTwoThousandTwentyFourAndThereafterMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
v3.23.3
DEBT (Details Narrative) - USD ($)
|
Nov. 29, 2022 |
Aug. 26, 2021 |
Oct. 31, 2023 |
Jan. 31, 2023 |
Debt Instrument [Line Items] |
|
|
|
|
Debt instrument, interest rate, stated percentage |
|
|
0.50%
|
|
Line of credit |
|
|
$ 500,000
|
|
Second Modification Agreement [Member] |
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
Line of credit facility, maximum borrowing capacity |
$ 2,000,000
|
|
|
|
Debt financial covenants, description |
Borrowers shall, at all times, maintain unrestricted cash of Borrowers at Bank in an amount not less than Two Million
Dollars ($2,000,000).
|
|
|
|
Second Modification Agreement [Member] | Base Rate [Member] |
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
Debt instrument, basis spread on variable rate |
1.50%
|
|
|
|
Debt instrument, interest rate, stated percentage |
3.25%
|
|
|
|
Second Amended And Restated Loan Agreement [Member] |
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
Principal amount |
$ 10,000,000
|
|
|
|
Long term debt, maturity, year two |
|
$ 500,000
|
|
|
Long term debt, maturity, year three |
|
1,000,000
|
|
|
Long term debt, maturity, year four |
|
2,000,000
|
|
|
Long term debt, maturity, year five |
|
3,000,000
|
|
|
Amortization of debt issuance costs |
|
250,000
|
|
|
Accretion expense |
|
$ 250,000
|
|
|
Second Amended And Restated Loan Agreement [Member] | Maximum [Member] |
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
Fixed charge coverage ratio |
|
|
1.20%
|
|
Second Amended And Restated Loan Agreement [Member] | Minimum [Member] |
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
Fixed charge coverage ratio |
|
|
1.00%
|
|
Second Amended And Restated Loan Agreement [Member] | Base Rate [Member] |
|
|
|
|
Debt Instrument [Line Items] |
|
|
|
|
Debt instrument, basis spread on variable rate |
1.50%
|
|
|
|
Debt instrument, interest rate, stated percentage |
3.25%
|
|
|
|
X |
- DefinitionFixed charge coverage ratio.
+ References
+ Details
Name: |
STRM_FixedChargeCoverageRatio |
Namespace Prefix: |
STRM_ |
Data Type: |
dtr-types:percentItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionAmount recognized for the passage of time, typically for liabilities, that have been discounted to their net present values. Excludes accretion associated with asset retirement obligations.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section 35 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481639/420-10-35-4
Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 420 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1
+ Details
Name: |
us-gaap_AccretionExpense |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionAmount of amortization expense attributable to debt issuance costs.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1F -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F
Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 835 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3
Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(8)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2
+ Details
Name: |
us-gaap_AmortizationOfFinancingCosts |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionPercentage points added to the reference rate to compute the variable rate on the debt instrument.
+ References
+ Details
Name: |
us-gaap_DebtInstrumentBasisSpreadOnVariableRate1 |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:percentItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionDescription of minimum financial levels (for example, tangible net worth and working capital) and achievement of certain financial ratios (for example, working capital ratio and debt service coverage ratio), and adherence to certain clauses which generally require or restrict certain actions (for example, entering into a debt arrangement with equal or greater seniority, and selling or discontinuing a certain business segment or material subsidiary) to be in compliance with the covenant clauses of the debt agreement. May also include a discussion of the adverse consequences that would result if the entity violates or fails to satisfy the covenants.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(22)) -SubTopic 10 -Topic 210 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 942 -SubTopic 470 -Section 50 -Paragraph 3 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480848/942-470-50-3
+ Details
Name: |
us-gaap_DebtInstrumentCovenantDescription |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionFace (par) amount of debt instrument at time of issuance.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 835 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1B -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B
Reference 3: http://www.xbrl.org/2003/role/exampleRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 69B -Publisher FASB -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B
Reference 4: http://www.xbrl.org/2003/role/exampleRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 69C -Publisher FASB -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C
Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 835 -SubTopic 30 -Section 45 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2
Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 835 -SubTopic 30 -Section 55 -Paragraph 8 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8
+ Details
Name: |
us-gaap_DebtInstrumentFaceAmount |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionContractual interest rate for funds borrowed, under the debt agreement.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1B -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.22(a)(1)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_DebtInstrumentInterestRateStatedPercentage |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:percentItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionLine items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 835 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1
Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(f)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-04(a)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1B -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B
Reference 5: http://www.xbrl.org/2003/role/exampleRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 69B -Publisher FASB -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B
Reference 6: http://www.xbrl.org/2003/role/exampleRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 69C -Publisher FASB -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C
Reference 7: http://www.xbrl.org/2003/role/exampleRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 69E -Publisher FASB -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E
Reference 8: http://www.xbrl.org/2003/role/exampleRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 69F -Publisher FASB -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F
Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1B -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B
Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1B -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B
Reference 11: http://www.xbrl.org/2003/role/exampleRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1B -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B
Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1B -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B
Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1B -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B
Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1B -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B
Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1D -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D
Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1D -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D
Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1D -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D
Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1E -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E
Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1E -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E
Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1E -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E
Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1F -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F
Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1F -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F
Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1F -Subparagraph (b)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F
Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1F -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F
Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1I -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I
+ Details
Name: |
us-gaap_DebtInstrumentLineItems |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionMaximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(b),22(b)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-04(a)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1E -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 1 -SubTopic 10 -Topic 470 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1
+ Details
Name: |
us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-04(a)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1E -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 1 -SubTopic 10 -Topic 470 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1
+ Details
Name: |
us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-04(a)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1E -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 1 -SubTopic 10 -Topic 470 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1
+ Details
Name: |
us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-04(a)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 470 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1E -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 1 -SubTopic 10 -Topic 470 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1
+ Details
Name: |
us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionThe carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.22) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section 45 -Paragraph 13 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481573/470-10-45-13
Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section 45 -Paragraph 14 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481573/470-10-45-14
+ Details
Name: |
us-gaap_LongTermLineOfCredit |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- Details
Name: |
us-gaap_TypeOfArrangementAxis=STRM_SecondModificationAgreementMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_VariableRateAxis=us-gaap_BaseRateMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_TypeOfArrangementAxis=STRM_SecondAmendedAndRestatedLoanAgreementMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
srt_RangeAxis=srt_MaximumMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
srt_RangeAxis=srt_MinimumMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
v3.23.3
INCOME TAXES (Details Narrative) - USD ($)
|
3 Months Ended |
9 Months Ended |
|
Oct. 31, 2023 |
Oct. 31, 2022 |
Oct. 31, 2023 |
Oct. 31, 2022 |
Jan. 31, 2023 |
Income Tax Disclosure [Abstract] |
|
|
|
|
|
Income Tax Expense (Benefit) |
$ 120,000
|
$ (9,000)
|
$ 59,000
|
$ (22,000)
|
|
Income Tax Expense (Benefit) |
(120,000)
|
$ 9,000
|
$ (59,000)
|
$ 22,000
|
|
Effective Income Tax Rate Reconciliation, Percent |
|
|
0.00%
|
|
|
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
|
|
25.00%
|
|
|
Uncertain tax positions |
$ 340,000
|
|
$ 340,000
|
|
$ 333,000
|
Income tax description |
|
|
The
Company and its subsidiaries are subject to U.S. federal income tax as well as income taxes in multiple state and local jurisdictions.
The Company has concluded all U.S. federal tax matters for years through January 31, 2019. All material state and local income tax matters
have been concluded for years through January 31, 2018. The Company is no longer subject to IRS examination for periods prior to the
tax year ended January 31, 2019; however, carryforward losses that were generated prior to the tax year ended January 31, 2019 may still
be adjusted by the IRS if they are used in a future period.
|
|
|
X |
- DefinitionAmount of unrecognized tax benefits.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 15A -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 10B -Publisher FASB -URI https://asc.fasb.org//1943274/2147482525/740-10-45-10B
+ Details
Name: |
us-gaap_UnrecognizedTaxBenefits |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
v3.23.3
EQUITY (Details Narrative) - USD ($)
|
|
|
9 Months Ended |
|
|
|
|
Jun. 15, 2023 |
Oct. 24, 2022 |
Oct. 31, 2023 |
Oct. 31, 2022 |
Jun. 28, 2023 |
Jan. 31, 2023 |
Jun. 22, 2022 |
Jun. 07, 2022 |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |
|
|
|
|
|
|
|
|
Common stock par value |
|
|
$ 0.01
|
|
|
$ 0.01
|
|
|
Proceeds from issuance of common stock |
|
|
|
$ 8,316,000
|
|
|
|
|
Number of additional shares authorized to issue |
1,000,000
|
|
|
|
|
|
|
|
Common stock, shares authorized |
|
|
85,000,000
|
|
|
85,000,000
|
|
65,000,000
|
180 Consulting LLC [Member] |
|
|
|
|
|
|
|
|
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |
|
|
|
|
|
|
|
|
Common stock issued for resale |
|
|
|
|
394,127
|
|
272,653
|
|
Third Amended And Restated 2013 Stock Incentive Plan [Member] |
|
|
|
|
|
|
|
|
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |
|
|
|
|
|
|
|
|
Number of additional shares authorized to issue |
|
|
2,000,000
|
|
|
|
|
|
Number of shares authorized to issue |
10,223,246
|
|
|
|
|
|
|
8,223,246
|
Third Amended And Restated 2013 Stock Incentive Plan [Member] | Maximum [Member] |
|
|
|
|
|
|
|
|
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |
|
|
|
|
|
|
|
|
Number of shares authorized to issue |
11,223,246
|
|
10,223,246
|
|
|
|
|
|
Purchase Agreement [Member] | 2022 Offering [Member] |
|
|
|
|
|
|
|
|
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |
|
|
|
|
|
|
|
|
Number of shares issued |
|
6,299,989
|
|
|
|
|
|
|
Common stock par value |
|
$ 0.01
|
|
|
|
|
|
|
Purchase price |
|
$ 1.32
|
|
|
|
|
|
|
Proceeds from issuance of common stock |
|
$ 8,316,000
|
|
|
|
|
|
|
X |
- DefinitionLine items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 808 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479402/808-10-50-1
+ Details
Name: |
us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAggregate number of common shares reserved for future issuance.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_CommonStockCapitalSharesReservedForFutureIssuance |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionFace amount or stated value per share of common stock.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_CommonStockParOrStatedValuePerShare |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:perShareItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionThe maximum number of common shares permitted to be issued by an entity's charter and bylaws.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(16)(a)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_CommonStockSharesAuthorized |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionThe cash inflow from the additional capital contribution to the entity.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 14 -Subparagraph (a) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14
+ Details
Name: |
us-gaap_ProceedsFromIssuanceOfCommonStock |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionNumber of additional shares authorized for issuance under share-based payment arrangement.
+ References
+ Details
Name: |
us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionNumber of shares authorized for issuance under share-based payment arrangement.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(3) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2
+ Details
Name: |
us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionPer share or per unit amount of equity securities issued.
+ References
+ Details
Name: |
us-gaap_SharesIssuedPricePerShare |
Namespace Prefix: |
us-gaap_ |
Data Type: |
dtr-types:perShareItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionNumber of new stock issued during the period.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(4)(b)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(i)(1)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3
Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1
Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
+ Details
Name: |
us-gaap_StockIssuedDuringPeriodSharesNewIssues |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Details
Name: |
us-gaap_PlanNameAxis=STRM_ThirdAmendedAndRestatedTwoThousandThirteenStockIncentivePlanMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
srt_RangeAxis=srt_MaximumMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_TypeOfArrangementAxis=STRM_PurchaseAgreementMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_PlanNameAxis=STRM_TwoThousandTwentyTwoOfferingMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
v3.23.3
COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)
|
1 Months Ended |
3 Months Ended |
9 Months Ended |
Oct. 31, 2023 |
Oct. 31, 2023 |
Oct. 31, 2022 |
Oct. 31, 2023 |
Oct. 31, 2022 |
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |
|
|
|
|
|
Non employee stock compensation |
|
|
|
$ 1,626,000
|
$ 1,212,000
|
Master Services Agreement [Member] | 180 Consulting LLC [Member] |
|
|
|
|
|
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |
|
|
|
|
|
Stock issued during period, shares, issued for services |
1,273,394
|
100,037
|
183,284
|
358,190
|
293,190
|
Professional fees |
|
$ 639,000
|
$ 751,000
|
$ 2,558,000
|
$ 1,781,000
|
Master Services Agreement [Member] | 180 Consulting LLC [Member] | Share-Based Payment Arrangement, Nonemployee [Member] |
|
|
|
|
|
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |
|
|
|
|
|
Non employee stock compensation |
|
60,000
|
|
176,000
|
|
SOW [Member] | 180 Consulting LLC [Member] |
|
|
|
|
|
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |
|
|
|
|
|
Professional fees |
|
$ 87,000
|
|
$ 468,000
|
|
X |
- DefinitionLine items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 808 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479402/808-10-50-1
+ Details
Name: |
us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionA fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10
Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section 45 -Paragraph 3 -Subparagraph (k) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3
Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-07(2)(b)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1
+ Details
Name: |
us-gaap_ProfessionalFees |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionAmount of noncash expense for share-based payment arrangement.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Subparagraph (a) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28
+ Details
Name: |
us-gaap_ShareBasedCompensation |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionNumber of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.
+ References
+ Details
Name: |
us-gaap_StockIssuedDuringPeriodSharesIssuedForServices |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:sharesItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Details
Name: |
us-gaap_TypeOfArrangementAxis=STRM_MasterServicesAgreementMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
dei_LegalEntityAxis=STRM_OneHundredEightyConsultingLLCMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementNonemployeeMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_TypeOfArrangementAxis=STRM_SOWMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
v3.23.3
SCHEDULE OF CARRYING AMOUNT OF GOODWILL (Details) - USD ($)
|
3 Months Ended |
9 Months Ended |
Oct. 31, 2023 |
Oct. 31, 2022 |
Oct. 31, 2023 |
Oct. 31, 2022 |
Goodwill and Intangible Assets Disclosure [Abstract] |
|
|
|
|
Beginning Balance |
|
|
$ 23,089,000
|
|
Impairment |
$ (9,813,000)
|
|
(9,813,000)
|
|
Ending Balance |
$ 13,276,000
|
|
$ 13,276,000
|
|
X |
- DefinitionAmount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10
Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 24 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(15)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1
Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1
Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1
Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 942 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(10)(1)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1
+ Details
Name: |
us-gaap_Goodwill |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- References
+ Details
Name: |
us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAmount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Subparagraph (b) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28
Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 24 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482573/350-20-50-2
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 45 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482598/350-20-45-2
+ Details
Name: |
us-gaap_GoodwillImpairmentLoss |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
v3.23.3
SCHEDULE OF FINITE-LIVED INTANGIBLE ASSETS (Details) - USD ($)
|
9 Months Ended |
|
Oct. 31, 2023 |
Jan. 31, 2023 |
Finite-Lived Intangible Assets [Line Items] |
|
|
Gross Assets |
$ 17,420,000
|
|
Accumulated Amortization |
3,978,000
|
$ 2,627,000
|
Impairment |
963,000
|
|
Net Assets |
12,479,000
|
|
Client Relationships [Member] |
|
|
Finite-Lived Intangible Assets [Line Items] |
|
|
Gross Assets |
9,700,000
|
|
Accumulated Amortization |
2,216,000
|
|
Impairment |
963,000
|
|
Net Assets |
$ 6,521,000
|
|
Client Relationships [Member] | Minimum [Member] |
|
|
Finite-Lived Intangible Assets [Line Items] |
|
|
Estimated Useful Life |
8 years
|
|
Client Relationships [Member] | Maximum [Member] |
|
|
Finite-Lived Intangible Assets [Line Items] |
|
|
Estimated Useful Life |
10 years
|
|
Internally Developed Software [Member] |
|
|
Finite-Lived Intangible Assets [Line Items] |
|
|
Estimated Useful Life |
9 years
|
|
Gross Assets |
$ 6,380,000
|
|
Accumulated Amortization |
1,565,000
|
|
Impairment |
|
|
Net Assets |
$ 4,815,000
|
|
Trademarks and Trade Names [Member] |
|
|
Finite-Lived Intangible Assets [Line Items] |
|
|
Estimated Useful Life |
15 years
|
|
Gross Assets |
$ 1,340,000
|
|
Accumulated Amortization |
197,000
|
|
Impairment |
|
|
Net Assets |
$ 1,143,000
|
|
X |
- DefinitionUseful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
+ Details
Name: |
us-gaap_FiniteLivedIntangibleAssetUsefulLife |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:durationItemType |
Balance Type: |
na |
Period Type: |
instant |
|
X |
- DefinitionAccumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(16)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1
Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2
+ Details
Name: |
us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
instant |
|
X |
- DefinitionAmount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 928 -SubTopic 340 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483147/928-340-50-1
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2
+ Details
Name: |
us-gaap_FiniteLivedIntangibleAssetsGross |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionLine items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 926 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5
+ Details
Name: |
us-gaap_FiniteLivedIntangibleAssetsLineItems |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAmount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 926 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5
Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2
+ Details
Name: |
us-gaap_FiniteLivedIntangibleAssetsNet |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
instant |
|
X |
- DefinitionThe amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28
Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482665/350-30-50-3
+ Details
Name: |
us-gaap_ImpairmentOfIntangibleAssetsFinitelived |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- Details
Name: |
us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=STRM_ClientRelationshipsMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
srt_RangeAxis=srt_MinimumMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
srt_RangeAxis=srt_MaximumMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=STRM_InternallyDevelopedSoftwareMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
X |
- Details
Name: |
us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
v3.23.3
GOODWILL AND INTANGIBLE ASSETS (Details Narrative) - USD ($)
|
3 Months Ended |
9 Months Ended |
Oct. 31, 2023 |
Oct. 31, 2022 |
Oct. 31, 2023 |
Oct. 31, 2022 |
Finite-Lived Intangible Assets [Line Items] |
|
|
|
|
Iimpairment of goodwill |
$ 9,813,000
|
|
$ 9,813,000
|
|
Impairment of intangible assets |
|
|
963,000
|
|
Customer Relationships [Member] |
|
|
|
|
Finite-Lived Intangible Assets [Line Items] |
|
|
|
|
Impairment of intangible assets |
|
|
$ 963,000
|
|
X |
- DefinitionLine items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 926 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5
+ Details
Name: |
us-gaap_FiniteLivedIntangibleAssetsLineItems |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:stringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAmount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Subparagraph (b) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28
Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 55 -Paragraph 24 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24
Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1
Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482573/350-20-50-2
Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Section 45 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482598/350-20-45-2
+ Details
Name: |
us-gaap_GoodwillImpairmentLoss |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- DefinitionThe amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.
+ ReferencesReference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 28 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28
Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482665/350-30-50-3
+ Details
Name: |
us-gaap_ImpairmentOfIntangibleAssetsFinitelived |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
debit |
Period Type: |
duration |
|
X |
- Details
Name: |
us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember |
Namespace Prefix: |
|
Data Type: |
na |
Balance Type: |
|
Period Type: |
|
|
v3.23.3
X |
- DefinitionCash payments to lessor's for use of assets under operating leases.
+ ReferencesReference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 25 -Subparagraph (g) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25
+ Details
Name: |
us-gaap_PaymentsForRent |
Namespace Prefix: |
us-gaap_ |
Data Type: |
xbrli:monetaryItemType |
Balance Type: |
credit |
Period Type: |
duration |
|
Streamline Health Soluti... (NASDAQ:STRM)
Historical Stock Chart
From Sep 2024 to Oct 2024
Streamline Health Soluti... (NASDAQ:STRM)
Historical Stock Chart
From Oct 2023 to Oct 2024